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Abstract
The present work presents a series of studies investigating neuropsychological aspects of
visual hallucinations (VHs) in Parkinson's Disease (PD) and high proneness to VHs in
the normal population. The aim of the thesis is to investigate whether the same risk
factors are implicated in both hallucinating PD patients and in high-prone individuals
from the normal population, i.e. the continuum hypothesis of VHs. To this end, new
instruments were designed to assess the nature of VHs in PD and to differentiate among ,
high and low hallucination-prone individuals. PD patients with and without VHs, age-
matched normal controls, and high and low-prone normal young individuals are assessed
on visual memory and executive tests from the CANTAB test battery, alongside tests
examining personality factors, sleep patterns, and demographic factors. The findings
suggest that VHs in PD and hallucination-proneness in the normal population are both
associated with a combination of different factors, particularly aspects of visual
processing and sleep patterns. Results from the five studies are interpreted with the
multifactorial models of VHs, suggesting that both VHs in PD and hallucination-
proneness in the normal population stem from concurrent neuropsychological
dysfunctions of several processing systems. However, a specific personality profile is
predictive of high hallucination-proneness in the normal population, but not in PD
patients. Therefore, two different models are proposed, arguing for similar, but not
identical set of risk factors in hallucinating PD patients and in high-prone normal
individuals.
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Chapter 1: Research Background
1.1 Parkinson's Disease: Background, Clinical Features and Neuropathology
James Parkinson (1755 - 1824) was a physician, social reformer and (as a hobby) a
geologist and palaeontologist. But it was "An Essay on the Shaking Palsy" (1817)
that brought him immortality. In the essay he describes "paralysis agitans"
(meaning "shaking palsy"), a condition that would later be named after him.
Parkinson's disease (also known as Parkinson Disease or PD) is the most common
neurodegenerative disease after Alzheimer's disease (Schapira, 2004). It is largely a
disease of the elderly: the prevalence increases with age from approximately 0.6%
in 65-69 years-olds to 3-4% in 80-84 years-olds, with a slight male predominance
(de Rijk et al., 1997; Twelves, Perkins, & Counsell, 2003).
Clinically, PD is characterized by tremor, muscle rigidity, postural instability,
slowing of physical movement (bradykinesia) and sometimes a complete loss of
physical movement (akinesia) (Jankovic, 2008; Serrano & Garcia-Borreguero,
2004). Neuropathologically, PD is characterized by the loss of dopaminergic
neurons I originating from the substantia nigra, and by a prominence of atypical
protein aggregates (so-called Lewy bodies) inside neurons of the substantia nigra,
locus coeruleus and raphe nucleus (Dauer & Przedborski, 2003). It is estimated that
60% - 80% of the dopaminergic neurons in the substantia nigra are lost before
motor symptoms of PD manifest (ibid). This means that the neurodegenerative
process is already present for a number of years before the first symptoms become
apparent (Scholtissen, Verhey, Steinbusch, & Leentjens, 2006).
There are eight dopaminergic pathways, but the three major ones implicated in
PD are the nigrostriatal, the mesocortical and the mesolimbic pathway (see Figure
1.1).
I Dopaminergic neurons are neurons whose primary neurotransmitter is dopamine, a hormone and
neurotransmitter involved in modulation of motor activity, cognition, motivation, reward, sleep,
mood, attention and learning.
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Figure 1.1. Sagittal view showing the main dopaminergic pathways.
The nigrostriatal dopaminergic pathway originates in neurons of the substantia
nigra and projects to the striatum (i.e., the caudate nucleus and putamen) (Schapira,
2004). This pathway is involved in modulating smooth and coordinated movement
(Contreras-Vidal & Stelmach, 1995, 1996).
The mesocortical and mesolimbic pathways originate from the midbrain
ventral tegmental area neurons and target the nucleus accumbens, the limbic
system, the hippocampus, and the prefrontal cortex (Chaudhuri, Martinez-Martin et
al., 2006). These systems modulate a range of non-motor, mainly cognitive and
emotive functions, such as reward, the psychomotor effects associated with drugs,
and working memory (Chaudhuri, Healy, & Schapira, 2006; Chaudhuri, Martinez-
Martin et al., 2006). Additionally, this system is associated with the ascending
reticular activating system, which contributes to sleep during night and arousal
during the day (Schapira, 2004).
In summary, the early dominant motor features of PD are traditionally related
to dopaminergic cell death. However, the neurodegeneration extends well beyond
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dopaminergic neurons even in the early stages of PD (Collerton, Perry, & McKeith,
2005; Dauer & Przedborski, 2003; Hornykiewicz & Kish, 1987). Involvement of
non-dopaminergic systems result in a variety of clinical features, such as visual
hallucinations, cognitive disturbances (executive, visuospatial, and memory
dysfunctions), depression, autonomic abnormalities, sleep disorders, fatigue,
blurred vision and weight loss or gain (Fenelon, Mahieux, Huon, & Ziegler, 2000).
Indeed, the symptoms that are not traditionally related to the dopaminergic system
frequently occur before the diagnosis is made and can be more prominent than the
motor signs of PD (Mosimann et al., 2006). Non-motor signs of PD also add to the
severity of illness, reduced life satisfaction, and shorten life expectancy (Inzelberg,
Kipervasser, & Korczyn, 1998). Therefore, it is not surprising that the number of
studies on the non-motor signs of PD has increased in recent years.
1.2 Phenomenology of VHs in PD
One of the most common non-motor signs of PD are visual hallucinations (VHs),
occurring in approximately 30% of patients with PD (Bronnick, Aarsland, &
Larsen, 2005; de Maindreville, Fenelon, & Mahieux, 2005; Fenelon et al., 2000;
Gupta, Singh, Khwaja, & Mehndiratta, 2004; Holroyd, Currie, & Wooten, 2001).
According to the Diagnostic and Statistical Manual of Mental Disorders
(DSM-IV, 1994) a hallucination is "a sensory perception that has the compelling
sense of reality of a true perception but that occurs without external stimulation of
the relevant sensory organ" (p.767). Hallucinations are distinguished from illusions,
which are misperception or misinterpretation of an actual external stimulus (ibid).
VHs in PD comply with the DSM-IV definition; they are recurring spontaneous
images of people, animals, or objects and are experienced as real (Barnes & David,
2001).
Fenelon et al. (2000) proposed three categories of hallucinations in PD: minor
forms (a feeling of a "presence" of another being, or someone "passing-by"),
formed (complex) VHs and auditory hallucinations. However, both auditory and
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simple hallucinations of flashes, dots, or grids are rare and in fact suggest a
differential diagnosis, independent of PO (Bodis-Wollner, 2003; Fenelon et al.,
2000; Inzelberg et al., 1998; Mosimann et al., 2006).
The phenomenology of VHs in PO has been examined in detail in small
number of studies (Barnes & David, 2001; Fenelon et al., 2000; Holroyd et al.,
2001). However, understanding the phenomenology of VHs has important
implications on the current recognition of the underlying brain structures that might
be implicated in the process of experiencing VHs (see Section 1.4). Therefore,
detailed studies are warranted, especially due to the difficulties in examining the
brain of the hallucinating PD patients with the use of neuroimaging and
electrophysiological techniques.
VHs in PD are usually described as vivid, well-formed, stereotyped and
repetitive images of relatives, friends, and unknown people, but also of animals and
objects (Barnes & David, 2001; Fenelon et al., 2000; Gupta et al., 2004; Haeske-
Dewick, 1995; Holroyd et al., 2001). The same image is often repeated, usually in
the same surrounding (Barnes & David, 2001); however, over time, many patients
report experiencing a range of hallucinatory images (Fenelon et al., 2000).
Similarly, the content is often ordinary, but it can range to the bizarre (e.g.,
unusually large body parts, half of a body part joined with furniture, images coming
from a ceiling and disappearing into the floor, etc.). The images frequently move
(Barnes & David, 2001), although the movement is often stereotyped and restricted
(either little movement or doing the same gesture or set of moves repeatedly over
time). Hallucinations are usually normal-sized, but they can also be unusually small
(Holroyd et al., 2001). They can appear either black and white, in monochrome or
in multiple colours (Bames & David, 2001).
Temporal aspects of VHs have revealed the importance of the sleep
generating brain functions in the occurrence of VHs in PD (see Section 1.4). Most
commonly, patients experience VHs on a weekly basis: daily or monthly intervals
of occurrence are rare (Barnes & David, 2001). Images usually appear for a few
minutes (images that last for seconds or hours are rare), but the duration can vary
according to the time of day, with longer occurrences either in the morning or in the
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evening (Barnes & David, 2001; Inzelberg et al., 1998). Hallucinations are most
likely to appear when the patient is drowsy or when the ambient light is dim (Goetz,
Vogel, Tanner, & Stebbins, 1998; Inzelberg et al., 1998). However, images are also
experienced in an alert state and most patients have their eyes open when the
images appear (Barnes & David, 2001; Kulisevsky & Roldan, 2004). Both onset
and offset are usually abrupt with no apparent trigger or voluntary effort
(Kulisevsky & Roldan, 2004).
Once developed, VHs persist and can lose their benign, non-threatening
character (Goetz, Leurgans, Pappert, Raman, & Sterner, 2001); patients with
dementia may especially lose their ability to identify the images as unreal
(Inzelberg et al., 1998). Fenelon et al. (2000) reported that insight was maintained
in all their patients without dementia and in 64% of the patients with dementia.
However, even patients without dementia who reported that they were aware of the
unreality of their visions admitted that they occasionally spoke to the images
because they looked real (ibid). The studies investigating VHs in PD patients with
dementia can be extremely valuable in predicting the development of the illness;
however, the results need to be addressed with care, because neurodegeneration is
extensive in dementia and the diagnosis of PD could be incorrect. Consequently, the
overall understanding of the phenomenon of VHs can be blurred.
In summary, VHs in PD are usually ordinary, stereotyped and non-threatening
images of people and animals. After the first disturbing or astonishing experiences,
patients usually become familiar with their presence and describe them as
unpleasant but not upsetting (Barnes & David, 2001; Diederich, Goetz, & Stebbins,
2005; Fenelon et al., 2000). Emotional responses rarely include frustration, anger or
fear (Barnes & David, 2001). The non-threatening nature of VHs and the preserved
insight into the hallucinatory nature of their VHs are probably the main two reasons
why PD patients do not spontaneously speak about VHs. Furthermore, patients
often reason that reporting VHs will make people think they are "going mad" and
might therefore be sent to a nursing home (Barnes & David, 2001). Similarly,
patients do not want to upset their friends and carers. Mosimann et al. (2006)
reported that 16% of the caregivers in their study were unaware of patients'
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hallucinations. The nature of VHs in PD has immediate treatment implications,
because it suggests that hallucinating PO patients as well as their carers would
greatly benefit from the cognitive treatment with reassurance and acceptance.
Patients' self-awareness and shame are therefore the main reasons why VHs
in PD have been long underreported. Additionally, the presence of VHs is difficult
to ascertain in cases of severe dementia, when patients report about their VHs more
freely but also lose the insight into of the unreality of the images (Fenelon et al.,
2000; Inzelberg et al., 1998). Taking these motives into account it is now estimated
that approximately one third of patients with PD have at least a transient experience
of VHs in the course of their illness (Aarsland et al., 1999; Bronnick et al., 2005; de
Maindreville et al., 2005; Fenelon et al., 2000; Gupta et al., 2004; Haeske-Dewick,
1995; Holroyd et al., 2001).
Several issues need to be addressed when conducting the studies with PD
participants. Firstly, the sample sizes are usually relatively low. This is because of
the relative rarity of the condition and the specific care that needs to be taken when
working with this fragile population (the duration of tasks, medication variations
throughout the day, etc.). Therefore, with the exception of Fenelon et al. 's (2000)
86 hallucinating PD patients, the studies operate with data of up to 30 participants.
Small sample sizes have implications on the further analyses and caution needs to
be taken when interpreting the results. Again, due to small sample sizes specific
characteristics of VHs are expressed descriptively (e.g., often, rarely, the majority,
etc.) rather than in exact numbers or percentages. Secondly, manifestation of PD
varies greatly across patients (Paulson & Stern, 1996). Therefore, specific
characteristics (e.g., age, dosage of dopaminergic and other medication, the duration
of illness, side that is more affected by tremor, etc.) need to be taken into account
when comparing PD patients. However, many studies do not report these
characteristics, and while the issue of the small sample sizes is difficult to
overcome, it is imperative that future studies are designed with greater care, taking
possible independent variables into consideration and making the samples as
homogenous as possible. Finally, with few exceptions (Barnes & David, 2001;
Fenelon et al., 2000) the presented studies have investigated the area of VHs using
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only quantitative methodologies. However, the phenomenology of VHs in PD is
under-researched and greater attention needs to be directed towards qualitative
descriptions of the phenomena. Similarly, except for one attempt (Diederich, Pieri,
& Goetz, 2003) no studies have addressed how PD patients cope with their VHs
behaviourally. Therefore, qualitative descriptions could give an insight into which
strategies are most efficient in ending VHs and could easily be applied in the
cognitive-behavioural strategies for PD patients with VHs.
1.3 Role of Neurotransmitter Systems and Treatment of VHs in PD
One of the most common explanations for VHs in PD is that they are simply a side-
effect of dopaminergic treatment; i.e., that higher dosages of dopaminergic
medication directly affect a higher incidence of VHs (Factor, Molho, Podskalny, &
Brown, 1995; Fenelon et al., 2000; Inzelberg et al., 1998; Korczyn, 2001). There is
a growing body of evidence, however, that suggests there is no simple association
between VHs and the dose of dopaminergic antiparkinsonian medications2•
Similarly, no association has been found between VHs and the length of levodopa'
administration (Diederich et aI., 1998; Holroyd et al., 2001).
The controversial issue of the involvement of dopaminergic medication in the
occurrence of VHs could be resolved in two ways: either by examining the
literature on hallucinations in PD in the "pre-Ievodopa" era" or by examining PD
patients who are not taking any dopaminergic medication. Both approaches give
little insight since there are very few published reports on VHs in PD before 1967
(Fenelon, Goetz, & Karenberg, 2006). Similarly, very few PD patients receive no
2 (Aarsland et al., 1999; Barnes & David, 2001; Diederich et al., 1998; Goetz, Wuu, Curgian, &
Leurgans, 2006; Graham, Grunewald, & Sagar, 1997; Haeske-Dewick, 1995; Holroyd et al., 2001;
Kulisevsky & Roldan, 2004; Merims et al., 2004; Sanchez-Ramos, Ortoll, & Paulson, 1996;
Santangelo et al., 2007).
3 Levodopa is the most common dopaminergic treatment for motor symptoms of PD; it was first
introduced in 1967 (Cotzias, Van Woert, & Schiffer, 1967) and has since then been the most
common neuropharmacological treatment for PD.
4 For a detailed review refer to Fenelon et al (2006).
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dopaminergic medication for their illness (in fact, among other criteria, a diagnosis
of PD is based on positive responses to the dopaminergic medication and is
therefore one of the first treatment options when the signs of parkinsonism occur).
Still, several authors report on PD patients who receive no dopaminergic treatment
but have vivid VHs (Berrios, 1995; Fenelon et al., 2006; Fenelon et al., 2000;
Holroyd et al., 2001). Furthermore, several authors (Fenelon et al., 2000; Goetz,
Pappert et al., 1998; Holroyd et al., 2001; Korczyn, 2001; Kulisevsky & Roldan,
2004) suggested that even if VHs are a part of PD (and not due to dopaminergic
administration), they are usually related to some facilitating factors, such as
dementia, depression, or erratic encephalopathy, which are based on non-
dopaminergic neurotransmitter systems. These risk factors will be examined in
greater detail in Section 1.5.
More and more authors believe that VHs are a part of PD and that medication
can worsen (but not cause) VHs. The involvement of non-dopaminergic factors has
motivated research to investigate the possible roles of other neurotransmission
systems in the generation of VHs in PD. Dysfunction in cholinergic' and
serotonergic" systems have been commonly associated with VHs in PD.
The importance of the cholinergic system in the generation of VHs was first
observed in another neurodegenerative disorder, namely dementia with Lewy
Bodies (DLB). Pathologically, DLB is characterized by development of abnormal
protein aggregation (Lewy bodies) throughout the brain. Clinical features include
dementia and complex VHs (both occurring early in the development of the
disease) and motor dysfunction, similar to that seen in PD. Cholinergic reduction
has been strongly implicated in VHs in DLB (Calderon et al., 2001; Ferman &
Boeve, 2007). Due to the striking pathological and clinical similarities between
DLB and PD, Calderon et al. (2001) suggested that cholinergic dysfunction in PO
may be important in the genesis of the VHs in the same way as in DLB. Similarly,
Korczyn (2001) suggested that the disturbances of the dopaminergic-cholinergic
5 Cholinergic neurons are neurons whose primary neurotransmitter acetylcholine is principally
involved in memory.
6 Serotonergic neurons are neurons whose primary neurotransmitter serotonin is involved in the
modulation of anger, aggression, body temperature, mood, sleep, sexuality, appetite, and
metabolism.
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balance are implicated in the occurrence of VHs in PD. Although the exact
mechanisms of a possible interaction between the two systems remain largely
unknown, many studies have shown that medication based on the cholinergic
system produces a modest improvement in psychotic symptoms in both PO and
OLB (AssaI & Cummings, 2002; Collerton et al., 2005; Fernandez, Wu, & Ott,
2003; Manford & Andermann, 1998; O'Brien, Firbank, Mosimann, Bum, &
McKeith, 2005; Williams-Gray, Foltynie, Lewis, & Barker, 2006).
Finally, apart from the dopaminergic and cholinergic system, the role of the
serotonergic system has been well recognized in the treatment of VHs in PO (AssaI
& Cummings, 2002; Scholtissen, Verhey, Adam, Weber, & Leentjens, 2006;
Zoldan, Friedberg, Livneh, & Melamed, 1995). Usually, the understanding of
neurotransmission involvement leads to better treatment options. However, in the
case of the importance of the serotonergic system in the occurrence of VHs in PD,
there seems to be the opposite trend - a link between the serotonergic system and
VHs has been established because of the remarkable effect of serotonergic
medication on the cessation of VHs. Although the precise nature of the interaction
remains largely unknown, Zoldan et al. (1995) proposed that VHs in PD occur due
to over-stimulation of serotonergic receptors.
Studies investigating the role of dopaminergic, cholinergic and serotonergic
systems in the occurrence of VHs in PD suggest that all three systems are
implicated in the generation of VHs in PO. While their precise functions (and
possible interactions between the systems) are yet to be fully delineated, the current
understanding of the underlying neurotransmission systems has had an important
role in the pharmacological treatment of VHs in PD.
The first line of treatment of VHs in PD is reducing dopaminergic treatment.
However, this approach is not always easy since reducing dopaminergic medication
can exacerbate parkinsonism (Korczyn, 2001). Similarly, Kulisevsky and Roldan
(2004) observed that controlling VHs and motor signs of PD comprises a so-called
"motion-emotion" dilemma: increasing dopaminergic dosage improves motor
ability but is also associated with the emergence of symptoms of psychosis. On the
other hand, reducing dopaminergic dosage reduces psychosis but can adversely
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affect the motor signs of PD. Due to the important role of dopaminergic medication
upon motor and non-motor signs of PD, medication dosages are essential
information in all studies with PO patients.
The suggested cholinergic involvement in VHs has resulted in the occasional
treatment of VHs in PD by cholinergic medication (Korczyn, 2001). Although such
treatment is beneficial in OLB (McKeith et al., 2000), cholinergic medication in PO
is most commonly used when signs of cognitive decline are present. Furthermore,
new antipsychotic drugs (based on the regulation of the serotonergic system) have
already promised to be more effective and side-effect free than cholinergic
medication. The "atypical" antipsychotic medications (e.g., clozapine, quetiapine,
olanzapine, and risperidone) were primarily developed for the treatment of
hallucinations in schizophrenia, but have been proved to be also effective in much
lower doses in hallucinating PD patients (Korczyn, 2001).
Alternatively, or in combination with neuropharmacological treatment,
cognitive-behavioural intervention has long been implemented in the treatment of
psychosis in other disorders (Barber & DeRubeis, 1989; Carver, Scheier, &
Weintraub, 1989; Delespaul, deVries, & van Os, 2002; Starker & Jolin, 1982). As
discussed in Section 1.2, hallucinating PD patients would benefit from a cognitive
approach based on acceptance and reassurance. However, cognitive-behavioural
approaches in the treatment of VHs in PD have so far not been satisfactorily
addressed (Barnes & David, 2001; Diederich et al., 2003). Therefore, many
questions regarding the behavioural approach and most efficient coping strategies
with VHs in PD remain unanswered (see Chapter 9). Recognizing the efficient ways
of dealing with VHs pharmacologically and with cognitive-behavioural treatment
could potentially improve patients' (and carers') quality of life.
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1.4 Neural Substrates of VHs in PD
The growing understanding of the underlying neurotransmission systems has led to
important treatment solutions for VHs in PD. Furthermore, the advent of
neuroimaging techniques, and a growing understanding of neurotransmitter
pathways that playa role in the generation of VHs in PD, have helped to identify
the underlying neural substrates for VHs in PD.
As discussed in Sections 1.1 and 1.3, the dopaminergic system is primarily
affected in PD. Further, human retinas contain dopaminergic neurons (Biousse et
al., 2004). Combining both, some authors (Manford & Andermann, 1998;
Rodnitzky, 1998) proposed that the dopaminergic system in PD might be affected
already from the retina onwards, which would consequently affect the function of
the visual cortex. This notion has been strengthened by two functional magnetic
resonance imaging (fMRI) studies, showing a decreased activation in the primary
visual cortex of PD patients with VHs (not hallucinating during the imaging), either
during visual stimulation tasks or in resting state (Holroyd & Wooten, 2006;
Stebbins et al., 2004). Furthermore, Stebbins et al. (2004) argued that the decreased
activation in the primary visual cortex results in the hyperactivation of visual
association cortex. Their findings were also confirmed by two single photon
emission computed tomography (SPECT) studies, showing aberrant activation of
the ventral visual pathways in the brain of hallucinating PD patients (Oishi et al.,
2005; Okada, Suyama, Oguro, Yamaguchi, & Kobayashi, 1999). Moreover, these
findings are in accordance with the complex phenomenology of hallucinatory
images in PD (as described in Section 1.2). Complex, coloured and detailed images
of people (sometimes in motion), objects and scenery point to the involvement of
both the ventral and dorsal visual pathways in the generation of VHs in PD. Finally,
a set of evidence for abnormalities in the visual association cortex of hallucinating
PD patients comes from the post-mortem analyses where accumulation of Lewy
bodies was evident in the visual association cortex (Harding, Broe, & Halliday,
2002; Perry et al., 1991).
11
Apart from the tMRI evidence of aberrant functioning of occipital-temporal
and occipital-parietal association cortices, Stebbins et al. (2004) also observed
degeneration of the frontal areas in hallucinating PD patients, specifically in the
superior frontal gyrus and cingulate cortex. Due to a strong connection between
VHs and sleep dysfunction, Manford and Andermann (1998) proposed the
brainstem as one of the possible areas in generating VHs; however, its role remains
largely unknown.
Taken together, the neuroanatomy of VHs in PD does not seem to be localized
in a specific area; rather, there is a complex neuroanatomical and neurotransmission
interaction between different brain areas, namely primary and association visual
cortex, with the input from the frontal cortex and the brainstem. The lesions of the
proposed areas manifest in a range of dysfunctions, which have been observed in
PD patients with VHs.
1.S The Continuum Hypothesis of VHs
VHs are a frequent psychiatric manifestation in the course of PD and specific
neurotransmitter systems and neural structures have been implicated to playa role
in the generation of VHs. However, VHs can also occur in a range of other
disorders, characterized by a different pathology than PD. For example, VHs
frequently appear in the course of degenerative disorders such as in DLB,
Alzheimer's Disease and in patients with fronto-temporal dementia (Fenelon et al.,
2000). Moreover, VHs can occur in a range of non-degenerative disorders, such as
narcolepsy-cataplexy syndrome, peduncular hallucinosis (i.e., midbrain and pons
lesions, resulting in vivid VHs), familial hemiplegic migraine (i.e., an autosomal
dominant classical migraine subtype that typically includes weakness of half the
body during the aura phase, which is often accompanied by vivid VHs), Charles
Bonnet syndrome (VHs of the blind), schizophrenia, hallucinogen-induced states,
and epilepsy (Collerton et al., 2005; Dauvilliers, Billiard, & Montplaisir, 2003;
Manford & Andermann, 1998). VHs are also prevalent among hospice inpatients
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(e.g., brain tumours, liver disease, epilepsy, etc.) (Fountain, 2001). These disorders
arise from different underlying pathologies; yet different underlying pathologies can
result in strikingly similar manifestations.
Moreover, VHs are frequent in some normal' individuals, usually in drowsy
states of consciousness (Girard & Cheyne, 2006; Ohayon, 2000; Ohayon, Priest,
Caulet, & Guilleminault, 1996). The most common occurrences of VHs in the
normal participants in Ohayon et al.'s study (1996) were at sleep onset (hypnagogic
hallucinations, occurring in 24.8%) and/or upon awakening (hypnopompic
hallucinations, occurring in 6.6%).
Hallucinations are therefore not always indicative of pathology, as suggested
by numerous studies which have established the occurrence of hallucinatory
experiences in a substantial number of people from the normal population (Aleman,
Boeker, & De Haan, 1999; Lopez-Rodrigo, Paino Pineiro, Martinez Suarez, Caro,
& Lemos Giraldez, 1997). For example, Bell et al. (2006) reported that
approximately 11% of the non-clinical sample in their study scored above the mean
of psychotic inpatients on the anomalous perceptual experiences questionnaire
(CAPS) (Bell et al., 2006). This provides further evidence that such experiences are
not, in themselves, pathological and that a considerable percentage of the
population successfully integrates anomalous percepts into their lives without
necessaril y leading to a psychiatric disorder. Lopez- Rodrigo et al. (1997)
emphasized that it is likely these people do not lose a sense of reality, as occurs
with some clinical populations; thus, the authors suggest that the hallucinatory
experiences with preserved insight would be better described as pseudo-
hallucinations or hallucinosis. From this perspective, pseudo-hallucinations in the
normal population are similar to VHs in PD, where patients retain insight into their
hallucinations.
Moreover, this is not the only resemblance between VHs in PD and proneness
to VHs in the normal population. Several authors have proposed that psychosis-like
experiences exist on a continuum, ranging from mild visual disturbances in the
7 In the present work. the term "normal population" refers to people without any known disorder or
long-term illness.
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normal population to the sometimes bizarre full-blown hallucinations characteristic
of psychiatric illness (Crow, 1998; Slade & Bentall, 1988). This idea has been
known as the continuum hypothesis, stating that psychosis-like experiences are
distributed (although to varying extent) throughout the general population, and that
full-blown psychosis represents the most extreme end of the population continuum'',
Therefore, VHs in PD and proneness to VHs in the normal population might share
similar predispositions, which are expressed in a lesser degree in the normal
population.
Following from the continuum hypothesis, it can be argued that similar
aberrant functioning is expressed across different cognitive domains in both
hallucinating PD patients and in normal individuals that are high-prone to have
hallucinatory experiences. This idea is in line with Lopez-Rodrigo et al. (1997) who
suggested that some qualitatively different factors differentiate people from high
and low-end of the continuum. To test the continuum hypothesis, the differences in
cognitive functioning between hallucinating and non-hallucinating PD patients need
to be compared to the differences between cognitive functioning between high and
low-prone normal individuals without a history of any psychiatric disorder.
Comparing VHs in a well-recognized neurological disorder to high proneness to
VHs in the normal population would offer a basis for inclusion of risk factors to
build a model for VHs. Consequently, such comparison would give an answer to
whether a unitary model can be applied in recurrent complex VHs across different
disorders that arise from various underlying pathologies.
1.6 Risk Factors for VHs
Even after a decade of research, the phenomenology and pathogenesis of VHs in
PD still remain poorly understood. Apart from the aforementioned medication
8 Hanssen et al., 2003; L. C. Johns & van Os, 2001; E. Peters, Joseph, Day, & Garety, 2004; E. R.
Peters, Joseph, & Garety, 1999; Stefanis et al., 2002; Verdoux & van Os, 2002.
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effect on the generation of VHs (see Section 1.3), a range of risk factors have been
implicated to playa role to the occurrence of VHs. Although some studies found
links between specific risk factor and VHs, and others have not, it is now believed
that VHs in PO are not a simple medication effect but are probably aggravated by a
number of risk factors. Even less is known why some normal individuals without a
history of any psychiatric or neurological disorder are high-prone to have
hallucinatory-like experiences and some are not. Stemming from the continuum
hypothesis that hallucination-proneness might be related to the same risk factors,
expressed in different degrees across disorders, the present section will address the
role of different risk factors. Some of them are tightly related to VHs in PO (e.g.,
temporal factors, severity of motor disability and mood), while others have been
proposed to have a role in both PO as well as in the normal population (e.g., visuo-
spatial and visual imagery abnormalities, abnormalities in executive functioning,
sleep disorders, genetics and some personality factors).
1.6.1 Temporal Factors
Temporal factors, such as age, duration of illness and onset of PD give inconclusive
results in relation to VHs in PD. On the one hand, numerous studies have identified
older age in a hallucinating PD group as a differentiating risk factor for the
occurrence of VHs (Fenelon et al., 2000; Goetz et al., 2006; Haeske-Dewick, 1995).
On the other hand, several studies found no such relation (Barnes & David, 2001;
Diederich et al., 1998; Inzelberg et al., 1998). Further, the duration of illness was
identified as an independent predictor of VHs in some studies (Barnes & David,
2001; Fenelon et al., 2000), but other studies found no difference in this respect
between hallucinating and non-hallucinating PD patients (Diederich et al., 1998;
Fenelon et al., 2006; Haeske-Dewick, 1995; Holroyd et al., 2001; Inzelberg et al.,
1998). Finally, Graham et al. (1997) observed that VHs were not associated with
age at onset of PD in their study.
As discussed in Section 1.2, PD often manifests with different symptoms at
the onset of the illness, and the progress of illness can vary greatly between patients
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(Paulson & Stem, 1996). Moreover, PD is a neurodegenerative disorder, ultimately
leading to extensive brain pathology and to a higher incidence of both motor and
non-motor complications. Therefore, it is not surprising that some studies
demonstrated a higher incidence of VHs among older and longer diagnosed
patients, especially in the cases of small sample sizes. However, these studies do
not offer firm evidence that prolonged illness and age are a factual risk factor for
development of VHs and not just a risk factor for more extensive pathology, and
therefore a higher risk for psychiatric manifestations.
More tentatively, VHs are generated when specific brain areas are affected by
the neurodegenerative process. Undoubtedly, pathology is extended in the later
stages of PD, resulting in the generation of VHs (among other signs); however, the
pathology progress is not uniform and can consequently result in an early
development of VHs. Therefore, rather than to the temporal factors, effort should be
put into investigating specific dysfunctions that are linked to the occurrence of VHs
in PD, especially in the early stages of diagnosis, when the pathology is less
extensive.
1.6.2 Motor Abilities
As with the temporal factors, there is controversy about the importance of the
severity of motor disability in the occurrence of VHs in PD. Motor status was more
severely affected in hallucinating than in the non-hallucinating PD patients in
several studies (Aarsland, Andersen, Larsen, Lolk, & Kragh-Sorensen, 2003;
Barnes & David, 2001; Fenelon et al., 2000; Haeske-Dewick, 1995; Holroyd et al.,
2001); however, other studies found no such link (Diederich et al., 1998; Goetz et
al., 2006; Inzelberg et al., 1998).
Extensive brain pathology results in worsening of motor and non-motor
abilities (Braak et al., 2003); therefore, it is not surprising that the incidence of VHs
is increased among severely disabled PD patients. However, VHs also occur in
patients with mild motor dysfunctions, suggesting that specific, rather than
extensive dysfunctions cause VHs in PD. Further investigations of
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neuropsychological dysfunctions are therefore especially warranted in hallucinating
PO patients with minor motor dysfunctions.
1.6.3 Cognitive Functioning
In line with the temporal factors and motor disability, there is inconsistency about
the importance of the severity of cognitive dysfunction in the occurrence of VHs in
PD. Some studies identified severe cognitive decline as the main risk factor
independently predictive of VHs (Fenelon et al., 2000; Haeske-Dewick, 1995;
Holroyd et al., 2001; Inzelberg et al., 1998). However, other studies found no such
link (Barnes & David, 2001; Goetz et al., 2006). Fenelon et al. (2000) suggested the
discrepancy occurs because PD patients with impaired cognition are not so self-
conscious and therefore report on their VHs more often than PD patients without
dementia; at the same time, patients without dementia are usually aware of the
stigma related to VHs, and therefore do not report having VHs unless explicitly
asked.
In line with the neuroimaging evidence of aberrant frontal functioning
(Matsui, Nishinaka et al., 2006b; Nagano-Saito et al., 2004; Stebbins et al., 2004),
several studies found reduced performance in executive functioning" in
hallucinating PD patients without dementia (Aarsland et al., 2003; Athey, Porter, &
Walker, 2005; Barnes & Boubert, 2008; Grossi et al., 2005; Meco, Bonifati,
Cusimano, Fabrizio, & Vanacore, 1990; Santangelo et al., 2007). According to
these studies, executive functions might be an important substrate for occurrence of
VHs even when dementia is not yet apparent. It is also in line with two longitudinal
studies where VHs were recognized as a risk factor for a later development of
dementia (Aarsland et al., 2003; Santangelo et al., 2007). However, other studies
suggested that since executive dysfunctions are noticeable even in the early stages
of PD, it is the executive dysfunctions that predict the occurrence of VHs, and not
9 Executive functions are defined as a set of brain processes, such as planning, abstract thinking, rule
acquisition, initiating appropriate responses and inhibiting inappropriate responses.
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the other way around (Barnes & Boubert, 2008; Grossi et al., 2005; Meco et al.,
1990; Sanchez-Ramos et al., 1996).
However, the main limitations of these studies are the methodologies, which
were used as the indicators of executive dysfunctions. The tasks were either brief
screening techniques (e.g., Mini Mental State Examination, Cambridge Cognitive
Assessment, Telephone Interview for Cognitive Status, etc.) or too specific (tests of
semantic and verbal fluency). Some tasks were reliable and valid measures of
reasoning and memory (Raven's 47 Coloured Progressive Matrices and Rey
Auditory Learning Test); however, the differences between hallucinating and non-
hallucinating PD patients on these tasks were not significant (Grossi et al., 2005;
Santangelo et al., 2007). Therefore, in order to explore the link between VHs and
executive dysfunctions, further studies using reliable, valid and standardized tasks
are warranted.
1.6.4 Visuo-Spatial Functioning
The aforementioned retinal dopaminergic deficiency in PD (see Section 1.4) may
alter a range of visual abilities in PD patients (Biousse et al., 2004; Manford &
Andermann, 1998; Rodnitzky, 1998), which can in tum facilitate the occurrence of
VHs. However, despite the intuitive reasoning that visual disturbances are
associated with VHs, surprisingly few neuropsychological and neuroimaging
studies have addressed this issue in hallucinating PD patients (Barnes, Boubert,
Harris, Lee, & David, 2003; Diederich et al., 1998; Ramirez-Ruiz, Junque, Marti,
Valldeoriola, & Tolosa, 2007; Uc et al., 2005). The studies have investigated the
following visuo-spatial functions: incidence of ocular disorders, visual acuity,
colour and contrast discrimination, visual object perception and visual memory for
faces.
Fenelon et al. (2000) suggested that a higher incidence of ocular disorders
(such as abnormal eye and eyelid movements, blurred vision, double vision, etc.) in
hallucinating PD patients facilitates the development of VHs. Three studies
(Chapman, Dickinson, McKeith, & Ballard, 1999; Holroyd et al., 2001; Uc et al.,
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2005) suggested it is a significantly reduced visual acuity in the better eye that
predisposes PD patients to VHs. However, Diederich et al. (1998) studied ocular
pathology in PD patients with normal visual acuity. They found more deficits in
colour and contrast discrimination in hallucinating patients. This visual deprivation
might consequently be the facilitating factor for the occurrence of VHs in PD
(Diederich et al., 1998). Similar ideas have been proposed by other authors (Barnes
& David, 2001; Korczyn, 2001), who noted that VHs are especially frequent in the
evenings and when the light is dim - in other words, when sensory inputs are
degraded. In their view, disturbances of the visual input result in hyper-activation of
the visual system, which gives rise to the generation of VHs (Barnes & David,
2001; Chapman et al., 1999; Diederich et al., 1998; Holroyd et al., 2001; Uc et al.,
2005). The idea that poor visual input can facilitate the occurrence of VHs seems
especially plausible, because VHs have been also reported in healthy individuals
who experienced vivid VHs after sensory deprivation (Solomon, Leiderman,
Mendelson, & Wexler, 1957; Suedfeld & Vernon, 1964) as well as in the states of
low arousal and sleep deprivation, when the visual input is reduced or disturbed
(Babkoff, Sing, Thome, Genser, & Hegge, 1989; Hidalgo & Caumo, 2002; Kollar
et al., 1969). Risk factors related particularly to sleep will be further addressed in
Section 1.5.8.
Apart from the ophthalmologic studies, few studies have addressed the role of
visuo-spatial functioning in the occurrence of VHs in PD. Barnes et al. (2003), for
example, found that hallucinating PD patients are impaired on object recognition
tests. They suggested that the failure to extract information from the stimuli might
be the facilitating factor in the occurrence of VHs. Similarly, the results are in
accordance with Ramirez-Ruiz et al. (2007) who, in addition to the failure of
recognition function, found deficits in visual memory for faces in hallucinating PD
patients. Both dysfunctions of the visual system in hallucinating PD patients (object
recognition and visual memory for faces) point to a degeneration of the association
cortex, which is in accordance with the evidence from the neuroimaging studies (as
described in Section 1.4). However, more studies need to address the role of the
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visual system in the generation of VHs in PD, using reliable and valid measures of
perceptual functioning.
1.6.5 Visual Imagery
A specific visual processmg function often related to VHs is visual imagery.
Vividness of mental imagery is defined as the degree of similarity of a mental
image to actual perception; the more vivid the image, the closer the experience is to
an actual perception of sensory input (Aleman et al., 1999). The idea that increased
vividness of mental imagery may be associated with hallucinatory experiences was
already expressed more than hundred years ago by Francis Galton (1883). However,
the results from both the normal population and schizophrenia patients remain
inconclusive; some authors reported that visual imagery is related to the occurrence
of VHs, and some found no relation between visual imagery and occurrence of
hallucinations (Aleman, Nieuwenstein, Boeker, & de Haan, 2000; Boeker, Hijman,
Kahn, & De Haan, 2000; Lopez-Rodrigo et al., 1997; Sack, van de Ven,
Etschenberg, Schatz, & Linden, 2005).
Despite the relatively long tradition of investigating the role of mental
imagery in schizophrenia and in the normal population high-prone to have VHs,
only one study has addressed the role of mental imagery in the generation of VHs in
PD (Barnes et al., 2003). In this study, the performance of hallucinating and non-
hallucinating PD patients was comparable, but hallucinating PD patients expressed
a higher tendency to report imaged stimuli as percepts. Therefore, the role of mental
imagery in the generation of VHs remains unclear, and calls for a further
investigation.
1.6.6Mood
Of all the risk factors, the role of depression in the occurrence of VHs gives the
most contradictory results. In 1995, Haeske-Dewick et al. (1995) found no
significant difference in depression between hallucinating and non-hallucinating PD
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patients. Conversely, Aarsland et al. (1999) and Sanchez-Ramos et al. (1996) found
the hallucinating PD patients in their groups scored higher on different depression
scales than the non-hallucinating PD patients. Similarly, hallucinating PD patients
had significantly more depressive symptoms than non-hallucinating patients;
however, none of the groups reached a cut-off criterion for depression (Holroyd et
al., 2001), using the Geriatric Depression Scale (Yesavage et al., 1982). Some
authors suggested that in patients who have been diagnosed with PD for more than
5 years, depression is statistically related to VHs (Fenelon et al., 2000); however,
another study found that depression was statistically related to VHs in patients with
shorter (and not longer) disease duration (Graham et al., 1997).
In summary, the studies give contradictory results and even in the cases where
depression is statistically related to VHs, the authors concluded that depression
might be a facilitating, but not a predictive factor for the occurrence of VHs
(Fenelon et al., 2000; Holroyd et al., 2001; Inzelberg et al., 1998). Furthermore, the
results of the studies give evidence that the role of depression is more complex than
initially thought and future studies need to address this issue in a more sophisticated
way. One possibility, for example, is to explore the link between depression and
specific behavioural coping strategies, which PD patients use in order to manage
their VHs. A more qualitative approach to the topic would give an insight into
whether specific behavioural techniques are linked to a better mood. If that is the
case, applying specific behavioural-cognitive management could have a beneficial
effect on the mood modification in hallucinating PD patients.
1.6.7 Personality
Personality traits are one of the least explored risk factors for the occurrence of
VHs. Several authors (Cangas, Errasti, Garcia-Montes, Alvarez, & Ruiz, 2006;
Jones & Fernyhough, 2006; Laroi & Van der Linden, 2005; Morrison et al., 2000)
proposed that meta-cognitive beliefs about thoughts can be implicated in
predisposition to VHs in both clinical and non-clinical populations. In their view,
hallucination-proneness in the normal population as well as full-blown
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hallucinations in psychiatric patients stem from over-reliance on the internal meta-
cognitive processes rather than on externally generated information that is obtained
from the sensory receptors. Furthermore, logistic analysis in another study indicated
that fantasy proneness was the best predictor of hallucinatory reports in the normal
population (Van de Yen & Merckelbach, 2003); however, the authors admit that the
precise nature of the link remains unclear. They suggest that the link could reflect a
general bias to endorse bizarre items or a subtle reality-testing deficit'",
In summary, there is some evidence that specific personality traits are related
to hallucination-proneness in both clinical and normal population. However, the
presented studies stem from clinical populations with auditory and not visual
hallucinations. Therefore, future studies need to address the role of personality
features in proneness to VHs. Further, although the studies give some evidence for
the importance of the top-down processing in schizophrenia, to date no study has
explored the implication of personality factors in hallucinating PD patients.
Therefore, future studies need to provide evidence that fantasy proneness and meta-
cognitive beliefs are implicated not only in schizophrenia, but in other disorders
suffering from VHs as well.
1.6.8 Sleep
As explained in Section 1.3, the neurodegeneration of PD extends beyond the
dopaminergic system and affects the serotonergic system and its sleep functions as
well. A number of studies have recognized a link between VHs and specific sleep
disturbances, pointing to the extended neurodegeneration of the midbrain neural
mechanisms (Chaudhuri, Martinez-Martin et al., 2006; Comella, Tanner, &
Ristanovic, 1993; Fenelon et al., 2000; Gupta et al., 2004; Manni et al., 2002;
Pacchetti et al., 2005). Furthermore, the link between sleep and VHs in the normal
population has been established in sleep deprivation studies and in disorders such as
narcolepsy-cataplexy, sleep paralysis, or even hypnagogic and hypnopompic
10 Reality testing is an ability to distinguish internally generated images and external percepts
(Johnson & Raye, 1981).
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hallucinations (Collerton et al., 2005; Dauvilliers et al., 2003; Girard & Cheyne,
2006; Manford & Andermann, 1998; Ohayon, 2000; Ohayon et al., 1996). Some
authors have suggested that particularly the dysfunction of the arousal system
causes unfaithful transmission of visual input, which together with the low
environmental luminance creates an ideal situation for misinterpreting visual stimuli
as real images (Chaudhuri, Martinez-Martin et al., 2006; Comella et al., 1993;
Fenelon et al., 2000; Manni et al., 2002). However, the exact mechanisms of the
link between sleep patterns and VHs are not fully understood, and future studies
need to address this issue. Specifically, the advent of new objective measures of
sleep patterns promises a more elegant approach to sleep research, avoiding the
disadvantages of the laboratory-based polysomnographic settings.
1.6.9 Genetics
Finally, the presence of the apolipoprotein E e4 allele was found to be the first
genetic risk factor for drug induced VHs in PD (de la Fuente-Fernandez, Nunez, &
Lopez, 1999; Feldman, Chapman, & Korczyn, 2006). Genetic predispositions to
VHs are outside the scope of the present study; however, further research in this
area is warranted.
1.6.10 Summary
VHs in PD, as in other pathologies, and hallucination-proneness in the normal
population are a complex phenomenon and their aetiology is far from understood. A
number of risk factors have been put forward as facilitating factors in the
occurrence of VHs in both PD and the normal population. However, it remains
unclear whether the same risk factors predispose PD patients to VHs and the normal
individuals to high hallucination-proneness. Further research is therefore needed to
establish the link, which could provide a basis for the possible holistic model for the
generation of VHs. As opposed to focusing attention on only one risk factor, the
following section will address the studies that tried to encompass several risk
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factors into a model of VHs in PD; however, no model has been proposed for
hallucination-proneness in the normal population to date.
1.7 Models of VHs
Putting different risk factors together, several hypotheses and models have been put
forward as a possible mechanism to explain which risk factors are implicated in the
occurrence of VHs in PD. In this section, the most cited and comprehensive models
of VHs are discussed.
1.7.1 VHs as a Release Phenomenon
Cogan (1973) proposed that VHs (regardless of the clinical diagnosis) are caused by
disruption of the normal flow of visual impulses, with subsequent release of
endogenous cerebral activity from the visual system. As described in Sections 1.3
and lA, ocular pathology in PD (especially dopaminergic deficiency in the retina)
can affect the primary visual cortex. Next, the lack of input from the primary visual
cortex results in over-activation of the associative visual cortex, and consequently
VHs occur (Stebbins et al., 2004). Cogan's model can thus be applied to explain the
genesis of VHs in PD, describing VHs as a release phenomenon, i.e., as a
disinhibition of neural structures, with increase in the excitability and spontaneous
activity of the disinhibited neurons. Although the model adequately describes the
pathology of the visual pathways, it is nonetheless relatively static, and does not
account for other risk factors, as described in Section 1.5 (e.g., mood and
personality, imagery, executive and sleep dysfunction).
1.7.2 VHs as a Brainstem Modulation
Building up from the release theory, Manford and Andermann (1998) expanded the
model by including a set of risk factors for occurrence of VHs. They suggested that
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three basic mechanisms, alone or in combination, underlie VHs with widely
differing causes: irritative processes acting on higher visual centres or pathways;
defective visual processing; and brainstem modulation of thalamocortical
connections (ibid). As discussed in Section 1.5.8, brainstem lesions are especially
implicated in PD, affecting ascending cholinergic and serotonergic pathways. The
brainstem abnormalities are often associated with disturbances of sleep and may
cause defective modulation of thalamocortical relationships, leading to a release
phenomenon (Manford & Andermann, 1998).
The main contribution of Manford and Andermann's model (1998) is the
acknowledgement that apart from the abnormalities of the visual system and
abnormal cortical release phenomenon, VHs can be attributed to abnormalities of
the ascending cholinergic and serotonergic brainstem (and thalamic) pathways
involved in the control of sleep-waking state. In support of this explanation,
disturbances of rapid-eye-movement (REM) sleep and intrusions of dream images
into waking state have been often associated with VHs in PD patients (Arnulf et al.,
2000; Manni et al., 2002; Nomura et al., 2003; Onofrj et al., 2002; Pappert, Goetz,
Niederman, Raman, & Leurgans, 1999). However, the model fails to address the
recently proposed frontal dysfunctions in hallucinating PD patients, as described in
Section 1.5.3.
1.7.3 Integrative Models
The integrative model of Diederich et al. (2005) is the most comprehensive model
accounting for VHs in PD to date. Similarly to the models based on the brainstem
modulation mechanisms, the model focuses on visual impairment, probably
reflecting dopaminergic retinal dysfunction, and on sleep/vigilance abnormalities,
probably reflecting dysfunctions of the ponto-geniculo-occipital system regulating
REM sleep. In addition, Diederich and colleagues (ibid) suggested that a model of
VHs in PD should also include aberrant activation of frontal cortex and lack of
suppression or spontaneous emergence of internally generated imagery through the
ponto-geniculo-occipital system. Further, the importance of the frontal lobe
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functioning was also recognized by Barnes et al. (2003) who proposed a multi-
factorial model, which includes a combination of degraded visual information about
the environment, impaired and perhaps fluctuating source monitoring in episodic
memory and an over-reliance of previously stored schemas.
The strongest advantage of the integrative models is that they are based on the
evidence from the studies on PO, and are not simply extrapolated from the evidence
about the risk factors in other disorders. Further, the models adequately address a
number of risk factors that predispose the occurrence of VHs in PD patients;
however, further empirical examination is needed to confirm the models, especially
the role of executive dysfunctions in the generation of VHs. The models' weakness,
however, is that they do not address the role of top-down, internally-driven
processes.
1.7.4The Perception and Attention Deficit (PAD) Model
The recently proposed PAD model (Collerton et al., 2005), primarily designed for
DLB, has aimed to account for all recurrent complex VHs across different
conditions. The authors suggested that VHs in different disorders are related to the
coexistence of attentional and visual perceptual impairments, mainly through the
disturbances in the lateral frontal cortex and the ventral visual stream system. The
model offers a tentative idea for inclusion of attention as a risk factor in occurrence
of VHs; however, the attention component of the model needs both theoretical and
empirical improvements, as it offers neither neurobiological accounts nor empirical
evidence for the existence of attention deficits across different disorders related to
VHs (Castelo-Branco, 2005; Halliday, 2005; Kirov, 2005; Mast, 2005; Morrison &
David, 2005; Smythies, 2005; Spencer & McCarley, 2005). The main limitation of
the model is that it fails to achieve its aim to be incorporated in any clinical disorder
presented with VHs (Dror, 2005; Ffytche, 2005a; Morrison & David, 2005;
Samsonovich, 2005; Tadin et al., 2005). Although exploration of attention
components is outside the scope of the present study, the model needs to be
empirically verified in future studies.
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1.7.5Summary
Section 1.6 described the risk factors that can be argued to play an important role in
the occurrence of VHs, and Section 1.7 presented the studies that tried to
incorporate those factors in the models. From a one dimensional model, believing
that VHs in PD are a simple medication effect, the models have developed and
today most authors are in favour of the integrative models (Barnes et al., 2003;
Diederich et al., 2005). However, further studies are needed to give firm empirical
evidence indicating which risk factors are implicated in both the occurrence of VHs
in PD as well as hallucination-proneness in the normal population. The present
thesis aims to address the issue of whether the same risk factors are implicated in
both hallucinating PD patients and high-prone normal individuals. The next section
will delineate the studies that will explore the risk factors. On the basis of the
empirical results, a new model to best explain VHs in PD and in the normal
population will be postulated.
1.8 Structure of the Thesis
VHs occur in a range of clinical disorders and in the normal population; different
aetiologies can therefore manifest in strikingly similar symptoms. Despite different
origins, similar risk factors have been suggested to playa role in the occurrence of
VHs in both PD and the normal population (see Section 1.6). However, to date no
studies have systematically explored the role of different risk factors from a
continuum hypothesis, stating that VHs are expressed in varying degrees across
clinical and non-clinical population. The aim of the present thesis is therefore to
explore whether the same risk factors are involved both in hallucinating PD patients
as well as in high-prone individuals from the normal population. Consequently, the
main contribution of the present work is to explore whether a unitary model can be
proposed for the occurrence of recurrent complex VHs in PD and for high
hallucination-proneness in the normal population.
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The present chapter has described PD, with a special focus on different
domains of VHs in PD: phenomenology of VHs in PD, the neurotransmitters and
neural substrates that are implicated in the generation of VHs. Next, the chapter has
introduced the idea that there are core similarities between hallucinating PD patients
and high-prone normal individuals without any history of psychiatric disorder. The
aim is to explore whether the same risk factors (and consequently a unitary model)
can be postulated for VHs.
The first part of the thesis (Chapters 2 and 3) presents both phenomena: VHs
in PD and hallucination-proneness in the normal population. Chapter 2 concentrates
on how VHs are expressed in PD and gives a detailed phenomenological
description of both the phenomena, as well as the important characteristics of
hallucinating PD patients. Similarly, the aim of Chapter 3 is to explore how
hallucination-proneness is expressed in the normal population, and how it is
measured. The aims of Chapters 2 and 3 are therefore to give a clear description of
both groups (PD and the normal individuals) and the characteristics of both
phenomena (VHs and proneness to VHs).
Next, the thesis presents a series of five experimental chapters (Part II),
exploring specific risk factors for the occurrence of VHs in PD and proneness to
VHs in the normal population as described in Section 1.6: the role of perception and
executive functioning (Chapters 4, 5, and 6), the role of personality processes
(Chapter 7) and the role of specific sleep patterns (Chapter 8).
Chapters 4, 5 and 6 aim to examine the role of different aspects of the visual-
executive functioning in the occurrence of VHs in both PD and high-prone
individuals. In particular, Chapter 4 aims to investigate the role of visual memory
and visual imagery in the occurrence of both VHs in PD and high proneness to VHs
in the normal group, using highly reliable and valid tasks (the Cambridge
Neuropsychological Test Automated Battery - CANT AB). Chapter 5 is the first
study to date to address the early visual processing components in high-prone
normal individuals using an electrophysiological tool (electroencephalogram).
Executive tasks from the CANTAB neuropsychological battery are used in Chapter
6, with the aim to explore executive functioning in both hallucinating PD patients
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and high-prone individuals. All three studies provide a novel account in exploring
the role of the association visual cortex and frontal functioning in the generation of
VHs in PD and proneness to VHs in the normal population.
Chapters 7 and 8 aim to investigate the role of specific sleep patterns and
personality factors in relation to VHs in PD and to hallucination-proneness in the
normal population. Chapter 7 examines which (if any) top-down processes
characterize hallucinating PD patients and high-prone normal individuals. This is
the first study to address the role of internally-driven processes in the generation of
VHs in both hallucinating PD patients and high-prone normal individuals. Chapter
8 examines specific sleep patterns that are implemented in the generation of VHs in
both PD and the normal population. It is the first study to provide such evidence
using actigraphy, an objective measure of sleep.
Finally, the aim of the last chapter (Chapter 9) is to provide the first detailed
description of how PD patients cope with their VHs, using a semi-structured
interview, which addresses the role of different coping strategies. The study also
explores the link between the level of depression and specific coping strategies. The
aim of the study is to extrapolate the coping strategies that are most efficient in
dealing with recurrent complex VHs in PD.
The conclusions and recommendations for future research are discussed in
Chapter 10 with special attention to improving the understanding of VHs in PD.
Models for VHs in PD and for proneness to VHs in the normal population are
proposed and future perspectives of the studies are discussed.
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Part I
Chapter 2: VHs in PD: Phenomenology
Chapter 3: Proneness to VHs in the Normal Population
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Chapter 2: VHs in PD: Phenomenology
2.1 Introduction
VHs are a common psychiatric manifestation in PO, affecting as many as 30% of
patients with PD (Fenelon et al., 2000; Gupta et al., 2004; Sanchez-Ramos et al.,
1996). Fenelon et al. (2000) note that when minor forms of VHs (e.g., sensations of
a presence, a sideways passage or illusion) are included in the count, the incidence
could reach 40%. Moreover, increased nursing home placement and, ultimately,
mortality rates are related to hallucinations (Goetz & Stebbins, 1993, 1995). These
links have greatly contributed to the increased attention to VHs in research. Goetz
and Stebbins (1993; 1995) emphasize that managing hallucinations in an efficient
way would be beneficial to patients, reducing the need for placement in nursing
homes. Also, the recent discovery of the importance of new antipsychotic drug
treatment of VHs in PD has also contributed to increased attention to the topic in
the past decade. VHs are therefore vital for differential diagnosis and prognosis
(Mosimann et al., 2008).
However, despite the increase of (mainly neuropharmacological) interest in
VHs in PD, the subject of the precise nature of VHs has been neglected in the
studies of PD. While it is understandable that the advances in neuropharmacology
are motivated with the aim to develop effective methods to eliminate hallucinations,
Giorgi (2003) argues that these motives are challenged when it comes to
understanding the phenomena by those experiencing hallucinations. Hallucinations,
but also delusions, illusions, false memories and so on imply falsehood; however,
true understanding of what the hallucinations represent to the individual could help
eliminate hallucinations by transforming their meaning (ibid).
Further, other advantages of detailed phenomenology of VHs in PD lie in the
understanding of the motives and dynamics of the phenomena. One question, for
example, is whether VHs are pathologies of bottom-up processes or, maybe, they
are pathologies of the imagination. If there are top-down components involved, how
do they affect VHs in PD? Giorgi (2003), for example, wonders as to whether
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hallucinators see "a real thing that is not there, or are they merely seeing a quasi-
thing or a pseudothing" (p.209). Specific phenomenological qualities of VHs might
be therefore one of the reasons why PD patients with VHs have insight into the
hallucinatory nature of the images. Therefore, detailed description of the
phenomena of VHs in PD gives rise not only to hermeneutics of it, but can also
offer suggestions for coping strategies.
Despite these potential benefits of the phenomenological approach, apart from
a few exceptions, which were addressed in Section 1.2 (Barnes & David, 2001;
Fenelon et al., 2000; Holroyd et al., 2001), previous literature does not provide
detailed descriptions of VHs. Similarly, there is no gold standard available to assess
VHs in PD: e.g., Parkinson's Psychosis Rating Scale (PPRS) (Friedberg, Zoldan,
Weizman, & Melamed, 1998), the PD - Psychosocial Questionnaire (SCOPA-PC)
(Visser et al., 2007) and the non-motor symptom questionnaire (NMSQuest)
(Chaudhuri, Martinez-Martin et al., 2006) either assess hallucinations only in a few
sub-items (Papapetropoulos et al., 2008)11 or are not specific enough for PD-related
hallucinations (e.g., the Neuropsychiatric Inventory, Cummings et al., 1994).
The aim of the present study is therefore to offer detailed description of VHs
in PD from a more qualitative perspective and clarify the characteristics of VHs as
described by the patients themselves. A thorough examination of the
phenomenology of VHs can offer predictions about the underlying mechanisms and
how hallucinations relate to other functions (e.g., to sleep, to ocular pathology, etc.)
which may open new paths to manage VHs behaviourally. Furthermore, in order to
better understand the phenomenon of VHs in PD, the study will determine whether
there is a set of demographic factors (such as age, dopaminergic dosage, disability
stage, etc.) upon which the frequency of VHs could be predicted. Finally, the study
aims to explore whether specific characteristics of VHs might predict the frequency
ofVHs in PD.
II A recently published questionnaire-based study of hallucinations in PD has been developed
independently from the present research and comprises similar, although much fewer, items
(Papapetropoulos et al., 2008).
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2.2 Methods
2.2.1 Participants
23 PO patients with VHs (16 male and 7 female) were recruited to participate in the
study about the phenomenology of VHs in PD. All patients were members of the
PO societies in the UK, with normal hearing and normal or corrected-to-normal
vision. Similar to Barnes et a1.'s study (2001), criteria for eligibility were a clinical
diagnosis of PD as assessed by their GPs and recurrent complex VHs, reported by
the patients at least once per week in the previous month. No retrospective data
were included in the study, in order to collect unambiguous reports; therefore,
patients who experienced recurrent complex VHs in the past, but not at the time of
the study, were not included. Of the present sample of hallucinating PD patients, 6
experienced VHs more than 5 times a week, 9 of them experienced VHs 2-5 times a
week, and 8 of them experienced VHs once per week. Based on the risk factors
stated in Section 1.6.3, exclusion criteria were a moderate or severe stage of
dementia, confirmed by the carers of the PD patients, and the loss of independent
maintenance of daily living activities, also reported by the carers.
In order to predict the frequency of VHs, several independent variables were
taken into account (see Section 1.6): age, amount of daily levodopa medication and
the use of any other medication, years since their diagnosis, side more affected by
PO (left, right, or both sides), and Hoehn and Yahr (1967) motor disability stage
(HY). HY is a frequently used system to express the progress of PD symptoms. The
scale assigns stages from 1 to 5 to specify the relative stage of disability:
- Stage one: Symptoms on one side of the body only;
- Stage two: Symptoms on both sides of the body. No impairment of balance;
- Stage three: Balance impairment. Mild to moderate disease. Physically independent;
- Stage four: Severe disability, but still able to walk or stand unassisted;
- Stage five: Wheelchair-bound or bedridden unless assisted.
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Finally, in order to take alternative facilitating factors for the occurrence of
VHs into account, the presence of frequent migraines and ocular pathology
(excluding correction glasses) were taken as additional independent variables in the
study.
The mean age of hallucinating PD patients in the present study was 68 years
(SD = 7.42). The mean daily levodopa dose was 498.86 mg (SD = 270.63). 2
participants were taking sleep medication and four other patients were taking
antidepressants at the time of the study. Years since diagnosis varied from one to
27, with the mean of 10 years (SD = 6.42). The mean HY disability stage was 2.08
(SD = .93), which specifies a relatively mild motor disability (symptoms were
bilateral, but there was no impairment of balance and patients could move around
independently). There was no difference in the side more affected by tremor: 10
patients reported more severe disability on their left side of the body, 8 reported
their right side was more affected by PD, and 5 patients reported having both sides
equally affected. Therefore, the majority of patients were not severely (bilaterally)
affected by tremor. In further accordance with the relatively low HY disability
stage, 20 patients (87%) were able to move around the house unassisted. In addition
to PD, half of all patients (12) suffered from another long term illness. Apart from
VHs, 10 patients had other vision related problems (mainly double vision, but also
loss of focus, cataract and conjunctivitis); however, only three patients reported
having frequent migraines. Detailed demographics are displayed in Table 2.1.
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2.2.2 Assessments
VHs questionnaire
The aim of the VHs questionnaire (see Appendix 1) was to extract detailed
information about the content of VHs in PD. The VHs questionnaire was designed
based on the existing phenomenological studies of VHs in PD (Barnes & David,
2001; Diederich et al., 2005; Fenelon et al., 2000) and with the aid of local PD
gerontologists 12. As discussed in Section 2.1, the subjective nature of the
hallucinatory phenomena requires an approach where people with hallucinations
can freely report about their experiences. Giorgi (2003) stressed that "hallucinatory
phenomena are not to be analysed in terms of objective criteria" (p.21S). In order to
rely on the previous findings and knowledge from experienced PD gerontologists as
well as on the spontaneous reports from the patients themselves, the VHs
questionnaire utilizes a semi-structured questionnaire.
The VHs questionnaire is comprised of 9 demographic questions (for a
detailed description see 2.2.1 and Appendix 1, Questions 1 - 9) and 18 questions
related to the nature of VHs (see Appendix 1, Questions 10 - 27). The latter request
a precise description of the images: how they appear, the ambient light when the
images appear, how the images are perceived by patients, etc. The majority of
questions are based on multiple-choice answers; however, several questions allow
patients to elaborate their answers in their own words (e.g., details of the most
common images patients see, how the images are distorted, what the patients
believe is the cause for hallucinations, etc.). The questionnaire took approximately
10-15 minutes to complete.
12 With the assistance of Dr Hilary Hart and Dr Sudhir Singh, John Radcliffe Hospital, Parkinson's
Disease Outpatient Clinic. Oxford.
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2.2.3 Procedure
The study was introduced verbally and information sheets (see Appendix 2) were
given out at the monthly meetings in various PD societies throughout the UK
between October 2006 and September 2007. Potential participants with VHs were
encouraged to take part. Those who decided to participate contacted the researcher
at the end of the meeting. Patients individually agreed on a convenient meeting time
with the researcher either in their own homes or at the society meetings venue. All
participants were then given the VHs questionnaire and were asked to fill it in
before the scheduled meeting. In accordance with the university research ethics,
completing the questionnaire was taken as a written informed consent.
Questionnaires were returned at the next meeting and further questions were asked
if the patient's responses were ambiguous. A debriefing document was sent by post
to the patients at the end of the study.
The present and all the following PD studies were approved by the University
Research Ethics Committee (see Appendix 3).
2.2.4 Analysis
The aim of the study was to provide detailed descriptions of the images experienced
by PD patients with VHs. Therefore, the participants' answers were taken as
qualitative descriptions of the phenomena. In order to identify the most prominent
characteristics of VHs in PD, specific characteristics of VHs were presented to the
patients in the form of multiple-choice questions and were analysed using the non-
parametric chi-square test. Further, all statistically significant characteristics
(variables) from the chi-square analysis were used in the multivariate analysis and a
logistic regression analysis was performed to predict the frequency of
hallucinations. Similarly, the demographic variables (temporal factors, medication
dosage, HY disability stage, etc.) were used to perform a logistic regression
analysis, upon which the frequency of VHs could be predicted.
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All quantitative analyses were performed using SPSS for Windows version
15.0 (SPSS Inc, Chicago, 111.,USA).
2.3 Results
Once the demographic information of the VHs questionnaire was completed (see
Section 2.2.1), patients were asked to describe the formes) of their VHs (see
Appendix 1 - Question 10). The patients' responses and descriptions are presented
in Table 2.2. The most common reports were the images of people (15 reports) and
animals (10 reports). There were 2 reports of simple shapes and patterns (on top of
seeing faces) and only one report of seeing trees and buildings. Four people
reported that the images they see have no particular form (e.g., unspecified or
blurred images).
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Patient Description of VHs
1 Ordinary people and animals.
2 Ordinary people. Despite images being sharp, cannot distinguish faces.
3 My wife.
4 Animals, children, insects.
5 Spiders, ordinary people.
6 If I see a mark on the carpet, the more I look at it, the more I can see a spider with
its legs kicking. I can look at an object and my mind tells me that I can see things
within the object that I know are not really there. It is like seeing a picture but the
picture can change into something completely different with the blink of an eye.
7 Shadows of people around cars, animals, children.
8 People, a dog.
9 Ordinary middle-aged people.
10 Hallucinations are blurred and cannot focus the details.
11 Shadowy animals, usually small rodents (mice) and spiders.
12 Mainly human faces or animal shapes.
I do quite often pick out outline shapes in things like carpets or other patterned
materials/things, pictures, shadows on the ground, etc. The best way to describe
this is to use the analogy of the young girl/old lady pen and ink drawing, where
depending on how you look at the drawing, you see either a young girl or an old
lady. These "images", will only last for seconds, and are not at all disturbing to me.
I have always seen some of these images, but I do think the problem has got much
worse/more frequent, since starting to take levodopa. An example: when looking at
a friend's picture of some old houses, yesterday evening, I saw in the pattern of
clouds in the sky of the picture firstly a man's face, and then a dog. Both "images"
disappeared after a few seconds. I also pick up, sometimes, what I think are
reflections from the edges of the lenses, which can appear as bright flashes in the
corner of my vision, or alternatively, dark patches sometimes.
13 Fine pattern of fine lines on bright white background. The pattern moves back and
forward. People.
14 People. Shapes - usually bright light or fireworks.
15 People.
16 People trying to harm me. People (sometimes recognizing family members) being
buried. Images are often coming towards me and trying to "get" me.
17 Hallucinations are blurred and cannot focus the details.
18 A girl sitting in a settee. A girl has thin legs, huge knees (like swollen) and big
head. A dog. People walking up and down the street, but the faces are not
distinguishable.
19 Mainly people and insects. When I am watching TV, I sometimes see people
wearing glasses or having a moustache which later disappear. I mistakenly see
people sitting in an empty car. I think my brain misinterprets what my eyes see.
20 Hallucinations are blurred and cannot focus the details.
21 People standing. People coming down from ceiling, when they hit the floor, they
disappear.
22 People's faces. Trees. Buildings.
23 Hallucinations are blurred and cannot focus the details.
T bl 22 D fVH
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Table 2.3 displays frequency and percentage reports about different
characteristics of VHs reported in the VHs questionnaire (see Appendix 1 -
Questions 11-27). Significantly different distributions of the answers from each of
the multiple-choice questions are asterisked (using chi-square analysis).
Table 2.3. Characteristics of VHs in PD.
Variable N %
Frequency of VHs
>5/week 6 26
2 to 5/week 9 39
l/week 8 35
Number of images
One 7 30
2 to 5 9 40
More than 5 7 30
Content
Stereotyped 9 39
Always different 10 44
Missing data 4 17
Clarity
Sharp 9 40
Blurry 8 35
Transparent 1 4**
Variable 5 21
Distortion of images
Present 9 39
Absent 12 52
Missing data 2 9
Reality of images
Seem real 10 43
Seem unreal 8 35
Not sure 5 22
Colour
Black and white 7 30
Single colour 4 17
Multiple colours 12 53
Movement
Present 19 83**
Absent 4 17**
Eyes
Open 15 66*
Closed 4 17*
Both 4 17*
Vision field
Complete 8 35
Partial 14 61
Missing data 1 4. .
Variable N %
Onset
Sudden 17 74*
Gradual 4 17*
Missing data 2 9
Trigger
Starts with percept 8 35
Starts without percept 14 61
Missing data 1 4
Duration of VHs
Hours 6 26
Minutes 8 35
Seconds 7 30
Missing data 2 9
Time of day
When waking up 4 17
When falling asleep 3 13
In the morning 4 17
In the afternoon 5 22
In the evening 7 31
Lighting
Bright 5 21
Dim 10 43
Dark 2 9*
Variable 6 27
Images talk to
The patient 1 4**
Each other 2 9*
Do not talk 20 87**
Images accompanied by
Voice 3 13*
Smell 1 5**
Touch 1 5**
Nothing 18 77*
Disturbed because of VHs
Yes 5 21**
No 18 79**
Perceived control
Yes 12 52
No 8 35
Missing data 3 13
* "1..2;significant difference In distribution of responses from chance, p<0.05 .
** "1..2;significant difference in distribution of responses from chance, p<O.OI.
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The most noticeable characteristics of VHs from the present sample were:
(a) Sudden appearance of "solid" images (either sharp or blurred clarity, but
not ghost-like, transparent images);
(b) Hallucinations were almost invariably perceived in the visual modality
only (hallucinations in other modalities were rare); similarly, the images did not
communicate either with the patients or (in the cases of multiple images) to each
other;
(c) Images were frequently in motion;
(d) The images were most commonly experienced when the patients had their
eyes open, and
(e) Although half of all patients reported having control over their VHs and
being able to make them disappear, the majority of patients (N=18) were not at all
disturbed by the images. One patient described the images as "not scary, just
annoying when wanting to fall asleep". Finally, one of the patients reported he liked
the images because "they keep me company".
Regression Anal ysis
The statistically significant variables (sudden onset, hallucinations in the visual
modality, moving images, open eyes, and non-threatening nature of the images)
were submitted to a regression analysis; however, no model could predict the
frequency of VHs on the basis of these variables (p = .742). Furthermore, using
regression analysis, no model could predict the frequency of VHs (i.e., more than 5
times per week, 2-5 times per week or once per week) based on the range of
demographic variables (temporal factors, HY disability stage, the amount of daily
levodopa dosage, etc.) (p = .786).
Finally, there were no statistically significant differences on a number of independent
variables between PD patients with and without ocular problems (see Table 4.2). PD
patients with ocular problems in the current studies were not at a higher risk for
developing VHs than PD patients without ocular problems. In addition, the possible
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role of ocular problems in development of VHs was also excluded, as there were no
statistically significant differences between PD patients with and without ocular
problems on the CANT AB visual memory and executive functions tests.
Table 2.4: Differences between PD patients with and without ocular problems: Means, SDs,
d Ian p-va ues.
PD with ocular PD without t df P
problems ocular problems
Age 72.50 (7.79) 71.27 (6.96) .338 19 .726
Gender 1.50 (.55) 1.31 (A8) .739 20 A40
HY Disability Scale 2.38 (l.60) 2.11 (1.02) .317 20 .687
Years since diagnosis 8.70 (6.60) 6.38 (5.57) .766 20 AI6
Side more affected by tremor l.67 (.82) 2.06 (.93) -.974 20 .370
Frequency of VHs 2.33 (.58) 2.00 (.82) .632 20 .576
lED
- total errors (adjusted) -.61 (1.59) -.08 (.65) -l.III 21 .279
- total errors (raw) -.39 (.95) -.37 (.97) -.048 21 .962
- completed stage errors .39 (.73) -.20 (1.38) .395 21 .697
- completed stage trials .64 (.83) .24 (1.29) .825 21 A19
- ED errors -.57 (1.17) -.86 (1.09) .608 21 .549
- ID errors .08 (1.25) .59 (.26) -1.484 21 .153
- stages completed -.78 (lA6) -.16 (.75) -1.330 21 .198
- total trials .03 (.77) -.18 (.86) .589 21 .562
- total trials (adjusted) -.65 (lA9) -.17 (.70) -1.055 21 .303
SOC
- problems solved in minimum moves -.33 (1.92) -.38 (1.14) -.079 21 .938
SWM
- between errors .15 (.68) -.02 (.97) A13 18 .684
- double errors A2 (.58) .34 (.93) .203 18 .841
- strategy -.25 (.37) -.38 (.77) A86 18 .633
- total errors -.14 (.67) -.34 (1.06) A39 18 .666
- within errors A4 (A2) .37 (.94) .204 ]8 .84]
DSM
- percent of correct answers -1.60 (2.33) -.84 (1.46) -.922 19 .368
- percent of correct simultaneous -.99 (2A7) -A3 (lA5) -.650 19 .524
answers
- probability of a double error -I .54 Cl.56) -.62 (1.12) -1.572 19 .133
PAL
- total number of errors .41 (A7) -.06 (.64) 1.532 12 .152
- average trials for a successful AD (.64) .09 (.65) .874 12 .399
solution
- average number of completed stages .33 (.67) .11 (.53) 1.012 12 .331
PRM
- percent of correct answers -.08 (1.16) -1.18 (1.50) 1.874 21 .075
SRM
-percent of correct answers -.33 (1.00) -.88 (.83) 1A19 20 .171
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2.4 Discussion
Providing detailed characteristics of VHs in PD has important implications for the
new research directions: understanding of both the underlying neural and functional
processes involved in the generation of VHs and, consequently, about the methods
to eliminate hallucinations (or at least effectively cope with them). Therefore, the
aim of the present study is to offer a detailed description of VHs in PD.
The patients from the study varied greatly according to their age, daily
levodopa dose, years since diagnosis, HY disability stage and the side of the body
that was more affected by tremor (as described in Table 2.1). There is therefore no
"typical" PD patient, as PD is expressed in different ways across patients (Paulson
& Stem, 1996). However, half of all patients (N = 11) had some form of ocular
pathology in the current study (see Table 2.1), which is comparable to the estimated
50% of ocular problems in old age in Great Britain (Government Statistical Service,
1988). Most of the reported pathologies affected visual acuity of patients (e.g., loss
of focus and double vision) and two reported having cataract. Visual acuity and
cataracts were independent Iy associated with VHs in age related eye disease
(Berrios & Brook, 1984; Teunisse, Cruysberg, Hoefnagels, Verbeek, & Zitman,
1996), in Alzheimer'S Disease (Chapman et al., 1999) and in Charles-Bonnet
Syndrome (Jacob, Prasad, Boggild, & Chandratre, 2004; Rosenbaum, Harati, Rolak,
& Freedman, 1987). Levine (1980) reports on association between VHs and
cataract. Moreover, even in PO, VHs were reported to disappear after cataract
surgery (Matsui et al., 2004). As discussed in Chapter 1, the dopaminergic system,
which is affected in PO, has projections to the human retina (Biousse et al., 2004)
and can affect all subsequent processing from the level of retina onwards. While the
results from the present study cannot postulate a causal link between ocular
problems experienced by the patients and VHs, the results suggest that age-related
vision problems present an additive problem on top of the impoverished
dopaminergic visual system.
If this is really the case, then the projections from the retina to the thalamus
and the primary visual cortex are additionally suboptimal due to the ocular
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pathology observed in the present sample of hallucinating PD patients. The
impoverished visual input in the primary visual cortex consequently alters all
further visual processing. Rosenbaum and Freedman (1987) and Lalla and Primeau
(1993) argued that a number of ocular pathologies, but also post-surgical eye
patching or sensory deprivation, may cause a lack in the usual afferent inputs,
producing spontaneous nerve impulses and visual experiences at any of the various
levels of visual processing. This hypothesis is in line with two other studies
(Manford & Andermann, 1998; Rodnitzky, 1998) which suggest that the
compromised dopaminergic system in the retina consequently affects the
functioning of all subsequent processes in the visual system, namely the ventral and
the dorsal visual pathways. In addition, impoverished data might give rise to more
top-down processing, and hence the tendency to generate things that are not really
there.
The descriptions of VHs in the present study were similar to those described
in the previous studies of hallucinating PD patients (Barnes & David, 2001; Fenelon
et al., 2000; Holroyd et al., 2001; Manford & Andermann, 1998). Patients described
the sudden onset of well-defined images (mainly people and animals) and were able
to recollect the features of the images as clearly as if they were actually looking at
them. The images were often moving around, although the movement was usually
rather restricted (e.g., the images repeated the same sequence of gestures or moves).
The finding about the clear, well-formed and moving images supports the
hypothesis about the early dysfunctions of the visual system, and suggests that both
the ventral and dorsal pathways, stemming from the primary visual cortex, might be
affected as a result, and involved in the generation of VHs in PD.
Goodale and Milner (1992) pioneered the work on the processing of visual
information. They suggested that visual perception depends on two systems: a
ventral stream of projections from the primary visual cortex to the inferior temporal
cortex, playing a major role in the perceptual identification of objects and form
representation, and a dorsal stream of projections from the primary visual cortex to
the posterior parietal cortex, involved in spatial awareness, guidance of actions, and
detecting and analyzing movements (ibid). Ffytche et al. (1998) provided firm fMRI
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evidence that the content of the hallucinations of patients with Charles-Bonnet
syndrome (VHs of the blind) reflects the functional specializations of the region.
Patients with Charles-Bonnet syndrome often perceive images of faces and objects,
and such hallucinations correlate with cerebral activity in the ventral visual cortex.
Although no neuroimaging studies have been done in PO patients during
hallucinations, some neuroimaging studies showed relatively increased activation of
the ventral stream in hallucinating PO patients in the resting (non-hallucinating)
state, compared to the non-hallucinating counterparts 13. The dysfunction of the
parietal-dorsal stream in the hallucinating PO patients in the resting state has been
suggested in several neuroimaging studies, where the authors found hypoperfusion
in the parietal lobe using PET (Matsui, Nishinaka et al., 2006b), grey matter volume
reduction using MRI (Ramirez-Ruiz, Marti et al., 2007), and significantly higher
density of the Lewy bodies in the dorsal areas using a clinical-pathological
comparison between the brain of hallucinating and non-hallucinating PD patients
(Papapetropoulos, McCorquodale, Gonzalez, Jean-Gilles, & Mash, 2006).
Putting the phenomenological descriptions from the present study (see Table
2.2) together with the neuroimaging and pathological findings, it can be
hypothesized that the nature of VHs in PO reflects the functional specializations of
the ventral and dorsal pathways. Thus, well-defined images of mainly people and
animals could reflect the activation of the ventral visual pathway and the reports of
the movement of the images (although restricted in nature) could suggest the
activation of the dorsal pathway during hallucinations in PD patients. However,
although a similar idea is expressed in two other studies (Boecker et al., 2007;
Mosimann et al., 2006), this hypothesis is based only on the phenomenological
results and the results from another disorder affected by VHs (Ffytche et al., 1998).
These speculations need to be supported by empirical evidence from PO patients
during their hallucinating states, as well as by a neuropsychological assessment of
functioning of the association visual cortex, which will be addressed in Chapter 4.
13 Aberrant activation of the ventral stream in hallucinating PD patients has been suggested by
Harding et al. (2002), Matsui et al. (2006b), Oishi et al. (2005), Okada et al. (1999) and Stebbins et
al. (2004).
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Furthermore, the hallucinating PD patients from the present study often
reported experiencing non-threatening hallucinations in the visual modality only.
Thus, VHs were rarely accompanied by voice, smell or touch (see Table 2.3).
Likewise, the images were rarely talking to each other or to the patient. The results
are in line with other studies reporting that hallucinations in other sensory
modalities are rare in PD (Diederich et al., 2005; Fenelon et al., 2000; Haeske-
Dewick, 1995; Inzelberg et al., 1998; Tousi & Frankel, 2004). Fenelon et al. (2000)
reported that in the very few cases where auditory verbal hallucinations were
present, they were always neutral and clearly different from the threatening auditory
hallucinations characteristic of schizophrenia. Moreover, Bodis-Wollner (2003)
suggested that the presence of auditory hallucinations in PD (especially without
VHs) raises a suspicion of an underlying primary psychiatric disorder. Mainly
visual and non-threatening hallucinations in PD patients from the present study
therefore indicate that VHs are not caused by a coexisting psychiatric disorder.
However, due to the neutral emotional response to VHs, the study raises the
question of how PD patients cope with their VHs (see Chapter 9) and whether there
are specific characteristics of the images that influence their responses.
The detailed descriptions of VHs of PD patients presented in the current study
revealed that despite the occasional bizarre appearances, the majority of the images
were non-threatening, repetitive and stereotyped, and provoked little or no
emotional response in the patients. All patients had preserved insight into the
hallucinatory nature of the images they saw. Therefore, it is not surprising that the
majority of the patients were not disturbed by or worried about their VHs.
Additionally, although some characteristics of VHs were not statistically
significant, the present study offers a line of alternative motives for patients' clear
insight and undisturbed response to the images. Firstly, the images were
experienced relatively often, occurring at least once a week (see Table 2.3). With
time, the patients may have learned that the images do not harm them and perceive
them as a part of their everyday life. Their emotional responses to the images might
therefore become neutral quite quickly. There are also a number of visual cues that
helped the patients to recognize the image as a hallucination, e.g., the clarity of the
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images might be different to the clarity of other objects in the environment (images
are often blurred, see Table 2.3), the images may occur in different colour than the
environment (e.g., in black and white or in a single colour), the images may
suddenly appear, where there was nothing before, starting without any percept. The
images are often stereotyped, occurring always at the same time and place. Finally,
some patients experienced the images as somewhat distorted, giving them the
qualities of the unreal percepts. Taking these visual cues into consideration, it is not
surprising that a substantial number of the patients (N = 13) reported that the
images they perceive look unreal.
The phenomenology of the VHs experienced by the PD patients from the
present study offers new insight into the nature of the images. There are a number
of cues that can be used by PD patients as indicators for recognizing the images as
unreal, and together with the unexciting content, offer a base for a non-emotional
and neutral response towards the images. The study raises the possibility of whether
specific characteristics of the images influence not only emotionally neutral
responses, but also moulding the behavioural coping responses of patients. These
questions will be addressed in detail in the context of patients' personality traits
(e.g., emotional responsiveness, self-control, self-consciousness, etc.) in Chapter 9.
Finally, apart from studying the characteristics of VHs in PD, the aim of the
present study was also to identify whether the frequency of VHs can be predicted
on the basis of the statistically significant characteristics of VHs (see Table 2.3) or
on the basis of the demographic variables (e.g., temporal factors, levodopa dosage,
disability stage, etc.). No model could adequately predict the frequency of VHs on
the basis of these variables in the current study. The results from the study support
the claim that the frequency of VHs is independent of the nature of VHs
experienced and of any other demographic data. VHs in PD are therefore more
likely to be related to more cognitive factors.
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2.4.1 Limitations
PO patients were selected on the criterion of absence of dementia; however, dementia
was evaluated on subjective measures, such as gathering reports from the carers and
asking about maintenance of activities of daily living. This poses a problem as a more
objective measure of cognitive decline should be accounted for in studies with PD
populations.
The Mini-Mental Status Examination (MMSE) (Folstein, Folstein, & McHugh,
1975) is the most routinely administered orientation measure used by neurologists to
screen for orientation and cognitive impairments informally (York & Alvarez, 2008).
It is sensitive to the presence of dementia, particularly in those with moderate to
severe forms of cognitive impairment; however, the MMSE appears to be less than
ideal when those with mild cognitive impairment are evaluated (Kuslansky, 2004;
Nys et al., 2005). In some patient groups, such as PD, using the MMSE as the only
method of cognitive assessment might not only be inappropriate, but even misleading;
a normal MMSE is likely to lead to the false assumption of preserved cognitive status
while in fact the patient might have severe frontal dysexecutive or visuospatial
symptoms (Bak & Mioshi, 2007). MMSE has been criticized for being insensitive to
differences between dementing disorders, and particularly to cognitive decline in
subcortical dementi as, such as PO (Huber & Bomstein, 1992; Jefferson et al., 2002).
In a recent study defining cognitive dysfunction as impaired performance on at least
three neuropsychological tests, there was no difference found in MMSE scores
between cognitively intact and cognitively impaired PO patients (Muslimovic, Post,
Speelman, & Schmand, 2005). Therefore, cognitive deficits are common in PO
patients with "normal" cognition based on MMSE performance, suggesting that mild
cognitive impairment is under-recognized in clinical practice due to routine use of
insensitive screening instruments (Mamikonyan et al., 2009).
Therefore, some other measures of cognitive decline should be used; some
authors suggest measures such as the Dementia Rating Scale (DRS) (Mattis, 1988),
which were designed to assess early cognitive impairment and was showed to be a
valid mental status screening test of cognitive functioning for individuals with PO
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(Brown et al., 1999), 1999). The other possibility is The Montreal Cognitive
Assessment (MoCA), which is more sensitive to subtle cognitive deficits in patients
with PO (Nasreddine et al., 2005). In summary, future research needs to take some
cognitive measures of dementia into account for early signs of dementia as important
covariates in the assessment of cognitive functioning.
2.4.2 Conclusions
Age-related ocular problems were a frequent complication factor in the
hallucinating PD patients from the present study, probably affecting the already
compromised dopaminergic-based visual processing. The impoverished data from
the early stages of visual processing onwards gives rise to aberrant subsequent
visual processing, as well as to more top-down processing. Well-formed and
moving images suggest suboptimal functional specialization of the ventral and
dorsal visual system in the hallucinating PD patients; however, this hypothesis is
strictly speculative and needs to be addressed by the means of using neuroimaging
techniques during the hallucinating state. Five specific features characterized VHs
in PO: sudden appearance of "solid" images, frequent movement of the images,
non-threatening nature, and images were experienced with the eyes open and in the
visual modality; however, these characteristics could not predict the frequency of
hallucinations using the regression analysis. Further, hallucinating PO patients
probably use a range of visual cues to preserve the insight into the hallucinatory
nature of the images and the nature of VHs in PD was probably reflected in a
composed emotional response; however, this is a significant finding and deserves
further investigation in greater details (see Chapter 9). Finally, the demographic
characteristics of the hallucinating PD patients could not predict the frequency of
VHs using regression analysis, and suggest the importance of other, more cognitive,
factors in the generation of VHs in PO.
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Chapter 3: Proneness to VHs in the Normal Population
3.1 Introduction
Chapter 2 investigated the detailed phenomenology of VHs in PD and explored how
the characteristics of the images relate to each other and to the demographics of the
hallucinating PD patients. VHs in PD do not only constitute well-formed images,
but also include "hallucinatory-like" experiences such as sensations of a presence, a
sideway passage, etc. (Fenelon et al., 2000). However, while hallucinatory-like
experiences are a frequent manifestation in clinical populations, they also occur in
the normal population, without any history of psychiatric disorders. Several authors
(Hanssen et al., 2003; Johns & van Os2001; Lopez-Rodrigo et al., 1997; Slade &
Bentall, 1988; Stefanis et al., 2002; Verdoux & van Os, 2002) have proposed that
such experiences range from mild visual disturbances to full-blown hallucinations,
characteristic of psychiatric illness. Stemming from the continuum hypothesis
(ibid), the present chapter aims to investigate the expression of visual images
further and explore how hallucinatory-like experiences are expressed in the normal
population.
One of the first attempts to measure psychosis proneness was with the
psychotic ism dimension as a personality feature (Eysenck, 1952; Eysenck &
Eysenck, 1976). According to this standpoint, psychosis proneness is a dimensional
construct ranging from normality (defined in culturally relative terms) to psychosis
(a similar idea to the continuum hypothesis). Psychosis proneness was later
developed into a multidimensional construct, promoting the development of the
schizotypy scale of Oxford and Liverpool Inventory of Feelings and Experiences
(a-LIFE) (Claridge et al., 1996; Mason & Claridge, 2006). Other approaches,
however, aimed to measure subtle psychotic symptoms in the general population,
most commonly delusion and hallucination-proneness. Two common scales, for
example, are the Cardiff Anomalous Perceptions Scale (CAPS) (Bell et al., 2006)
and the Launay-Slade Hallucinations Scale (LSHS) (Morrison et al., 2000;
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Morrison, Wells, & Nothard, 2002). These scales are often used as measures of
hallucination-proneness, because they consider not only clear visual hallucinations,
but mainly rely on subjective experiences (e.g., a feeling of a presence of another
being). However, a shortcoming of the scales is the over-emphasizing of
hallucinatory experiences in the visual and auditory modalities, and consequently
leaving the relationship between different modalities under-researched.
In order to investigate the nature of hallucination-predisposition in the healthy
young population, the aim of the present study is two-fold: firstly, to construct a
valid and reliable measure of hallucination-proneness taking visual, auditory and
other sensory modalities into consideration; and secondly, to investigate how
hallucination-proneness is expressed in the normal population using a constructed
hallucination-proneness questionnaire. The study will give evidence as to whether
such an approach is useful in differentiating people from the normal population who
are extremely high and extremely low-prone to have hallucinatory-like experiences.
Following from the hypothesis about qualitative differences between high and low-
prone individuals (Lopez-Rodrigo et al., 1997), the present study will proceed to
offer a basis for following studies, investigating whether the cognitive differences
between high and low-prone normal individuals correspond to the same cognitive
differences between hallucinating and non-hallucinating PD patients.
3.2Methods
3.2.1 Construction of the Hallucination-Proneness Questionnaire (HQ)
The HQ was constructed by adapting questions from the Cardiff Anomalous
Perceptions Scale (CAPS) (Bell et al., 2006) and the Launay-Slade Hallucinations
Scale (LSHS) (Morrison et al., 2000; Morrison, Wells, & Nothard, 2002) because
they focus on subtle perceptual distortions rather than on full-blown hallucinations,
the latter not being commonly observed in the normal population. Furthermore, the
purpose of the questionnaire is to observe the relationship between hallucination-
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proneness in different modalities. Therefore, the questions asked in the HQ reflect a
subjective evaluation, representing hallucination-proneness from visual, auditory
and other modalities with approximately the same number of items included in each
scale. In the final version of the HQ, three scales were developed, namely visual (9
items), auditory (10 items), and other sensory modality scale (10 items). The HQ
items, by category, are attached in Appendix 4. Each item is presented with a
statement requiring an answer ranging from 0 ("certainly does not apply to me") to
4 ("certainly applies to me"). However, in Chapter 2, the issue of measuring
"realistic" and "pathological" experiences was raised (Giorgi, 2003). For the same
reason, the constructed questionnaire allows the participants to clarify and give
explanation for each numerical answer they chose.
Apart from proneness to hallucinatory experiences in the specific perceptual
modality, the sum of all three scales presents the total HQ score.
3.2.2 Participants
An opportunity sample of 555 undergraduate students (384 females and 171 males)
from Oxford Brookes University, with a mean age of 21.61 years (SD = 5.94; range
from 17 to 29), completed the HQ (278 students completed it between May 2006
and October 2006 and 277 students in January 2008). Apart from age and gender,
the following variables were collected in the present study: handedness, the
presence/absence of dyslexia, vision and hearing problems, and the
presence/absence of psychiatric or neurological disorders. All participants had
normal or corrected-to-normal vision and hearing. Participants with a history of
psychiatric or neurological disorders were excluded from the sample (2 cases).
Questionnaires with one or more missing answers were excluded from the analysis
(14 cases).
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3.2.3 Procedure
Written permissions from lecturers of different disciplines were obtained before
introducing the study at the beginning of the lectures. Questionnaires were
distributed together with the information sheets (Appendix 5) in the class. At the
end of the lecture, the questionnaires were collected. In order to avoid coercion, the
exact percentage of returned questionnaires is unknown; however, it is estimated
that between 40-70% of the students in each class completed the questionnaires.
The students were informed that the study was anonymous, but for the purpose of
the follow-up studies, the students were asked to leave their electronic contact
details if they so wished.
The present and all the following studies with the normal individuals were
approved by the University Research Ethics Committee (see Appendix 3).
3.2.4 Analysis
First, descriptive statistics were calculated for all three scales (visual, auditory and
other modality scale) as well as for the total HQ sum. Correlation analysis was
performed between all HQ scales to test if there is a link between the individual
scales. One-way analysis of variance (ANOVA) was used to test the differences on
the three HQ scales and the total HQ sum among different age groups, and the
independent t-tests were used to test the differences on HQ among other
dichotomous measures (i.e., gender, handedness, dyslexia, vision and hearing
problems). A logistic regression analysis was performed to predict the outcome of
the HQ on the basis of the independent variables (age, gender, vision and hearing
problems, dyslexia and handedness). Finally, principal component analysis (PCA)
was performed to test if 29 HQ items can be explained in terms of a much smaller
number of factors. PCA reveals the internal structure of the data in a way which
best explains the variance in the data, and the variances extracted by the factors are
called the eigenvalues (Stevens, 1992). The number of retained factors was
determined by the eigenvalues greater than 1 (also known as the Kaiser's criterion).
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All analyses were performed with SPSS Version 15.0 (SPSS Inc., Chicago,
IL).
3.3 Results
The reliability coefficient was high for all three scales and for all items of the HQ
(Cronbach a for the auditory scale was .805, for visual scale .802, for other
modalities .859 and for all items of the HQ .922). Descriptive statistics for all three
scales and the HQ total sum are displayed in Table 3.1. The range was wide for all
HQ scales: for the visual scale was from 0 to 30 (out of 36 maximum possible
points), for the auditory scale from 0 to 31 (out of 40 maximum possible points),
and for the other sensory modalities from 0 to 36 (out of 40 maximum possible
points). Hallucination-proneness in other sensory modalities (taste, touch, olfaction,
etc.) was twice as frequent as proneness to visual or auditory hallucinations. The
results indicate a wide dispersion of hallucination-proneness in the normal
population; however, low hallucination-proneness was more frequent than high
hallucination-proneness, as indicated by the positively skewed distributions of all
three scales and the final HQ score (see Table 3.1).
Table 3.1. Descri tive statistics for all HQ scales and the final HQ score.
8.76 (6.86) 8.86 (7.12) 14.63 (8.68) 32.12 (19.97)
.779 (.104) .856 (.104) .249 (.104) .483 (.105)
-.102 (.207) .180 (.208) -.889 (.208) -.603 (.209)
Visual Auditor Other H
M(SD)
Skew (Std Error)
Kurtosis (Std Error)
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The results of the correlation are displayed in Table 3.2. All three scales and
the final HQ score were significantly positively correlated.
Table 3.2. Correlation matrix.
Visual
Auditory
Other
HQ
1
.692**
.704**
.891**
.614**
.855** .894**
Visual Auditory Other HQ
** Correlation is significant at the 0.01 level.
Participants' responses were not statistically different depending on their
gender, vision or hearing problems, handedness and dyslexia (see Table 3.3).
Table 3.3. T-test results for the HQ scales.
Visual t=0.24, t=0.12, t=-1.22,
p=0.813 p=0.908 p=0.225
Auditory t=-1.37, t=0.14, t=-1.04,
p=O.I72 p=0.889 p=OJOO
Other t=I.08, t=-0.12, t=-0.56,
p=0.283 p=0.908 p=0.579
HQ t=0.11, t=0.05, t=-1.01,
=0.91 =0.959 =0.313
Hearing
roblems
t=-0.86,
p=0.389
t=-0.89,
p=0.374
t=0.96,
p=0.335
t=-0.22,
=0.824
The results indicate that hallucination-proneness in all modalities are more or
less equally expressed in the normal population regardless of gender, other vision or
hearing problems, handedness or dyslexia.
Correlation between age and the measures of HQ were calculated (see Table
3.4); there are no statistically significant correlations. However, it has to be stressed
that the age range (see Section 3.2.2) of the student sample is limited (ranging from
17 to 29) and therefore any differences based on age are not likely to be observed.
Table 3.4. Pearson's correlations between age and all measures of HQ.
HQ- visual HQ- auditory HQ- other HQ - total
scale scale modalities scale
Age .024 -.037 -.035 -.016
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Regression Analysis
Using a logistic regression analysis, no model could predict the HQ outcome or the
outcome of the individual scales on the basis of the independent variables that were
taken into account in the present study (i.e. gender, vision or hearing problems,
handedness and dyslexia). The regression analysis results are presented in Tables
3.5 to 3.8.
Proportion of the variance of the visual scale of the HQ explained by the
model is 13%. The ANOVA showed that the model is not a significant predictor of
HQ-visual scale (F = 1.179, d.f. = 5/449, P = 0.318. Overall, the regression analysis
is not significant and individual predictors are not significant either (for exact
values of the independent variables see Table 3.5).
Table 3.5: Resression anal~sis for the visual scale of the HQ.
Model Standardized
Coefficients (Beta) t Q
(Constant) .730 .466
Gender -.028 -.592 .554
Age .024 .519 .604
Vision -.07l -1.498 .135
Problems
Hearing .026 .550 .583
Problems
Dyslexia .067 1.420 .156
Proportion of the variance of the auditory scale of the HQ explained by the model is
5%. The ANOVA shows that the model is not a significant predictor of HQ-
auditory scale (F = .478, d.f. = 5/445, p = 0.793. Overall, the regression analysis is
not significant and individual predictors are not significant either (for exact values
of the independent variables see Table 3.6).
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Table 3.6: Regression analysis for the auditory scale of the HQ.
Model Standardized
Coefficients (Beta) t p
(Constant)
Gender .046
Age -.013
Vision -.018Problems
Hearing .020Problems
Dyslexia .049
.920 .358
.959 .338
-.283 .778
-.369 .712
.418 .676
1.038 .300
Proportion of the variance of other sensory modality scale of the HQ explained by
the model is 11%. The ANOVA shows that the model is not a significant predictor
of HQ-other scale (F = 0.943, d.f. = 5/443, P = 0.453. Overall, the regression
analysis is not significant and individual predictors are not significant either (for
exact values of the independent variables see Table 3.7).
Table 3.7: Regression analysis for the other sensory modalities scale of the HQ.
Model Standardized
Coefficients (Beta) t 12
1 (Constant) .920 .358
Gender -.046 -.970 .333
Age -.021 -.432 .666
Vision
-.045 -.937 .349Problems
Hearing -.031 -.661 .509Problems
Dyslexia .066 1.385 .167
Proportion of the variance of the HQ(total) explained by the model is 9%. The
ANDV A shows that the model is not a significant predictor of HQ-other scale (F =
0.771, d.f, = 5/440, p = 0.571. Overall, the regression analysis is not significant and
individual predictors are not significant either (for exact values of the independent
variables see Table 3.8).
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Table 3.8: Regression analysis for the HQ.
Model Standardized
Coefficients {Beta} t ~
(Constant) 1.687 .092
Gender -.016 -.328 .743
Age .000 .000 1.000
Vision Problems -.055 -1.155 .249
Hearing Problems .002 .036 .971
Dyslexia .068 1.423 .156
Principal Component Analysis (PCA)
PCA revealed 6 factors, where the eigenvalue was higher than 1, which accounted
for 55% of the variance (see Table 3.9). The first factor accounted for 32% of the
variance and was defined as general hallucinatory tendency.
Component Eigenvalue % of Variance Cumulative %
1 9.270 31.966 31.966
2 1.988 6.854 38.820
3 1.365 4.708 43.528
4 1.195 4.120 47.648
5 1.089 3.756 51.403
6 1.052 3.629 55.033
Next, absolute values of the individual items extracted with the PCA that were
less than .40 were suppressed (Stevens, 1992). Even with the .40 suppression value,
all 29 items of the HQ loaded on the first factor (see Appendix 6). Therefore, the
factor analysis strongly supported the one-dimensional solution of the proneness to
the hallucinatory experiences, which is in line with statistically significant positive
correlations between the scales (see Table 3.2).
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3.4 Discussion
The aim of the present study was to investigate how hallucination-proneness is
expressed in the normal population, using a measure of hallucination-proneness in
the visual, auditory and other sensory modalities. The results suggest that the HQ,
which was constructed on the basis of other hallucination-proneness questionnaires
and has a high internal reliability, elicits a wide range of answers, varying from low
to high hallucination-proneness (see Table 3.1). This was true not only for the total
HQ score, but also for all three scales (the visual, the auditory and the other
modalities). The results therefore suggest that hallucinatory experiences are
expressed in varying degrees in the normal population. These results are in line with
several authors who proposed a continuum nature of the hallucinatory experiences
(Crow, 1998; Lopez-Rodrigo et al., 1997; Slade & Bentall, 1988).
The results from the present study suggest that although the majority of
participants experienced occasional occurrence of hallucinatory experiences, high
incidence of hallucinatory-like experiences were rare (the distributions for all scales
were positively skewed, see Table 3.1). Based on the results from the present study,
hallucination-proneness is therefore likely to lie on a continuum, with the majority
of people occasionally experiencing some anomalous perceptions either in the
visual, auditory or other sensory modalities. Similar distribution was also suggested
by both Aleman et al. (2001) and Bentall and Slade (1985), who used the LSHS
(Morrison et al., 2000; Morrison, Wells, & Nothard, 2002).
Regarding hallucination-proneness in different modalities, the multi-
dimensionality of the HQ was investigated with the principal component analysis.
Although 6 factors were yielded, all 29 items of the HQ saturated on the first factor,
with a higher explanatory variance than all the other 5 factors together. Therefore,
the first factor can be described as a tendency towards hallucinatory experiences,
and hallucination-proneness (as measured and defined in the present study) can be
considered a one-dimensional construct. Further, the one-dimensional construct is
based on strong correlations between the HQ items (see Table 3.2), and is
additionally supported by the positive significant correlations between all HQ scales
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and the final HQ score. High hallucination-proneness in the visual modality
therefore implies high proneness to hallucinatory experiences in all the other
modalities. This is an important finding because it gives evidence that
hallucination-proneness in the normal population differs from hallucinations in PD
patients who usually report hallucinations in the visual modality. As described in
Section 1.2 and in the results of Chapter 2, hallucinations in modalities other than
visual are rare in PD and imply a differential diagnosis, independent of PD (Bodis-
Wollner, 2003; Fenelon et al., 2000; Inzelberg et al., 1998; Mosimann et al., 2006).
Finally, the scores on all three HQ scales and the final HQ score were not
dependant on the participants' age, gender, dyslexia, handedness, and vision or
hearing problems, confirmed by the ANOVA results (see Table 3.3). Similarly, the
independent variables could not predict the final outcome of the HQ scales or the
final HQ score using regression analysis. The results therefore suggest that the
differences between the high and low-prone normal individuals may be related to
the cognitive factors (see Section 1.5), rather than to the independent variables. The
findings are in line with Lopez-Rodrigo et al. (1997), who suggested there are
qualitative differences between individuals who are high and low-prone to have
hallucinatory experiences. Similar to VHs in PD, the results from the present study
suggest that there is a need for further exploration of the underlying cognitive risk
factors that contribute to higher hallucination-proneness in individuals from the
normal population.
3.4.1 Limitations
The main limitation of the current study is that the sample may not be wholly
representative of the normal population, as the participants were an opportunistic
sample of the undergraduate students. The aim of the study, however, was to
develop an instrument which would be able to identify high and low-prone
individuals from the continuum of the hallucinatory experiences. Although
replication of the study is warranted on a sample from the general population, it is
unlikely that the sample had an effect on the usefulness of the HQ to differentiate
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high and low-prone individuals. Further, for future analyses of the cognitive risk
factors involved in hallucination-proneness, matching the independent variables
between high and low-prone individuals might be of a higher importance than a
truly representative sampling from the general population.
Further, a specific limitation of the present study was a lack of control of those
students who have experienced altered states of mind due to the use of drugs. Drug
use is associated with several medical complications, both acute and long-lasting
(Ricaurte & McCann, 2005); chronic use of recreational drugs may, for example,
cause increased nervousness, irritability, and psychosis, an altered state of mind.
Chronic abusers may become paranoid and may suffer auditory and VHs, as well as
erratic and violent behaviour (Chiras, 2005). Furthermore, withdrawal from the drug
can cause severe depression (ibid). Chronic exposure to drug use may permanently
modify the nervous system. Therefore, the limitation of the present study is a lack of
control for drug use and future studies should screen for it. In future years, research
priorities include the possible role of previous drug use in the subsequent proneness
to hallucinatory experiences or even a possible development of neuropsychiatric
illness.
Finally, a limitation of the present study was that there was no attempt to assess
either the reliability or the validity of the HQ. One possible approach to demonstrate
validity is to ensure that the items within a measure are inter-related and therefore
measure a single construct. Factor analysis is often used to demonstrate relationships
among items. In the present study, the factor analysis showed one single factor,
indicating the concept is unidimensional. Another approach to demonstrate validity is
to simply test whether an instrument measures what is was supposed to measure. In
the current study, for example, it would be useful to assess the validity by
administering other hallucination-proneness questionnaires, such as the Cardiff
Anomalous Perceptions Scale (CAPS) (Bell et al., 2006) and the Launay-Slade
Hallucinations Scale (LSHS) (Morrison et al., 2000; Morrison, Wells, & Nothard,
2002). Similarly, although the Cronbach a reliability coefficient was high for all three
scales and for all items of the HQ, an additional test-retest reliability analysis would
be necessary to assess the reliability of the HQ. Test-retest reliability is an excellent
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measure of score consistency because it allows the direct measurement of consistency
from administration to administration. However, a possible shortcoming of the test-
retest reliability is that this coefficient is not the easiest to do in practice because of its
problems and limitations. One limitation related to the present study is that it requires
two administrations of the same test with the same group of individuals. This can be
expensive and demanding of people's time. In terms of the present study it would be
difficult to ask 555 participants to fill out the same questionnaire after a period of
time. Finally, if the time interval is short, participants may be overly consistent
because they remember some of the questions and their responses. Despite all of these
limitations, both reliability and validity are the crucial elements in quantitative
research, especially when trying to establish a new measure. Therefore, the limitation
of the present study is a lack of control to assess the test-retest reliability and validity
to ascertain that the HQ really measures hallucination-proneness and that the degree
of errors that are non-systematic and measures hallucination proneness consistently
over time.
3.4.2 Conclusions
In order to investigate the nature of hallucination-predisposition in the healthy
young population, the aim of the present study was two-fold: firstly, to construct a
valid and reliable measure of subtle perceptual distortions (not only clear
hallucinations) taking the equal representations of visual, auditory and other sensory
modalities into consideration; and secondly, to investigate how hallucination-
proneness is expressed in the normal population using the constructed
hallucination-proneness questionnaire. The HQ is a useful tool for identifying
individuals who are high and low-prone to have hallucinatory-like experiences. The
results confirmed previous reports that hallucination-proneness is a concept that is
expressed in different degrees in the normal population without any history of
psychiatric disorders. Further, hallucination-proneness is a unitary concept,
encompassing high proneness to anomalous perceptions in the visual, auditory and
other sensory modalities. All three scales, as well as the final HQ score, could not
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be predicted with the independent variables (age, gender, dyslexia, handedness, and
vision or hearing problems), implying that specific cognitive risk factors may
predispose high-prone individuals to hallucinatory experiences. Similar findings
and therefore a hypothesis that cognitive, rather than demographic, factors are
implemented in VHs were proposed in PD patients (Chapter 2). Possible risk factors
(based on the ones described in Section 1.6) will be addressed in the following
studies, namely the role of perceptual, imagery and executive functions, sleep
patterns and meta-cognitive processes.
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Summary of Part I
Part I examined the nature of VHs in PD and hallucination-proneness in the normal
population. VHs in PD and hallucination-proneness in the normal population were
not related to, or predicted by, any independent variables examined. The findings
from the studies suggest that hallucinating PD patients and high-prone normal
individuals differ from non-hallucinating PD patients and low-prone normal
individuals in cognitive functioning, rather than in demographics. Several possible
cognitive risk factors may have a role to play (see Section 1.6) and part II will
investigate the following factors: visual memory and visual imagery (Chapter 4),
early visual processing components (Chapter 5), executive functions (Chapter 6),
meta-cognitive processes (Chapter 7) and sleep patterns (Chapter 8). Finally,
Chapter 9 will address behavioural cognitive strategies that PD patients themselves
develop to cope with their VHs. Comparing if the same risk factors are implicated
in both hallucinating PD patients and in high-prone individuals will aid
understanding as to whether hallucinations and hallucination-proneness are
alleviated by the same cognitive factors, upon which a new model for VHs could be
built.
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Part 1114
Chapter 4: Visual Memory and Visual Imagery in Hallucinating PO Patients and
in High-Prone Normal Individuals
Chapter 5: Early Visual Processing Components in High-Prone Normal
Individuals: an EEG Study
Chapter 6: Executive Functions in Hallucinating PO Patients and in High-Prone
Normal Individuals
Chapter 7: Personality in Hallucinating PO Patients and in High-Prone Normal
Individuals
Chapter 8: Sleep Patterns in Hallucinating PO Patients and in High-Prone Normal
Individuals
Chapter 9: Behavioural Cognitive Coping Strategies in Hallucinating PO Patients
14 The main findings from Chapters 4-8 have formed the basis of an article which has been accepted
for publication (Maravic, in press), see Appendix 7.
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Chapter 4: Visual Memory and Visual Imagery in Hallucinating
PD Patients and in High-Prone Normal Individuals
4.1 Introduction
Following the detailed phenomenology of VH in PD in Chapter 2, it has been
suggested that the functioning of the association visual cortex is affected in
hallucinating PD patients. The visual system is based on dopaminergic pathways
which are impoverished in PD. In addition, age-related vision problems, which are
not in themselves sufficient for the generation of VHs in the general population,
represent an additional risk factor in PD population. Several authors (Chapman et
al., 1999; Diederich et al., 1998; Fenelon et al., 2000; Holroyd et al., 2001; Uc et
al., 2005) have suggested that poor visual input affects the early stages of visual
processing and the subsequent processing in the visual association cortex. This area
has traditionally been associated with higher level processing of visual information
and multi-sensory integration. Despite the growing evidence for impaired
functioning of the association visual areas in hallucinating PD patients, the
functioning of these areas remains poorly investigated.
Two studies have investigated the role of visuo-spatial functioning in
hallucinating PD (Barnes et al., 2003; Ramirez-Ruiz, Junque et al., 2007). Both
studies suggest dysfunctions of object recognition and visual memory for faces in
hallucinating PD patients, which point to a degeneration of the association visual
cortex. It can therefore be hypothesized that dysfunctions of the higher level visual
processing are implicated in the occurrence of VHs in PD; the same hypothesis
which was tentatively put forward in Chapter 2.
The aim of the current study is to further explore the role of a higher level
perceptual processing in the generation of VHs in PD, using a well-known, reliable
and valid neuropsychological battery. The Cambridge Neuropsychological
Automated Testing Battery (CANTAB) is an accurate, sensitive, reliable and well-
validated battery assessing a range of cognitive domains (22 tests altogether) such
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as visual memory, executive functioning, attention, semantic/verbal memory and
decision making and response control (CANTABec1ipse, 2006). Importantly, the
interpretation of results can be easily understood by a trained assistant. Apart from
high measure characteristics, the CANTAB has the advantage of detecting early
cognitive changes in different disorders: its tests are language independent and
culturally blind, it provides normative data and the touch-screen technology delivers
rapid and non-invasive cognitive assessment (ibid).
Visual memory tests from the CANTAB battery have yet to be tested in the
PD group in relation to VHs. If hallucinating PD patients perform worse on the
visual memory tasks than non-hallucinators, this would point to dysfunctions of
such higher level perception processes in the occurrence of VHs in PD. In contrast,
similar performance between the two PD groups on this task would support an
explanatory model for VHs in PD without inclusion of these visual processing
functions. In addition, the results from Chapter 2 suggest that VHs is PD reflect the
functional specialization of the visual areas and specific brain areas are sensitive for
specific visual memory tasks (see Section 4.2.2); therefore, possible dysfunctions in
performance on different tasks of visual memory will contribute to our
understanding of which underlying neural mechanisms are likely to be related to
VHs in PD.
Another perceptual attribute related to VHs is visual imagery. It is defined as
the degree of similarity of a mental image to actual perception; the more vivid the
image, the closer the experience is to an actual perception of sensory input (Aleman
et al., 1999). In contrast to higher level perceptual processing, visual imagery
correlates with fMRI activity in the early visual cortex (Amedi, Malach, & Pascual-
Leone, 2005; Cui, Jeter, Yang, Montague, & Eagleman, 2007) and frontal lobe
(lshai, Ungerleider, & Haxby, 2000). As discussed in Chapter 2, the high incidence
of age-related visual abnormalities in an already compromised dopaminergic retinal
system, could suggest that the visual input projection to the primary visual cortex is
suboptimal and would manifest itself in a dysfunction of early visual processing
(e.g., visual imagery). To date, only one study has addressed the issue of visual
imagery in VHs in PD (Barnes & L Boubert, 2008), which found that hallucinating
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and non-hallucinating PD patients did not differ in their imagery capabilities;
however, hallucinating PD patients expressed a higher tendency to report imaged
stimuli as percepts. Hence, the role of visual imagery in the generation of VHs
remains unclear and future studies are warranted to address the role of visual
imagery in their occurrence.
Stemming from the continuum hypothesis, the role of visual memory and
visual imagery might not only be implicated in a well known neurological disorder,
characterized by VHs, but also in the normal population who are high-prone to
having hallucinatory-like experiences. Currently, no studies have addressed the role
of visual memory in high-prone individuals; therefore, the present study will
pioneer this research. Visual imagery studies from the normal population have
detailed contradictory results: some authors report that visual imagery is related to
the occurrence of VHs, and some find no relation between visual imagery and
occurrence of hallucinations (Aleman et al., 1999; Aleman et al., 2000; Lopez-
Rodrigo et al., 1997).
The aim of the present study is to examine whether VHs in PD and
hallucination-proneness in the normal population arise from degradation of visual
memory and/or altered visual imagery. The results will provide a line of evidence as
to whether these visual functions can be considered as necessary factors in the
hypothetical model of the occurrence of VHs in PD and hallucination-proneness in
the normal population.
4.2 Methods
4.2.1 Participants
PD Group
10 PD patients with VHs and 20 PD patients without were recruited for the visual
memory and visual imagery study. All patients were members of the PD societies in
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the UK, with normal hearing and normal or corrected-to-normal vision. A criterion
for eligibility was a clinical diagnosis of PD as assessed by their GPs, and the
exclusion criterion were a moderate or severe stage of dementia, confirmed by the
carers of the PD patients, and the loss of independent maintenance of daily living
activities, also reported by the carers. The independent variables (as justified in
Section 1.6) were the same as stated in Chapter 2 (Section 2.2.1): age, amount of
daily levodopa medication and the use of any other medication, years since their
diagnosis, side of the body more affected by PD, the presence/absence of migraine,
the presence/absence of ocular pathology (not including correction glasses) and HY
motor disability stage. As far as the assessment of vision is concerned, patients were
asked if they are wearing glasses, and if so they were asked to use them during the
testing. Further, and as described in Chapter 2, patients were asked if they have any
additional ocular pathology or if they have ever consulted a doctor because of their
vision problems (e.g., double vision, cataract, loss of focus, conjunctivitis, etc.).
However, no formal assessment of patents' visual acuity was taken.
Demographics of hallucinating and non-hallucinating PD patients are
summarised in Table 4.1. The criteria for grouping patients as hallucinating PD
patients were recurrent VHs in the past month. 1 patient had VHs once a week, 7
had them 2-5 times a week, and 2 patients had VHs more than 5 times a week. 20
participants who have never experienced VHs were grouped as non-hallucinating
PD patients.
N
Age
Years since
diagnosis
Levodopa
(mg)
HY
Hallucinating Non-hallucinating Control Normals - Normals-
PD atients PD . atients
10 (6 male) 20 (15 male)
67.1 (6.9) 71.4 (7.8)
9.4 (5.4) 5.9 (5.8)
523.1 (278.1)
2.1 (1.06)
477.3 (286.3)
2.1 (1.08)
Data (except number of participants) are presented as means (±standard deviations).
HY refers to the Hoehn-Yahr disability scale (1967).
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Control Group
For the visual imagery tasks, 11 age-matched control participants (see Table 4.1)
were contacted on a snowball basis". All participants had normal hearing and
normal or corrected-to-normal vision. The exclusion criterion was a history of
psychiatric or neurological disorders.
The CANTAB normative database was created with over 3000 control subjects
(aged 4-90) who participated in various research studies, most being English-
speaking UK residents (CANT ABeclipse, 2006). Apart from age, the CANTAB
battery also offers comparison depending on gender and the NART estimated IQ. The
exact number of normative controls varies according to the CANTAB tasks, as well
as on the age-range, and is presented in Table 4.2. The numbers of the normative
database participants vary because they come from control data from a variety of
studies, the total of could not really be expected to distribute evenly over the age
groups. The numbers are different because new measures were added at different
stages in the development of the battery. As it can be seen from Table 4.2, the number
of normative database is extensive; for this reason it was utilised rather than
collecting new data from age-matched participants. New collection would supply
lower numbers than the CANT AB can provide, and it is therefore more reliable
source of comparison than collecting new data.
Table 4.2. Number of normative controls extracted for the CANT AB analysis.
Age-range
50-59 60-69 70-79
DMS 37-124 34-411 34-408
PAL 52-135 88-445 109-462
PRM 87-394 30-400 87-394
SRM 88-133 31-401 88-394
IED 38-96 60-158 53-171
SOC 80 179 187
SWM 80 63-] 83 66-190
15 A technique, where the current study participants recruit future participants from among their
acquaintances.
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Results were compared as closely as possible to the participants' age range,
namely 50-59, 60-69 and 70-79. Therefore, a performance of a 72 year old PO patient
was compared to the database of healthy volunteers aged between 70 and 79.
Apart from age-range and gender, the normative database of CANT AB also
offers the possibility of comparing the data from participants of the same IQ range (as
assessed by the NART); however, this was not taken into account in the current
studies. The implications of not including NART are discussed in the limitations
section (see Section 4.4.1).
Performance of CANT AB tasks was presented as the standard z-score that
compared each patient with the mean performance of healthy subjects matched by age
and sex. The CANT AB program was used to calculate z-scores on the basis of the
extensive normative database included in CANTAB. A positive value indicates better
than average performance and a negative value indicates poorer than average
performance.
High and Low-Prone Normal Individuals
12 individuals, low-prone to experience VHs (low-prone individuals) and 16
individuals, high-prone to experience VHs (high-prone individuals, see Table 4.1)
were recruited for the study (see Appendix 8). They were all undergraduate students
at Oxford Brookes University with normal hearing and normal or corrected-to-
normal vision. Exclusion criterion was a history of psychiatric or neurological
disorder. As in Chapter 3 (see Section 3.2.1), the following independent variables
were collected in the present study: age, gender, handedness and the
presence/absence of dyslexia. The students received a compensation for their
participation. There were no drop outs.
71
4.2.2 Assessments
CANTAB Visual Memory TestsJ6
The CANT AB was originally devised to assess cognitive function in elderly and
patients with dementia (Robbins et al., 1994), but quickly began to be used in the
analysis of cognitive function in a range of adult neuropsychiatric syndromes,
following drug treatments in healthy volunteers, and also in a neurodevelopmental
context (Lee, Owen, Rogers, Sahakian, & Robbins, 2000). Two main guiding
principles have been to use some tests that can be related to the extensive
neuropsychological literature in animals and human participants and to employ tests
that can be broken down into their discrete cognitive components in order to define
more readily which functions are impaired and which are spared, and thus the
overall specificity of any deficits (ibid).
Visual memory tasks of the CANT AB battery include the following four
tasks: Delayed Matching to Sample task (DMS), Paired Associated Learning
(PAL), Pattern Recognition Memory (PRM) and Spatial Recognition Memory
(SRM).
Delayed Matching to Sample (DMS)
DSM is a test of immediate and delayed perceptual matching. In this task, a
participant is presented with a stimulus. Next, four stimuli (of which one is the
same as the original stimulus and three are distractors) appear, either
simultaneously with the original stimulus or with a delay of 4 or 12 seconds (Figure
4.1). The participants are instructed to indicate when they recognise the target
stimulus among the distractors as quickly and accurately as possible.
Administration time is approximately 10 minutes. This test is primarily sensitive to
damage in the medial temporal lobe area, with some input from the frontal lobes
(CANTABeclipse, 2006). The DMS test of visual recognition memory is derived
16 The CANT AB battery and advice on its administration and analysis were provided by Dr Zola
Mannie and Dr Catherine Harper. Department of Psychiatry. University of Oxford.
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from an analogue paradigm used with monkeys (Mishkin, 1982; Passingham, 1985)
and the results showed that the prefrontal lesions in monkeys impair performance
both at short delays and in a simultaneous condition. The neural substrates include
lesions to different regions of the temporal lobes, the midline thalamic nuclei, and
the ventromedial prefrontal cortex (Murray, 1992; Owen, Sahakian, Semple,
Polkey, & Robbins, 1995). Sahakian et al. (Sahakian et al., 1988) found deficits of
delayed matching in patients with Alzheimer's Disease, whereas PD patients
showed deficits in both simultaneous and delayed condition.
Figure 4.1. An example of the DMS task.
DMS has the following outcome measures:
a) Percent of correct simultaneous answers: This measure reports, as a
percentage, the number of occasions in which the participant selected the correct
stimulus in trials when the stimulus was left in view whilst the target stimulus and
the three dis tractors were simultaneously presented.
b) Percent of all correct answers: This measure reports, as a percentage, the
number of occasions in which the participant selected the correct stimulus in trials
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when the target stimulus and the three distractors had been hidden, with delays of 0,
4 and 12 seconds. The percentage of correct solutions for all delay conditions gives
a good overall impression of visual memory ability, when compared with the
percentage of correct solutions for the simultaneous condition. The discrepancy
between percent correct (simultaneous) and percent correct (all delays) indicates the
increased memory load of delay conditions.
c) Probability of making a double error: This measure reports the probability
of a double error - an error occurring when the previous trial was responded to
incorrectly. Mitchell and Dalrymple-Alford (2006) suggested that larger thalamic
lesions would have a temporary effect on spatial working memory, and only in
terms of double errors. Higher amount of double errors in hallucinating PD patients
and/or in high-prone normal individuals would therefore reveal poorer performance
on spatial working memory and more extensive thalamic lesions in these groups.
Paired Associates Learning (PAL)
PAL assesses episodic visual memory and new learning. In this task, a participant is
presented with six or eight boxes, which are opened (and then closed) in a
randomized order. One or more of the boxes contain a pattern. The patterns shown
in the boxes are then displayed in the middle of the screen, one at a time, and the
participant must touch the box where the pattern was origin ally located. If the
participant makes an error, the boxes are opened again to remind the participant of
their locations. When the participant gets all the locations correct, they proceed to
the next stage. There are five stages with a different number of patterns (one, two,
three, six or eight). The stages always start with the easiest one (a stage with only
one pattern) and then progress in difficulty. If the participant cannot complete a
stage correctly, the test terminates. Administration time is approximately 10
minutes. This test is primarily sensitive to changes in medial temporal lobe
functioning (CANT ABec1ipse, 2006).
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PAL has the following outcome measures:
a) Total number of errors: This measure reports the total number of errors,
with an adjustment for each stage not attempted due to previous failure. This
adjustment is calculated by summing the number of patterns not attempted and
subtracting the number of patterns divided by the number of boxes from it. This
result is then multiplied by the number of trials allowed for the stage (ten in the
clinical mode). For aborted runs, the adjustment is based on the stages, trials and
responses not attempted due to the abort, with each missed response giving rise to
an adjustment of 1 - 1 / number of boxes.
b) Average trials for a successful solution: This is calculated by calculating
the total number of trials required (maximum score = 10 trials per stage) to locate
all the patterns correctly in all stages attempted, and dividing the result by the
number of successfully completed stages.
c) Average number of completed stages: This is a key indicator of the
participant's overall success, recording how many stages were successfully
completed. When analysing other outcome measures from PAL it is crucial that
analyses are conducted with reference to the number of stages completed. Clearly, a
participant that fails prior to the successful completion of the 8-pattern stage will
have had less opportunity to make errors than a participant who completes the test.
Pattern Recognition Memory (PRM)
PRM is a test of visual pattern recognition memory in a 2-choice forced
discrimination paradigm. In this task, a participant is presented with a series of 12
patterns, one at a time, in the centre of the screen. These patterns are designed so
that they cannot easily be given verbal labels. In the recognition phase, the
participant is required to choose between a pattern they have already seen and a
novel pattern. In this phase, the test patterns are presented in reverse order to the
original order of presentation. Administration time is approximately 10 minutes.
This test is sensitive to dysfunction in medial temporal areas of the brain and
relatively insensitive to dysfunction in the frontal lobe (CANTABec1ipse, 2006).
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The following outcome PRM measure was taken:
Percent of correct answers: This is the number of correct responses, expressed
as a percentage. This is a good indicator of overall performance on a test of visual
short-term recognition memory, which is impaired in disorders such as mild to
moderate Alzheimer's disease (Swainson et al., 2001).
Spatial Recognition Memory (SRM)
SRM is a test of spatial recognition memory in a forced-choice paradigm. In the
presentation phase, a white square is shown on the screen in five different locations.
Each appearance of a square marks a location on the screen, which the participant
must later remember. In the recognition phase, the square reappears in the same five
locations as in the presentation phase, in the reverse order to the original order of
presentation. On each appearance, it is paired with an identical distractor square in a
location not used in the presentation phase. The participant must touch the square in
the location that has appeared before, whilst ignoring the distractor. This test is
primarily sensitive to dysfunction in the frontal lobe, and relatively insensitive to
temporal lobe damage (CANT ABeclipse, 2006). Increased activation in right
parahippocampal gyrus during the PAL task have been shown in neuroimaging
studies in healthy volunteers (Maguire et al., 1998; Owen, Doyon, Petrides, &
Evans, 1996). Furthermore, animals (Miyashita, Kameyama, Hasegawa, &
Fukushima, 1998) and humans (M. L. Smith & Milner, 1981) with temporal lobe
lesions show impairments on the PAL task. The PAL task therefore requires intact
medial temporal lobe, and more specifically, hippocampi (Wood et al., 2002).
Administration time is approximately 10 minutes.
The following outcome SRM measure was taken:
Percent of correct answers: This is the number of correct responses, expressed
as a percentage.
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Visual Imagery
The Vividness of Visual Imagery Questionnaire (VVIQ) (Marks, 1973) is a
subjective measure of the vividness of visual imagery (see Appendix 9). It is an
extension of the visual subscale of the Betts scale (Richardson, 1969). VVIQ
consists of 16 descriptions that are rated on a 5-point Likert-scale:
The image aroused by an item might be:
1- "Perfectly clear and as vivid as normal vision",
2 - "Clear and reasonably vivid",
3 - "Moderately clear and vivid",
4 - "Vague and dim", or
5 - "No image at all, you only 'know' that you are thinking of an object".
Four questions refer to imagining a (familiar) person, and twelve refer to imagining
a scene (a rising sun, a familiar shop, a country scene). Participants imagine the
scene with their eyes open, and then rate the items. Next, they try to imagine the
same scene, but this time with their eyes closed. Participants again rate the
vividness of the imagined scene. The questionnaire is scored by summing the
ratings. Lower scores indicate more vivid imagery. Cui et a1. (2007) demonstrated
that subjective vividness (measured by the VVIQ) is correlated with the early visual
cortex activity, as measured by the fMRI.
4.2.3 Procedure
PDGroup
The study was introduced verbally and information sheets were given out at the
monthly meetings in various PD societies throughout the UK between April and
May 2008. Potential participants were encouraged to participate regardless of
whether they had vision/perception problems and VHs or not. Those who decided to
take part contacted the researcher at the end of the meeting. Patients individually
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agreed on a convenient meeting time with the researcher either in their own homes
or at the society meeting venue. After a brief description of the aim of the study, the
methodology and the debriefing preference, participants were encouraged to ask
further questions before starting the experiment. Participants were reminded to
notify the researcher if they felt tired during the testing. This is important because
when dopaminergic medications start wearing off (the "off-phase") PD patients get
stiff muscles, which makes their movement slow and tiresome (see Section 1.1).
The PD patients were also asked how they felt before the beginning of each task
and, when necessary, testing was temporarily stopped so they could take their
prescribed medication (2 cases). The visual memory tasks from the CANTAB
battery and the visual imagery questionnaire were then administered and completed
in a single session lasting approximately one hour. All participants completed every
stage of the research. Debriefing took place at the end of the study at the PD society
meetings, patients' homes or, if preferred, sent by post.
Control Group
The VVIQs were distributed to the age-matched control group. All participants
were given a stamped envelope to send it back to the experimenter once they filled
in the questionnaires. Debriefing was carried out either in person, by phone, or post
depending on the participant's preference.
High and Low-Prone Normal Individuals
277 students without any history of neurological or psychiatric illness filled in the
Hallucination-Proneness Questionnaire (HQ, see Section 3.2.1). The top 5% (i.e ..
the high-prone individuals who scored 17 points and above) and the bottom 5% of
the visual scale distribution of the HQ (i.e., the low-prone individuals who scored 4
points and below) were invited to participate in a perception and visual imagery
study. 12 low-prone and 16 high-prone normal individuals agreed to participate in
the study. After a brief description of the aim of the study, the methodology, and the
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debriefing options, participants were encouraged to ask further questions and were
reminded to notify the researcher if they needed a break during the testing for any
reason. Normal individuals from the present and all subsequent studies were then
asked to read and sign the informed consent form (Appendix 10) in accordance with
the university research ethics. The visual memory tasks from the CANT AB battery
and the visual imagery questionnaires were then administered, and completed in a
single session lasting approximately one hour. All testing was completed in
February 2008. A debriefing sheet was sent to the participants who expressed a
wish to receive it.
4.2.4 Statistical Analysis
Statistical analysis was performed using SPSS for Windows version 15.0 (SPSS
Inc., Chicago, IL). Descriptive statistics were used to describe the profile of
hallucinating and non-hallucinating PD patients and of high and low-prone normal
individuals. The demographics and the CANTAB features of hallucinating and non-
hallucinating PD patients and of high and low-prone normal individuals were
compared using t-tests for independent samples. The CANTAB tasks are provided
with a normative database; the standardised scores were therefore used as a
comparison for both PD groups.
4.3 Results
4.3.1 Demographics
Independent sample t-tests showed no difference between hallucinating and non-
hallucinating PD patients on any of the following independent variables: age,
gender, daily dopamine dosage, HY disability stage, years since diagnosis, side of
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body more affected by PO, migraine, and any other concurrent illness (all p-values
> .182). Further, there was no interaction between the presence of VHs and ocular
pathology (F=1.212, df=I,20, p=.284). The two PD groups only differed in the
presence of VHs in the hallucinating group (see Table 4.1).
Likewise, using the independent t-test, there was no difference between high
and low-prone participants in age, gender, vision and hearing problems, dyslexia or
handedness (all p-values > .397).
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4.3.2 CANT AB Visual Memory Task
The results from the CANTAB Visual Memory tasks and the statistical differences
between hallucinating, non-hallucinating and the control group are summarised in
Table 4.3. Hallucinating PO patients significantly differed from non-hallucinating
PO patients on some measures of the OMS task (percent of correct delayed answers
and probability of a double error) in the absence of differences between the two PD
groups on other measures (see Table 4.3).
Table 4.3. Visual memory results: Means, SDs, and t-tests results.
CANTAB Hallucinators Non-hallucinating t df P
Visual Memory Test PD patients PD patients
DSM
Percent of correct delayed
answers - absolute values 48.25 (19.157) 74.85 (15.009) -3.036 17 .007- standardized value -2.87 (1.764) -0.43 (1.380)
Percent of correct
simultaneous answers
- absolute values 76.43 (25.935) 90.00 (10.954) -1.246 17 .230- standardized value -1.78 (2.734) -.34 (1.155)
Probability of a double error
- absolute values .41 (.212) .19(.135) 2.538 17 .028- standardized value -2.07 (1.516) -.49 (.963)
PAL
Total number of errors
- absolute values 81.57 (91.782) 74.15 (69.389) .065 19 .949- standardized value .60 (.531) .10 (.500)
Average trials for a successful
solution
- absolute values 2.91 (2.380) 2.16 (.583) 1.171 19 .256- standardized value .62 (.628) .26 (.474)
Average number of completed
stages
- absolute values 6.00 (2.887) 6.69 (1.652) -.462 19 .649- standardized value .27 (.040) .14 (.540)
PRM
Percent of correct answers
- absolute value 75.00 (15.591) 76.79 (17.428) -.317 20 .755- standardized value -.88 (1.427) -.72 (1.594)
SRM
Percent of correct answers
- absolute values 71.88 (12.230) 70.83 (10.408) .]74 ]9 .864- standardized value -.60 (1.087) -.70 (.923)
Data are presented as means (±Standard deviations). CG - control group
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Table 4.4. Interaction between the presence ofVHs and ocular
pathology for all visual memory tasks.
CANTAB Mean
Visual Memory Test [Square df F Si!!.
DSM
Percent of correct delayed 1.818 1.110 .315
answers
Percent of correct .333 .576
simultaneous answers 1.312
Probability of a double error .J 33 .107 .750
PAL
Total number of errors .207 1 .767 .431
Average trials for a successful .206 I .799 .422
solution
Average number of completed .059 .134 .733
stages
PRM
Percent of correct answers .396 1 .166 .691
SRM
Percent of correct answers 1.046 1.133 .312
Table 4.4 shows there is no interaction between the presence of VHs and ocular
pathology on none of the visual memory tasks between hallucinating and non-
hallucinating PD patients.
Table 4.5. Anal sis of Variance between Grou and Condition.
Source Type III Sum df Mean F Sig.
of uares S uare
Corrected 7246.4528 3 2415.484 7.755 .000
Model
Intercept 201796.079 201796.079 647.860 .000
Group 2756.532 1 2756.532 8.850 .005
Condition 4393.439 4393.439 14.105 .001
Group x 406.629 406.629 1.305 .261
Condition
Error 10590.349 34 311.481
Total 232501.277 38
Corrected Total 17836.801 37
"Group" refers to hallucinators and non-hallucinators and "condition" refers to
simultaneous and delayed condition (0, 4 or 12 ms delay).
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Further, a 2 x 2 (hallucinators/non-hallucinators x simultaneous/delayed condition)
between subjects factorial ANOVA was conducted on the test of delayed matching
to sample (DMS) (see Table 4.5). There was a significant main effect for group
(hallucinators/non-hallucinators), F(l, 34) = 8.85, p = .005. Non-hallucinators (M =
82.42, SD = 14.985) performed overall better than hallucinators (M = 65.17, SD =
26.286). There was also a significant main effect for condition
(simultaneous/delayed), F(l, 34) = 14.105, p = .001. Participants solved the
simultaneous condition (M = 85.52, SD = 18.626) significantly better than the
delayed condition CM = 64.79, SD = 20.424). There was, however, no significant
interaction between group and condition, F(l, 34) = 1.305, p = .261. Hallucinators
performed consistently better on the simultaneous condition (M = 76.43, SD =
25.935) than the delayed condition CM = 48.25, SD = 19.157). Likewise, non-
hallucinators performed consistently better on the simultaneous condition (M =
90.00, SD = 10.954) than the delayed condition (M= 74.85, SD = 15.009) (see also
Table 4.3).
Finally, no statistically significant differences in visual memory were found
between high and low prone normal individuals on any of the CANTAB Visual
Memory tasks (all p-values > .209, see Table 4.6).
Table 4.6. Visual memoryresults:Means, SDs,and t-tests results.
CANTAB High-prone Low-Prone t df P
Visual Memory Test Individuals Individuals
DSM
Correctdelayed answers .11 (.11) .09 (.08) -.481 26 .634
Correct simultaneousanswers .06 (.25) .08 (.29) .204 26 .840
Probabilityof a double error .03 (.07) .06 (.12) .739 26 .467
PAL
Tomlnumberoferro~ 4.88 (3.88) 7.83 (5.42) 1.69 26 .104
Averagetrials for a successful 1031 0.40) 10.15 (3.43) -.172 26 .865
solution
Averagenumber of completed 8.00 (.00) 8.00 (.00) a a a
st~es
PRM
Correctanswers 20.75 (3.73) 19.17 (2.69) -1.244 26 .224
SRM
Correctanswers 1631 (2.09) 15.67 (2.90) -.686 26 .499
a = t-test could not be computedbecause the standarddeviations of both groups are O.
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4.3.3 Visual Imagery
Table 4.7 illustrates the descriptive statistics for the VVIQ for the PO, control and
student groups. When hallucinating and non-hallucinating PD groups and the
control group were compared on the vividness of visual imagery task, there were no
significant differences between the groups on any measures of the task (all p-values
> .480). Similarly, no statistically significant differences on visual imagery were
found between high and low-prone normal individuals (all p-values > .231).
Table 4.7. Visual ima e results:Means and SDs.
Group M(SD)
Hallucinating PD 2.35 (.814)
Non-hallucinating PD 2.26 (.762)
Control group 1.87 (.697)
Normals - high-prone 2.11 (.912)
Normals -low-prone 2.30 (1.027)
4.4 Discussion
The aim of the study was to examine whether VHs in PD and proneness to VHs in
the normal population arise from degradation of visual memory and impaired visual
imagery, and in so doing, expand the current theoretical understanding of the
occurrence of VHs in PD and proneness to VHs in the normal population. To this
end, visual memory tests from the CANTAB battery and the vividness of visual
imagery questionnaire were used in both PD and the normal groups.
Hallucinating and non-hallucinating PD patients did not differ in a number of
independent variables that were taken into account, such as age, gender, daily
levodopa dose, years since diagnosis, side of body more affected by PD, migraine,
vision problems or any other concurrent illness (see Table 4.1). Similarly, high and
low-prone normal individuals were similar in terms of age, gender, handedness,
dyslexia, and vision and hearing problems. Therefore, given the homogeneity of the
demographic characteristics of both PO patients and the normal individuals, any
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perceptual and imagery differences between the groups on the CANTAB tasks were
hypothesised to be related to VHs or to the proneness to VHs in the hallucinating
PO group and in the high-prone normal group, respectively. Apart from the
homogeneity of the demographic characteristics, both PO and the normal groups
were recruited within the same sample group; hallucinating and non-hallucinating
PO groups were recruited from the same PO societies and high and low-prone
groups were recruited from the healthy young student population. Importantly, none
of the PO patients was diagnosed with dementia; therefore, possible differences in
cognitive functioning in the hallucinating PD group could not be attributed to it.
Further, the mean HY score (Hoehn & Yahr, 1967) in both PD groups was 2.10
(SD=1.0), indicating a relatively early (motor) stage of PD (see Table 4.1). An
intact cognitive performance was therefore expected in both PD and normal groups,
and all differences in CANTAB performance could be attributed to VHs in the PD
hallucinating group or to the proneness to VHs in the high-prone normal group.
Examination of the differences between hallucinating and non-hallucinating
PO patients and the age-matched control group (as indicated by the standardised
scores; see Table 4.3) revealed inconsistent results between the four visual memory
tasks. As reported by several other studies (Owen et al., 1993; Owen et al., 1995;
Sahakian et al., 1988), PD patients show impaired performance on some measures
of the visual memory tasks. On three visual memory tasks (PAL, PRM and SRM),
there was no statistically significant difference in performance between the three
groups. Further, hallucinating PD patients scored significantly lower on the DMS
task than the non-hallucinating counterparts or control group. These disparate
findings suggest that visual memory comprises of functionally and neurologically
different elements and is not a unitary concept.
Further, while the PAL and the PRM are sensitive to dysfunction in medial
temporal lobe, and the SRM to dysfunction in the frontal lobe (CANTABeclipse,
2006), the DMS combines simultaneous sensitivity for temporal and frontal lobe
dysfunctions (CANTABeclipse, 2006; Eskandar, Optican, & Richmond, 1992;
Miller & Desimone, 1994). Hallucinating PD patients displayed significantly lower
on the DMS compared with non-hallucinating patients and the control group in the
85
absence of differences on the PAL and the PRM. It could thus be hypothesised that
a combined effect of temporal and frontal dysfunction is more pronounced than
temporal or frontal dysfunction alone in hallucinating PO patients. The hypothesis
that the temporofrontal dysfunction is implicated in hallucinating PO patients is
consistent with evidence from an autopsy (Harding et al., 2002) and an tMRI study
(Stebbins et al., 2004). Harding et al. (2002) found a higher density of Lewy bodies
in both the temporal and frontal regions in the hallucinating PD patients. The only
fMRI study to date that combines the role of both temporal and frontal lobe in
occurrence of VHs in PD (Stebbins et al., 2004) has suggested that a pattern of
relative hyperactivity of the frontal cortex in conjunction with decreased cortical
activation in the posterior occipoparietal areas may play a role in the
pathophysiology of VHs. The present study is the first to provide behavioural
evidence of involvement of both systems simultaneously, as a specific dysfunction
of the visual memory. There is therefore a need to further investigate the role of
frontal lobe functioning in VHs in PD, both through the executive functioning and
personality components, which will be addressed in Chapters 6 and 7, respectively.
Finally, hallucinating PD patients showed significantly poorer performance
than non-hallucinating patients on the simultaneous as well as the delayed matching
to sample task (measures of the DMS; please refer to Table 4.3). In addition, there
was no interaction between group (hallucinating and non-hallucinating PO patients)
and the condition (simultaneous and delayed) (see Table 4.5). Non-hallucinating PO
patients consistently performed better than their hallucinating counterparts, and
both groups consistently performed better on the simultaneous condition. Several
authors (Chapman et al., 1999; Diederich et al., 1998; Fenelon et al., 2000; Holroyd
et al., 2001; Uc et al., 2(05) suggested that the poorer performance in the
hallucinating PO patients might be related to perceptual deficits. as hallucinating
PD patients in their studies suffered from poorer visual acuity than their non-
hallucinating counterparts. However, the results from the present study (see Tables
4.4 and 4.5) show that both groups performed better on the simultaneous condition.
These results would suggest that the significantly poorer performance in delayed
condition reflects a failure in the visual memory. rather than perceptual
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dysfunctions. However, the hallucinating PO patients performed significantly worse
than their non-hallucinating counterparts, therefore, it is important to acknowledge
that the results do not invalidate the possibility that perceptual problems might also
be implicated in the hallucinating PO patients. The limitation of the present study,
however, is that visual acuity has not been assessed systematically, and the impact
of visual acuity could not be addressed satisfactorily. In order to establish the
extend to which perceptual problems could potentially affect the performance of the
hallucinating PO patients, future studies need to take a multidisciplinary approach,
addressing the role of ocular pathology with appropriate ophthalmologic measures.
In line with the continuum hypothesis, stating that hallucinations are
expressed in different degrees in the general population, the aim of the present
study was to explore the performance on the CANTAB visual memory tasks in
hallucinating PO patients and high-prone individuals. In contrast to the PO patients,
no differences in performance on any visual memory tasks were observed between
high and low-prone individuals (see Table 4.6). The results of the present study
therefore give evidence that higher level perception processing is intact in high-
prone individuals and can therefore not be implicated in the hypothetical model of
proneness to VHs in the normal population. These results are therefore not in
agreement with the continuum hypothesis, as dysfunction in visual memory has
been showed in hallucinating PO patients, but not in the high-prone normal
individuals.
However, it can be argued that the CANTAB battery shows impaired
performance of a well extended pathology (such as PO). and that pathology in high-
prone normal individuals is too subtle to be observed by the use of behavioural
methodology. Therefore, a study investigating underlying neural mechanisms using
a neurophysiologic methodology is warranted and will be addressed in the
following chapter (see Chapter 5).
Apart from investigating visual memory, the study also aimed to explore how
(if at all) visual imagery relates to VHs in PO and in high-prone individuals. The
present study found no differences between the groups on any measures of the
visual imagery (for faces and objects/scenes. and with open and closed eyes; see
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Table 4.7). These results are consistent with the study of Barnes et al. (2003) and
suggest that the visual imagery of hallucinating PD patients and high-prone
individuals is intact, and probably not involved in the occurrence of VHs.
Despite non-significant findings in the visual imagery task, the hypothesis that
top-down processing, especially rich fantasy and vivid imagination, may be
connected to the generation of VHs in PO and to higher hallucination-proneness in
the normal population is not called into question, as Stebbins et al. (2004) suggest
that VHs are indeed evoked by internally driven frontal lobe functioning. Therefore,
chapters 6 and 7 will explore whether executive and personality factors could be
potential attributes for VHs in PD and hallucination-proneness in the normal
population.
4.4.1 Limitations
Robbins et al. (2007) acknowledge that the main caution regarding the CANTAB
battery is not to assume there is a one way relationship between a deficit on any
CANTAB test and brain damage to an anatomically defined region. They emphasise
that many brain regions are interconnected in neural networks networks, meaning that
performance on any task may be impaired due to lesions in widely distributed brain
Structures. The challenge in the light of the present study is to understand which
distinct types of information processing are implicated in those PO patients who
experience VHs. Such studies would aid the current understanding of what are the
underlying mechanisms for the occurrence of VHs in PD.
Further, although hallucinating PO patients had normal or corrected-to-normal
vision and claimed they saw the patterns well, they scored significantly lower than
their non-hallucinating counterparts and the control group on the OMS task of the
CANTAB. The results from the present study suggest that the poorer performance
in the hallucinating PO patients is more likely to be due to the memory, rather than
perceptual, impairments (see Tables 4.4 and 4.5). However, given the crude
assessment of visual acuity in the present study, it cannot be entirely ruled out that
visual acuity in hallucinating PO patients is impaired and, consequently, the poorer
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performance of the hallucinating PO patients arises from lower visual acuity.
However, if hallucinating PD patients really have reduced visual acuity, it remains
unclear why the performance would be worse only on one, but not the other visual
memory tasks. Therefore, future studies are warranted to match the hallucinating
and non-hallucinating sample according to their visual acuity, using a more precise
ophthalmologic measure of visual acuity. A multidisciplinary approach including an
optometrist would be therefore highly useful in future studies on hallucinations in
PO when the emphasis is based on the functioning of the visual system, such as in
the present study where visual memory and visual imagery were assessed.
4.4.2 Conclusions
In summary, DMS was the only visual memory test where hallucinating PD patients
differentiated from their non-hallucinating counterparts. The finding points to the
simultaneous aberrant functioning of both visual and frontal areas in hallucinating
PO patients, and is supported by the neuroimaging study. Thus, these areas must
play a role in the occurrence of VHs in PD. However, no such differences were
found between high and low-prone normal individuals, and the results are therefore
not in agreement with the continuum hypothesis, as there is a specific dysfunction
present in hallucinating PD patients, but not in the high-prone normal individuals.
However, although no difference in visual memory was found between high and
low-prone individuals, the results could reflect intact behavioural, but not
necessarily intact neural, functioning. An electrophysiological study investigating
the role of the visual system will be carried out (see Chapter 5). The results from the
present study also suggest that dysfunctions of higher level perceptual processing
may be related to the frontal lobe functioning. Similar to what was proposed in
Chapter 2, top-down processing may be triggered in the system due to the
impoverished visual processing, and hence there is a higher chance of
hallucinations occurring. VHs in PD and hallucination-proneness in the normal
population will be examined in relation to frontal functioning, namely executive
functions and personality factors (Chapters 6 and 7, respectively).
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Chapter 5: Early Visual Processing Components in High-Prone
Normal Individuals: an EEG Study 17
5.1 Introduction
The results from the perception study (see Chapter 4) showed evidence that specific
disruptions in visual memory are related to VHs in PO, but no such link was found
in the high-prone individuals from the normal population. Nonetheless, it has been
suggested that proneness to VHs might possibly occur due to impairments in the
visual system which are so subtle in nature that they cannot be observed by
behavioural testing. Therefore, an electrophysiological or psychophysical testing
could serve as a solution to uncover the possible link between proneness to VHs
and the visual processing in the high-prone normal individuals.
Numerous studies have found disruptions of early electrophysiological brain
responses to external stimuli (also known as event-related potentials or ERPs) in a
wide range of psychiatric and neurological conditions, such as schizophrenia
(Butler et al., 2008; Campanella, Montedoro, Streel, Verbanck, & Rosier, 2006a;
2004), PD (Kida, Tachibana, Takeda, Yoshikawa, & Okita, 2007), Williams
Syndrome and autism (Grice et al., 2001). Since these disorders are frequently
accompanied by VHs, it may be the case that the observed modulations of early
visual components are expressions by a visual dysfunction, which may in turn
facilitate the occurrence of VHs in the patients.
ERPs that have been most commonly linked to face processing are the PI, the
N170, and the P2. ERP components are referred to by a preceding letter indicating
17 The study presented in the current chapter was conducted in collaboration with David
Schwartzman (Oxford Brookes University) and Dr Cornelia Krancioczioch (University of
Portsmouth). The results have formed the basis of a joint publication (see Schwartzman, Maravic,
Kranczioch, & Barnes, 2008, see Appendix 11). Ksenija Maravic ran the data collection, while
David Schwartman analyzed the EEG data and produced the figures. Ksenija Maravic analyzed the
behavioural data and assisted in both the statistical analysis of the EEG data and in writing the
publication.
90
polarity followed by the typical latency in milliseconds (Luck, 2005). Thus, the PI
and P2 ERPs components are described as a positive voltage deflection occurring
approximately 100 and 200 milliseconds after stimulus onset, respectively, whereas
the N170 component describes a negative voltage deflection 170 milliseconds after
stimulus onset. In the context of the face perception paradigm, PI is assumed to
reflect the extraction of finellocal information from face stimuli (Herrmann, Ehlis,
Ellgring, & Fallgatter, 2005; Liu, Harris, & Kanwisher, 2002), N170 is assumed to
reflect face-specific structural encoding (Eimer, 2000), and P2 deeper processing,
which is required when ambiguous face stimuli need to be categorized (Latinus &
Taylor, 2006).
Following from these studies, VHs are associated with altered visual
processing components; if VHs lie on a continuum of severity, then differences in
early visual processing components might be evident between high and low
hallucination-prone participants. Therefore, the aim of the present study is to
investigate the differences in local feature based processing (faces) and holistic
processing (Mooney) between high and low-prone individuals using a classic face
perception experimental design, which is known to reliably elicit early ERPs
(Eimer, 2000; Herrmann, Ehlis, Ellgring, & Fallgatter, 2005). The results will
provide evidence if early visual processing components differ in the high and low-
prone normal individuals. If that is the case, the disruptions in early processing may
serve as a bottom-up process, facilitating the proneness to frequent occurrence of
hallucination-like experiences. However, if the disruptions of early processing are
not recorded, hallucination-proneness in the normal population is probably
attributable to personality related top-down processes.
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5.2 Methods
5.2.1 Participants
According to their score on the HQ (see Section 3.2.1), 11 high-prone (8 female,
two left-handed, mean age 23.6 years, SD=9.1) and 11 low-prone normal
individuals (7 female, one left-handed, mean age 23.4 years, SD=5.0) were
recruited in the study. As described in Section 3.2.1, a high total score of the visual
scale of the HQ indicates frequent experiences of visual misperception, for example
distorted images of people and environment, especially in relation to distortions in
lighting, patterns and shapes. High scores do not indicate frank hallucinations.
Furthermore, high proneness to visual experiences should not be confused with high
ability for visual imagery as there were no significant differences between high and
low-prone participants (t=1.079 p=O.309, see Chapter 4) on the Vividness of Visual
Imagery Questionnaire (Marks, 1973). All participants were undergraduate students
from Oxford Brookes University with normal or corrected-to-normal vision. The
exclusion criterion was a history of psychiatric disorder. All students received
compensation for their participation.
5.2.2 Stimuli
Stimuli were photographs of faces, Mooney faces'', and scrambled Mooney faces.
Mooney faces are high-contrast pictures of human faces, and scrambled Mooney
faces are Mooney faces modified in the Photoshop software until the faces are not
recognisable any more (see Figure 5.1). Faces and Mooney faces were presented in
either an upright or inverted orientation (see Figure 5.1).
18 Mooney pictures were kindly provided by Aaron Schurger from Princeton University.
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Figure 5.1. Examples of stimuli. L to R: face, face inverted, Mooney, Mooney inverted,
and scrambledMooney face.
The experiment was programmed in the E-Prime experimental operating
system software (Psychological software tools, Inc., Pittsburgh, Pennsylvania,
USA). All face photographs were matched for luminance and presented in frontal
view, with the eyes placed at the centre of the screen. All stimuli where adjusted to
maintain identical size (400 x 400 pixels), and occupied approximately 30 x 4.50 of
visual angle.
5.2.3 Electroencephalogram (EEG)
Electroencephalography is a technique that records the electrical activity of the
brain. Signals are picked up by electrodes placed to the scalp, and are then
amplified and filtered, before finally recording on a computer. The EEG does not
give information about the structure of the brain (the spatial resolution is low,
because the electrical waves are attenuated and distorted by passing through the
skull). However, EEG offers excellent information about specific time locked
cognitive events (the temporal resolution is high, because it detects changes in
electrical activity in the brain on a millisecond time scale).
5.2.4 Recording and Data Analysis
Electrical activity was recorded using an electrical Geodesic Sensor Net with 128
electrodes (Electrical Geodesic inc.) (Tucker, Liotti, Potts, Russell, & Posner, 1994)
and was digitized at a rate of 250 Hz. The recording was done with a hardware
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band-pass filter of 0.01 Hz to 100 Hz. Before each recording, impedance of all 128
electrodes was kept below 50 kn (Ferree, Luu, Russell, & Tucker, 2001).
Unsegmented (raw) data were digitally filtered offline using a band-pass of 0.01-
30Hz.
For all conditions, target locked epochs (epochs of activity in a time sequence
shortly before and after the target is presented) were created for conditions in which
participants reported perceiving a face. Each epoch started 100 ms before onset of
the target and ended 1000 ms afterwards. The segments were highlighted if they
contained eye blinks or movements, as defined by eye channel activity greater than
50 Jlv. Two data sets (one from a high and one from a low-prone group) were
excluded from the final ERPs data analysis due to excessive artefacts. The data
were then processed by an ocular artefact reduction technique to correct the eye
blinks and eye movements (Gratton, Coles, & Donchin, 1983). If noise occurred in
more than 20% of trials on any channel, that channel was excluded from further
analysis. Segments were then average-rereferenced (referenced against the mean of
all the other channels) and epochs were baseline corrected for the first 100 ms
before the onset of the stimulus.
Conditions (face, inverted face, Mooney face, inverted Mooney face, and
scrambled Mooney face) were compared between high and low-prone groups by
producing t-tests for every 4 ms sample between the two waveforms for the entire
epoch. All statistics were processed using the MATLAB software version 7.1.
Scripts were adapted from Astle et al. (2006). Two waveforms were considered to
be significantly different if the significance was maintained for a minimum of 10
consecutive samples (40 ms). However, two significant points in time were
considered to be a continuation of the same difference in amplitude if the gap
between the two points was smaller than 10 samples (Astle et al., 2006; Rugg,
Doyle, & Melan, 1993).
The following time windows were selected for further analysis over electrode
52 (corresponding to the parietal-temporal junction electrode P3 from the
international 10120 system): 80-130 ms for the PI component (Herrmann, Ehlis,
Ellgring, & Fallgatter, 2005; Liu et al., 2002), 140-170 ms for the N170
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(Campanella, Montedoro, Streel, Verbanck, & Rosier, 2006b; Eimer, 2000;
Herrmann, Ehlis, Ellgring, & Fallgatter, 2005; Herrmann, Ellgring, & Fallgatter,
2004; Liu et aI., 2002) and 200-260 ms for the P2 component (Latinus & Taylor,
2006; Sugase, Yamane, Ueno, & Kawano, 1999). Electrode P3 was selected
because it exhibited the maximum significance across all conditions. The peak
(maximum value) can occur anywhere within these time windows. Therefore, the
adaptive mean algorithm (which finds a peak within a specified time window, and
redefines the time window around this peak) needed to be performed. Finally, the
mean voltage can be calculated from the new time windows.
The mean adaptive means were used to perform the between group t-tests.
Onl y significant differences are reported.
Latency - The onsets of the PI, N 170 and P2 were calculated from the peak
amplitude defined by the adaptive mean time window.
5.2.5 Procedure
281 Oxford Brookes University undergraduate students, none of whom had any
neurological or neuropsychiatric disorder, completed the HQ. 13 participants with
high and 13 participants with low visual scale score of the HQ were invited to
participate in the study. There were 4 drop outs; therefore, 11 high and 11 low-
prone normal individuals participated in the study.
After a brief description of the aim of the study, the methodology and their
task, all participants were encouraged to ask questions and were reminded to notify
the researcher if they felt tired or needed to take a break during the testing. After the
EEG electrodes were placed on the participants' scalps, participants were seated in
an electromagnetically protected cubicle in a dark room, with a computer screen
placed approximately 120 cm in front of them. Participants were asked to hold the
response box in their both hands.
The participants' task was to first look at the presented image and then
indicate whether they perceived the image to be a face or not by pressing the left or
right button of the response box, using their left and right index finger. Response
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buttons were randomized for each participant. Participants were asked to press the
response button as quickly as possible. They were also asked to maintain central
eye fixation and to avoid blinking during the picture presentation. However, they
could blink when the pictures were not presented.
For each category of stimuli there were one hundred images presented in a
random order in 10 blocks of fifty trials (500 stimuli altogether). First, a stimulus
was presented for 200 ms. Next, a black screen appeared for 1000 ms. Finally, a
response window occurred, lasting up to 5000 ms, in which the participants were
asked to press a button indicating whether they perceived the image as a face or not.
There was a 1000 ms blank screen before the next trial started.
All testing was completed in November 2006 and lasted approximately one
hour.
5.4 Results
5.4.1 Behavioural Results
In 99% of trials for face and inverted face stimuli, both high and low-prone
individuals correctly reported seeing a face. Similarly, both groups correctly
recognized an image of a face in the Mooney face condition in 92% of the trials.
Not surprisingly, the correct identification was much lower in the inverted Mooney
face condition, with 58% of trials perceiving an image as a face in low-prone, and
60% of trials in the high-prone group. In the scrambled Mooney condition, low-
prone participants reported seeing a face in 20% of trials, and high-prone
participants in 26% of trials. None of the behavioural differences between high and
low-prone individuals was statistically significant.
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5.4.2 Latency Effects
There were no statistically significant differences in the latency effects between
high and low-prone individuals for PI, N170 or P2 in any condition.
5.4.3 Amplitude Effects
P1 Effects
In the face condition, PI (located in the parieto-temporal regions) amplitude was
statistically smaller (t(18) = 3.012, P = .007) in high-prone (M = 1.06 IlV, SD = .97)
compared to low-prone individuals (M = 2.35 IlV, SD = .94) between 76-120 ms
after stimulus presentation (see Figure 5.2, A). Similarly, in face inverted condition,
PI amplitude was statistically smaller (t(18) = 2.34, P = .031) in high-prone (M =
1.47 IlV, SD = 1.09) compared to low-prone participants (M = 3.34 IlV, SD = 2.27)
between 80-124 ms after stimulus presentation (see Figure 5.2, B). In inverted
Mooney stimuli condition, PI amplitude was statistically smaller (t(I8) = 2.76, p =
.013) in high-prone (M = .89 IlV, SD = 1.01) compared to low-prone participants
(M = 2.65 IlV, SD = 1.75) between 52-100 ms after stimulus presentation (see
Figure 5.2, D). Additionally, topographic plots indicated that this condition was also
associated with fronto-central activity (see Figure 5.2, D). No statistical significance
was found in the Mooney faces and scrambled Mooney condition between high and
low-prone individuals (see Figure 5.2, C and E).
N170 Effects
In all conditions, clear N170 components were observed over posterior electrodes.
However, for this time window no consecutive significances were observed in the
mean amplitudes between high and low-prone individuals for all conditions (see
Figure 5.2).
97
P2 Effects
In the inverted face condition, parieto-ternporal P2 mean amplitude was statistically
smaller (t(18) = 2.39, P = .028) in high-prone (M = 1.50 I1V, SD = 2.43) compared
to low-prone individuals (M = 4.56 I1V, SD = 3.23) between 232-340 ms after
stimulus presentation (see Figure 5.2, B). In the Mooney faces condition, mean
amplitude was statistically smaller (t(18) = 2.37, P = .029) in high-prone (M = .65
I1V, SD = 2.28) compared to low-prone participants (M = 4.93 I1V, SD = 5.233)
between 276-356 ms after stimulus presentation (see Figure 5.2, C). No statistical
significance was found in the faces, Mooney faces and scrambled Mooney
condition between high and low-prone individuals (see Figure 5.2, A, D and E).
A
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---Low Prone
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Figure 5.2, A-E. Parietal-temporal PI and P2 time locked to target-onset
at 0 ms. Waveforms are taken from electrode 52 and topographic plots
apply to time periods of consecutive significance at electrode P3. In the
topographical plots, dark circles designate significantly greater positivity
for low-prone compared to high-prone individuals. Arrows indicate the
electrode where the waveforms were recorded.
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5.5 Discussion
The behavioural results from the present study show that both high and low-prone
normal individuals perceived the images as faces in approximately the same
percentages of trials across all conditions. This is in line with the results from
Chapter 4, where deficits in visual functioning in high-prone normal individuals
were not observed using the traditional neuropsychological behavioural
assessments. Therefore, the aim of this study was to observe the early visual
components using a classic face perception paradigm, using the EEG. The present
study is the first to explore the neurophysiologic basis in face processing in high-
prone normal individuals.
The results from the present study show that amplitude means in both early
and late ERPs components are statistically lower in high-prone compared to the
low-prone normal individuals. Moreover, these lower amplitudes were observed as
early as 100 ms after stimuli of faces and inverted faces were presented, mainly
over the temporal-parietal regions. The PI is a face selective component correlated
with face categorization processes that extract fine/local information (Herrmann,
Ehlis, Ellgring, & Fallgatter, 2005; Liu et al., 2002; Sugase et al., 1999). The
observed differences in PI between high and low-prone individuals might therefore
suggest that the process of extraction of fine information is somewhat disrupted in
the high-prone group. This distortion might not be extensive enough for full-blown
hallucinations to occur, but can nonetheless serve as a basis for proneness to
misinterpreting visual information, resulting in higher proneness to hallucinatory-
like experiences.
Similarly, reduced mean amplitudes were observed in high-prone individuals
in the Mooney faces condition; however, they lacked consecutive significance (see
Figure 5.2, C). One possible explanation why no consecutive significance was
observed is that the faces presented were altered and do not display all the criterion
characteristics of a face (Latinus & Taylor, 2005), and that is why no significant
differences were observed in the Mooney condition. Therefore, the task being
performed is altering. The lack of all standard features of the face might result in
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the associated PI to be less susceptible to the differences in fine processing. For this
reason, it was surprising to find statistical differences in the mean amplitude
between high and low-prone individuals in the inverted Mooney condition. Inverted
Mooney faces were recognized as faces in only 60% of the trials in both groups. In
contrast to the expected posterior distribution in the other face conditions, frontal
central topography was observed in the inverted Mooney condition (see Figure 5.2,
D). The distinct frontal distribution probably reflects additional, probably holistic
processing that is required when stimuli of this type are presented. The role of
frontal lobe functioning in occurrence of VHs has been already raised in Chapter 4
and will be addressed in detail in Chapters 6 and 7.
Further, no periods of consecutive significance were found for the NI70
component between high and low-prone individuals in any of the conditions (see
Figure 5.2). Lack of significant differences are difficult to interpret and possible
explanations are often a matter of speculation (Luck, 2005). The N170 component
has been shown to reflect the structural encoding of faces (Eimer, 2000; Herrmann,
Ehlis, Ellgring, & Fallgatter, 2005). The results from the present study might
therefore indicate that both high and low-prone individuals are equally able to
extract information about configuration of faces. However, in order to avoid the
beta error type!", future studies need to address the issue of structural encoding and
employ a perception task that includes structural modifications of faces (Bentin,
Golland, Flevaris, Robertson, & Moscovitch, 2006). However, based on the context
of the present study no significant differences in NI70 components between high
and low-prone individuals were found.
Finally, the reduced amplitudes were observed for the posterior P2
components in the high-prone individuals in the inverted faces and Mooney faces
conditions (see Figure 5.2, B and C). A similar pattern of reduced amplitudes was
also found for the inverted Mooney faces condition in the high-prone individuals
(see Figure 5.2, D), but the differences lacked consecutive significance. It has been
suggested that the P2 component (in particular the left-lateralized) reflects a more
19 Beta error refers to a type of statistical error concluding there is no difference between the groups
when there really is one.
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extensive and deeper processing of indistinct face stimuli which allows the
categorization of these stimuli (Latinus & Taylor, 2006). The results from the
present study therefore propose that this later processing is altered in the high-prone
group. Two possibilities for this impairment arise; either the lower P2 amplitudes
result from earlier PI aberrations of the extraction of fine/local information, or they
are independent from the previous PI effects and simply reflect a lack of later
processing stages once a face has been identified in high-prone individuals.
The results from the study are important in understanding the factors that
contribute to hallucination-proneness in the normal population and also in VHs in
clinical populations such as PD. Electrophysiological responses of high-prone
individuals were objectively different, yet apparently not a sufficient element for
generating VHs. The findings from this study therefore give evidence that
modulations of early evoked visual responses are not a sufficient factor for
developing VHs in the normal population. However, further issues have been raised
by the study, namely if there is a specific threshold that is reached in clinical
populations with full-blown hallucinations, but not in the high-prone normal
individuals. Since the EEG study was only carried out on the normal population,
and not with the PD group, it is not possible to conclude whether or not the same
modifications are present in the hallucinating PD population. It was therefore not
possible to infer as to whether or not the continuum hypothesis is supported; that is,
if hallucinating PD patients show the same patterns of EEG response to the high-
prone normal individuals. In order to ascertain this claim, future studies need to be
carried out on hallucinating and non-hallucinating PD patients.
In summary, the present study provides a novel method of studying subtle
neurophysiological differences between high and low-prone normal individuals. It
is the first study to provide evidence that high-prone individuals display disruption
of early visual processing components in the face perception paradigm, as early as
100 ms after the stimulus is presented. This finding could reflect that subtle
differences, not extensive enough for the development of VHs, may in turn result in
higher frequency of experiencing hallucinatory-like images in the high-prone
individuals. The results from the study therefore provide evidence for inclusion of
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the bottom-up neurophysiological components in the model accounting for
hallucination-proneness in the normal population, and open a new path of
researching the underlying pathology associated with VHs in clinical populations.
5.5.1 Limitations and Further Studies
Apart from the hypothesis that VHs are related to a specific electrophysiological
response threshold, several other issues were raised when interpreting the results
from the present study and need to be addressed in the future studies. First, the
results show evidence that early visual processing components in the face
perception paradigm are different in high and low-prone individuals, possibly
predisposing the high-prone group to a higher incidence of hallucinatory-like
experiences. Whether or not high-prone individuals are at higher risk for developing
full-blown hallucinations in later years is impossible to conclude; only a
longitudinal study could explore that possibility.
Second, the aim of the study was to observe the early visual processing
components in high-prone individuals. However, apart from significant differences
between high and low-prone individuals in the PI and P2 components, several
statistical differences have been found in later visual components. The effect is
either due to the disruption of earlier components, as seen between high and low-
prone individuals in face, inverted face and inverted Mooney faces, or an indicator
of a higher cognitive processing of non-conventional face stimuli. The latter
hypothesis is in line with aberrant frontal activation in the high contrast Mooney
faces condition, probably reflecting an involvement of top-down processes.
Investigation of top-down processes in proneness to VH in the normal population is
therefore warranted and will be addressed in Chapters 6 and 7.
Third, the highly ambiguous scrambled Mooney stimuli may be processed
differently in high and low-prone group (Latinus & Taylor, 2005); however, no
differences have been found between the two groups. In the scrambled Mooney
condition, the only analysed trials were the ones that participants responded they
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saw a face, which happened in 20% of the trials in low and 26% of the trials in
high-prone individuals. Low number of trials could have contributed to a higher
chance for beta error. Therefore, the study of the later visual processing components
in the scrambled faces conditions is warranted in sufficient number of trials.
Finally, an important point to note when interpreting ERP components is that
a given ERP component that is elicited by differing experimental tasks is likely to
reflect activity from different neural structures and also different psychological
processes. A well documented example of this phenomenon is provided by Luck
(2005), who demonstrates that modulation of the N2 which is elicited by an
attentional bias in social categorization tasks is not the same N2 generated by tasks
involving conflict or inhibition of responses and is therefore not reflecting identical
neural sources. Therefore, within the context of this study, care should be taken
when making conclusions about the functional significance of each component of
interest. From Collerton et al.'s (2005) PAD model there is the possibility that any
differences between the electrophysiological responses of low and high-prone
individuals seen in this study could potentially be due to attentional differences, or
to some degree, a mix of both attentional and visual processing impairments in
high-prone individuals. Within the context of ERP face perception paradigms, the
PlOO (located at lateral occipital electrodes with a latency of 80-110 ms) has been
correlated with facial processing (Herrmann et al., 2004; Liu et al., 2002). Itier &
Taylor (2004) found that the PlOO was earlier and significantly larger for faces in
either normal or inverted orientations compared to control stimuli. Their findings
are consistent with intracranial recordings from macaque monkeys showing that
global information about faces is processed by 110 msec (Sugase et al., 1999).
Furthermore, Herrmann et al.(2004) found increased PlOO amplitudes to faces
compared to buildings which they interpreted as being related to early
categorization processes. Additionally, in a magnetoencephalography (MEG) study,
Liu et al. (2002) found a significant response component to faces located over
occipitotemporal areas at a latency of approximately 100 msec (MlOO) compared to
control stimuli which they related to face categorization. Their data suggests that
different features are extracted from the faces at -lOOms fine/local information vs.
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-170ms coarse/global information. Therefore, it seems likely that in the current
study the main differences observed between high and low-prone individuals in the
PIOO component reflect differences in visual processing, relating to the extraction
of fine/local information rather than attentional processes.
As presented in Figure 5.2, (B-D) later differences (300ms) between the two
groups showed high levels of significance. These findings may be explained by
Campanella et al. (2006b), who found a reduction in the amplitude of the N170
component in patients with flourishing schizophrenia which they attributed to a
reduction in PIOO amplitude. This suggested that schizophrenics' impairments in
face processing may be due to earlier disruption of general visual processing. The
differences seen in the P300 and later components reported in this study may well
be caused by a dysfunction in the early visual processing stages of the face stimuli.
It is possible that normal functioning of attentional and resource allocation
components is reliant on earlier successful processing of stimuli. Impairments in
these earlier components, such as the PlOO, may underlie the divergence observed
in later components (P300) between high and low prone individuals.
5.5.2 Conclusions
Significantly lower PI and P2 amplitudes were found in the high-prone compared
to the low-prone normal individuals. Deficiencies in early visual processing
components (seemingly independent of face recognition processes) might in tum
affect the visual processing of high-prone individuals. This may not be extensive
enough to manifest in VHs, but enough for a frequent occurrence of hallucinatory-
like experiences. Apart from posterior areas, the results showed lower activation in
frontal areas in cognitively challenging situations (i.e., inverted Mooney faces),
suggesting that frontal top-down functioning is implicated in hallucination-
proneness in the normal population. This is an important finding and will be
addressed in Chapters 6 and 7.
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Chapter 6: Executive Functions in Hallucinating PD Patients and in
High-Prone Normal Individuals
6.1 Introduction
The results from both previous studies (see Chapters 4 and 5) highlighted the frontal
dysfunctions as a potential explanatory candidate in understanding VHs in PD and
hallucination-proneness in the normal population. Two areas of investigation were
proposed to explore the role of the frontal functioning: executive functions and
personality factors. The present study will address the role of executive functioning
in relation to VHs in PD and hallucination-proneness in the normal population.
Chapter 7 will investigate the role of top-down personality processes in VHs in PD
and in the hallucination-prone normal population.
The executive functions are defined as a set of brain processes, such as
planning, abstract thinking, rule acquisition, initiating appropriate responses and
inhibiting inappropriate responses (as defined by, for example, Miller & Cohen,
2001; Norman & Shallice, 2000; Posner & Petersen, 1990). A major difficulty is the
heterogeneity of frontal lobe impairments and executive forms; however, the
following tests have been argued to reflect some of these processes: Wisconsin
Card Sorting Test, Tower of London test, source memory tasks, working memory
and memory retrieval, tests of fluency and spatial working memory tests, Raven's
Coloured Progressive Matrices and the executive functioning subtests of the
Cambridge Cognition Neuropsychological Test (Foster, Black, Buck, & Bronskill,
2007; Gazzaniga, 2002; Golden, Espe-Pfeifer, & Wachsler-Felden, 2000; Leeds,
Meara, Woods, & Hobson, 2001; Phillips, 2007; Rabbitt, 2007; Robbins et al.,
2007; Roth et al., 1986). In addition, the Frontal Assessment Battery (FAS)
(Dubois, Slachevsky, Litvan, & Pillon, 2000; Iavarone et al., 2004) is a brief
screening battery for frontal dysfunction that includes six executive tasks, namely
similarities task, phonological fluency, motor series, conflicting instructions, go-no
go task and prehension behavior (environmental autonomy).
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Many studies have reported a decline of specific executive functions in
hallucinating PD patients, such as memory and abstract thinking (Athey et al.,
2005), inhibitory disability (Barnes & Boubert, 2008; Santangelo et al., 2007), the
go/no-go FAB subtest, verbal learning-immediate recall task and semantic and
phonological fluency tasks (Grossi et al., 2005; Santangelo et al., 2007), and a
general decline in executive functioning (Imamura, Wada-Isoe, Kitayama, &
Nakashima, 2008). Greater activation and frontal hypermetabolism were also
evidenced in some neuroimaging studies (Nagano-Saito et al., 2004; Stebbins et al.,
2004).
However, the majority of these authors report intact functioning on several
executive domains, including most of the Executive Functioning subtests of the
CAMCOG (Athey et al., 2005), delayed free recall and Raven's Coloured
Progressive Matrices score (Grossi et al., 2005), fluency (Barnes et al., 2003), and
delayed verbal recall (Santangelo et al., 2007). In accordance with the findings,
several neuroimaging studies found no frontal lobe alterations in hallucinating PD
patients as compared to non-hallucinating PD patients (Matsui, Nishinaka et al.,
2006a, 2006b; Oishi et al., 2005; Ramirez-Ruiz, Marti et al., 2007). Furthermore,
Capitani and colleagues (2007) believe that a severe cognitive deficit is not
sufficient by itself to invariably cause hallucinations, because VHs do not exceed
the 25% incidence rate even in extremely advanced cases of dementia (Capitani et
al.,2007).
The studies have therefore offered inconsistent results, and the link between
VHs and executive functions is uncertain. Furthermore, it remains unclear whether
VHs are a predisposing or a resulting factor of executive dysfunctions, or if VHs
and executive functions are elevated by unrelated underlying mechanisms. Thus,
one possibility is that executive functions may be an important substrate for the
development of VHs even when the signs of dementia are not yet apparent. This
notion is in line with two longitudinal studies where VHs were recognized as a risk
factor for a later development of dementia (Aarsland et al., 2003; Santangelo et al.,
2007). However, other studies suggest that the executive dysfunctions cause, or at
least precede, VHs (Barnes & Boubert, 2008; Grossi et al., 2005; Meco et al., 1990;
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Sanchez-Ramos et al., 1996). As a third position, Fenelon et al. (2000) suggested
that PD patients with impaired cognition are not so self-conscious and for that
reason report experiencing VHs more often; therefore, VHs and a decline in
executive functioning are independent, but can masquerade as dependant variables.
Resolving this issue is especially desirable for setting up the diagnostic criteria of
VHs and executive functions in the course of the neurodegenerative disorders.
In the normal population, a specific executive dysfunction has been identified
to relate to hallucination-proneness: a source memory deficit. This is a dysfunction
of distinguishing the real from the imaginary (also known as a reality monitoring or
reality discrimination deficit, see Johnson & Raye, 1981). A dysfunction of source
memory offers one of the most straight-forward explanations for predisposition to
VHs: a failure in reality monitoring leads to confusion between self-generated
mental images and perception, resulting in hallucinations. Although source memory
has been proposed as the main contributing factor for the development of
hallucinations in the normal population and in patients with schizophrenia (Aleman
et al., 2000; Boeker et al., 2000; Lopez-Rodrigo et al., 1997; Rankin & O'Carroll,
1995), the link between hallucination-proneness and source monitoring is far from
confirmed (Keefe, Arnold, Bayen, & Harvey, 1999). Apart from the different
patient group that the studies stem from (i.e., schizophrenia), this link has only been
proposed for hallucinations in the auditory, and not visual, modality. The only
source memory study in PD patients with VHs (Bames et al., 2003) showed that
hallucinating PD patients made more source memory errors than their non-
hallucinating counterparts. However, the authors were unable to conclude which
factor is more critical for the genesis of VHs because the patients from their study
also showed deficits in perception.
In summary, executive functions have been poorly investigated in PD patients
with VHs and in high-prone normal individuals. Therefore, the aim of the present
study is to explore the differences in executive functioning between hallucinating
and non-hallucinating PD patients; and between high and low-prone normal
individuals. In particular, further investigations are required to verify the usefulness
of simple executive tasks in identifying non-demented PD patients at risk for the
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development of hallucinations, while taking independent factors into consideration
(e.g., age, years of diagnosis, disease severity, levodopa dose, etc). Comparing if
executive functions are implicated in both hallucinating PD patients and in high-
prone individuals will be an aid to current understanding as to whether
hallucinations and hallucination-proneness are alleviated by the same cognitive
factor, and will therefore serve as evidence to explain the occurrence of VHs in PD
and proneness to VHs in the normal population.
6.2 Methods
6.2.1 Participants
PD Group
9 PD patients with, and 17 PD patients without, VHs were recruited for the
executive functioning study. All patients were members of the PO societies in the
UK, with normal hearing and normal or corrected-to-normal vision. A criterion for
eligibility was a clinical diagnosis of PD as assessed by their GPs, and excluding
criteria was a moderate or severe stage of dementia, confirmed by the carers of the
PD patients, and the loss of independent maintenance of daily living activities, also
reported by the carers. The independent variables were the same as stated in the
previous studies of this research: age, amount of daily levodopa medication and the
use of any other medication, years since their diagnosis, side of the body more
affected by PO, the presence/absence of migraine, the presence/absence of ocular
pathology (not including correction glasses) and HY motor disability stage.
Participants' demographics are summarized in Table 6.1. The criteria for
grouping patients as PD hallucinators were recurrent VHs in the past month. 2
patients had VHs once a week, 5 had them 2-5 times a week, and 2 patients had
VHs more than 5 times a week. 17 participants who have never experienced VHs
were grouped as PD non-hallucinators.
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Table 6.1. Participants' demographics.
N
Age
Years since
diagnosis
Levodopa,
daily dose
HY
Hallucinating
PD patients
9 (6 male)
68.5 (7.2)
7.8 (6.3)
513.6 (266.3)
2.30.23)
Non-hallucinating
PD patients
1702 male)
71.7 (6.8)
6.1 (5.6)
482.5 (269.1)
2.0 (1.36)
High-prone Low-prone
normals normals
16 (4 male) 12 (4 male)
21.1 (3.6) 21.6 (3.5)
Data (except the number of participants) are presented as means (±standard
deviation). HY refers to the Hoehn-Yahr disability scale (1967).
Control Group
The CANTAB Executive functions tasks are supplied with a normative database
from approximately 1000 elderly normal participants, which serves as a comparison
age-matched control group. Instead of comparing the raw scores, CANTAB
expresses the results as standardized scores.
High and Low-Prone Normal Individuals
The same student sample from the visual memory and visual imagery study
(Chapter 4) participated in the executive functioning study. Therefore, 12 low-prone
and 16 high-prone individuals were recruited for the executive functioning and
source memory study (see Table 6.1). They were all undergraduate students from
Oxford Brookes University with normal hearing and normal or corrected-to-normal
vision. The exclusion criterion was a history of psychiatric disorder. The students
received compensation for their participation. All participants completed all stages
of the study.
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6.2.2 Assessments
CANTAB: Executive function, working memory and planning tests
It is desirable that any cognitive examination should be a relatively brief and
straightforward assessment. Executive function, working memory and planning
tests of the CANTAB battery (CANTAB Eclipse 3.0, Cambridge Cognition)
(Sahakian & Owen, 1992) include five tasks, assessing different aspects of
executive functions, working memory and planning. All five measures are primarily
sensitive to changes of the fronto-striatal areas of the brain and are standardised and
widely used measures of executive functioning (CANTABeclipse, 2006). However,
in order to prevent the effects of tiredness, stiffness or tremor from prolonged
testing condition in the PD group, the testing was scheduled to last no longer than
45 minutes. This time limit allowed no more than 3 tests to be carried out.
Therefore, despite the fact that all 5 executive tasks of the CANTAB are widely
used and standardised tasks of executive functioning, the present study employed
only three tasks in order to insure the best performance of both PD and the normal
population group and to avoid the effects of tiredness.
All participants completed the following three executive functioning tasks:
IntralExtra Dimensional Set Shift (lED), Stockings of Cambridge (SOC) and
Spatial Working Memory (SWM). As described in more details in the next section,
lED and SOC are modifications of widely used neuropsychological assessments of
executive functioning, namely the "Wisconsin Card Sorting Test" (Berg, 1948) and
the "Tower of London" task (Culbertson & Zillmer, 1998), respectively. As such,
they are widely accepted and used tasks, so it makes sense to contribute to
knowledge by employing well-known tasks in one of the first studies which look at
the differences in executive functioning between hallucinating and non-
hallucinating PD patients. Furthermore, it has been shown in recent studies that the
SWM impairments may be present at the early stages of the development of
psychosis (Bartok, Berecz, Glaub, & Degrell, 2005). As discussed in Chapter 1,
VHs in PD are thought to lead to the development of malign signs of psychosis
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(Goetz et al., 2001); therefore, a SWM as a potential indicator between psychotic
and non-psychotic states, was used in the present study. The tests have been shown
to be particularly sensitive to frontostriatal syndromes ranging from neurosurgical
excisions for tumors or epilepsy (Owen, Downes, Sahakian, Polkey, & Robbins,
1990) to Parkinson's (Owen et aI., 1992) and Huntington's diseases (Lawrence et
al., 1996).
Due to the obvious motor dysfunction in the PD group (especially during the
"off' state, when the medications start wearing off), all latency measures were
omitted in the analysis.
Intra/Extra Dimensional Set Shift (lED)
lED is a test of rule acquisition and attentional set shifting. It features visual
discrimination and attentional set formation, maintenance, shifting and flexibility of
attention. lED is a modification of the "Wisconsin Card Sorting Test" (Berg, 1948).
In this task, two artificial dimensions are used: colour-filled shapes and white lines.
Simple stimuli are made up of just one of these dimensions, whereas compound
stimuli are made up of both, namely white lines overlying colour-filled shapes (see
Figure 6.1). In the first block, the participant must learn which of the two colour-
filled shapes is correct by touching it, and continue doing so until the criterion is
reached (6 consecutive correct responses). In the next block, the contingencies are
reversed, so that now the previously incorrect stimulus is correct. In the next stages,
the second dimension (white lines) is introduced. If at any stage the participant fails
to reach the criterion after 50 trials, the test terminates. Administration time is
approximately 7 minutes. The test is primarily sensitive to changes of the fronto-
striatal areas of the brain (CANT ABeclipse, 2006). The deficits in the lED
performance have been observed following orbitofrontal and lateral prefrontal
damage (Dias, Robbins, & Roberts, 1996). Clark et al. (2004) suggest that
topographical connections exist between the ventral parts of the prefrontal cortex and
ventral parts of the striatum. Support for this claim is offered by a number of studies
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where lesions to the ventral striatum disrupts reversal learning, leading to preservative
response tendency (Annett, McGregor, & Robbins, 1989; Stem & Passingham, 1995).
--- -- -
I Ai'
Figure 6.1. An example of the IED task.
lED has the following outcome measures:
a) ID errors: This is the total number of errors taken to successfully complete
an intra-dimensional (ID) shift (the shift of attention to a novel exemplar within a
previously relevant perceptual dimension).
b) ED errors: This is the total number of errors taken to successfully complete
an extra-dimensional (ED) shift (the shift of attention to a novel exemplar of a
previously unrewarded perceptual dimension).
c) Total errors (raw): ID and ED errors taken together, these two measures can
give a relative measure of attentional "flexibility". Performance at this stage is
sensitive to cognitive deficits in PD (Downes et al., 1989) but can also be sensitive
to pharmacological manipulation of dopamine function by, for example, sulpiride
(Mehta, Sahakian, McKenna, & Robbins, 1999).
d) Total errors (adjusted): This is a measure of the participant's efficiency in
attempting the test. Thus, whilst a participant may pass all nine stages, a substantial
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number of errors may be made in doing so. It is crucial to note that participants
failing at any stage of the test by definition have had less opportunity to make
errors. Therefore, this adjusted score is calculated by adding 25 for each stage not
attempting due to failure. This value of 25 is used since participants must complete
50 trials to fail a stage and half of these could be correct by chance alone.
e) Stages completed: This is the total number of stages the participant
completed successfully. There are nine stages to be completed in this task in the
clinical mode. Participant completing all stages are deemed to have "passed the
test".
f) Completed stage trials: This is the number of trials undertaken on all
successfully completed stages.
g) Total trials (adjusted): This is the number of trials completed on all
attempted stages with an adjustment for any stages not reached. The adjustment
adds 50 for each stage not completed due to failure at an earlier stage.
Stockings of Cambridge (SOC)
SOC is a test of spatial planning, spatial working memory and motor control which
gives a measure of frontal lobe function (CANT ABeclipse, 2006). SOC is a
modification of the "Tower of London" task (Culbertson & Zillmer, 1998). In this
task, the participant is shown two displays (upper and lower), both containing three
coloured balls. The displays are presented in such a way that they can easily be
perceived as stacks of coloured balls held in stockings or socks suspended from a
beam. The participant's task is to use the balls in the lower display to copy the
pattern shown in the upper display. The balls may be moved one at a time by
touching the required ball, then touching the position to which it should be moved.
At first it is only necessary to move one ball, the number being increased in steps to
five moves. If the participant makes more than double the number of moves
necessary for the simplest solution, the problem is terminated. If the computer
terminates three problems in a row, the entire test ends. There is no time limit. The
researcher demonstrates the first problem. After that, participants must make all the
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moves themselves. The test has been found to be sensitive to frontal lobe damage in
several neuroimaging studies, especially in the left mid-dorsolateral frontal cortex
(Owen et al., 1990; Owen et al., 1996). However, the result that only the left
prefrontal activation reached significance does not necessarily indicate that the
process of planning is strongly lateralized to the left hemisphere, but is more likely
to have been an artifact of the substraction technique employed (Owen, 1997). This
is supported by Owen et aI's study (1996) where significant right dorsolateral
prefrontal cortex activation was observed compared with a resting condition in the
difficult planning condition prior to the subtraction of the specific task control
condition. Therefore, planning deficits are evident in patients with either right or
left prefrontal cortical damage (Owen et al., 1990; Owen et al., 1995; Shallice,
1982). Administration time is approximately 10 minutes.
The following SOC measure was used:
SOC Problems solved in minimum moves: This is a fundamental measure,
recording the number of occasions upon which the participant has success fully
completed a test problem in the minimum possible number of moves. For the
clinical mode, this is scored out of a possible 12 problems, since eight practice
problems are excluded from the calculation (the first six problems in the first block
and the first two problems in the second block). This measure is a succinct
expression of overall planning accuracy in sac (Robbins et al., 1998).
Spatial Working Memory (SWM)
SWM is a test of the participant's ability to retain spatial information and to
manipulate remembered items in a working memory. It is a self-ordered task, which
also assesses heuristic strategy. This test is a sensitive measure of frontal lobe and
"executive" dysfunction (CANTABeclipse, 2006). The test begins with a number of
coloured squares (boxes) being shown on the screen. The participant must touch each
box in tum until one opens with a blue "token" inside (a search). When a blue token
has been found, the participant has to place it in the right column ("home") by
touching the right-hand side of the screen. The participant must then begin a new
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search for the next blue token. It may be found in any of the boxes that so far have
been empty. This is repeated, until a blue token has been found in every box on the
current screen. Touching any box in which a blue token has already been found is an
error. The number of boxes is gradually increased from three to eight boxes. The
colour and position of the boxes used are changed from trial to trial to discourage the
use of the stereotyped search strategies. The participant decides the order in which the
boxes are searched. The computer determines the number of empty boxes that must
be visited (discounting errors). Performance at the harder levels of this task is
enhanced by the use of the heuristic search strategy. The task has been related to the
activity of the frontal lobe, as shown in a number of lesion and electrophysiological
studies in nonhuman primates (Goldman-Rakic, 1987), neuropsychological studies of
patients with frontal lobe damage (Owen et al., 1990; Owen et al., 1996; Owen et al.,
1995) and functional neuroimaging studies in humans (Owen, 1997). Owen et al.
(1990) showed that impaired performance on this task in neurosurgical patients with
frontal lobe excisions may be related to the inefficient use of a particular search
strategy associated with superior performance in normal participants. Furthermore,
Owen et al. (1998) showed that during the SWM task, an increased activity was
evident in the ventrolateral and premotor regions of the right frontal lobe in patients
with PD.
Administration time is approximately 8 minutes.
The following outcome SWM measures were taken:
a) Within errors: Within errors are defined as the number of errors made
within a search, i.e. the number of times a participant revisits a box already found to
be empty during the same search. This is calculated for trials of four or more tokens
only.
b) Between errors: Between errors are defined as times the participant revisits
a box in which a token has previously been found. This is calculated for trials of
four or more tokens only.
c) Double errors: These are occasions where the participant has committed an
error that can be categorised as both a within and between error. This is calculated
for trials of four or more tokens only.
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d) Total errors: This is the number of times a box is selected that is certain not
to contain a blue token and therefore should not have been visited by the
participant, Le. between errors + within errors - double errors.
e) Strategy: Owen et al. (1990) have suggested that an efficient strategy for
completing this task is to follow a predetermined sequence by beginning with a
specific box and then, once a blue token has been found, to return to that box to
start the new search sequence. An estimate of the use of this strategy is obtained by
counting the number of times the participant begins a new search with a different
box for 6- and 8-box problems only. A high score represents poor use of this
strategy and a low score equates to effective use.
Source Memory Task
Source memory is thought of as memory for the characteristics of the specific
conditions or context under which a memory is acquired (Drag, Bieliauskas,
Kaszniak, Bohnen, & Glisky, 2009). It has been suggested that source memory
abilities are related to the integrity of the frontal lobes, more specifically the
dorsolateral prefrontal cortex, as has been demonstrated by studies using lesion
evidence, neuropsychological data, and neuroimaging (Craik, Morris, Morris, &
Loewen, 1990; Dobbins, Simons, & Schacter, 2004; Glisky, Rubin, & Davidson,
2001; Nolde, Johnson, & D'Esposito, 1998; Trott, Friedman, Ritter, Fabiani, &
Snodgrass, 1999). Craik et al. (1990) demonstrated that source memory correlated
with measures of verbal fluency and the Wisconsin Card Sorting Test (WCST).
In this computerized task, designed by SuperLab Version 2 (Cedrus
Corporation, San Pedro, California, USA), participants were presented with a series
of objects which were shown in either the form of a contoured picture ("picture",
see Figure 6.2), a word ("word") or a spoken word ("sound"). 24 objects were
presented for each category. The objects were taken from the Snodgrass and
Vanderward (1980) set of standardized 2-D jpeg images. All pictures were of the
same size (400 x 400 pixels). At the encoding stage, 72 objects were presented on a
computer screen (24 pictures, 24 words and 24 sounds). Each picture and written
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word was displayed for 2 seconds, and a white screen which lasted for 2 seconds
was displayed between the presentations of the stimuli. A description of how a
study was carried out is offered in section 6.2.3.
Figure 6.2. Examples of the "picture" stimuli.
The following source memory outcome measures were taken:
a) Same picture: Same picture is defined as the number of correct answers
made in the test stage when participants recognise the picture which was
previously shown in a picture format. The maximum number of correct
answers is 8 (8 same pictures are presented in the first and test stage).
b) Same sound: Same sound is defined as the number of correct answers made
in the test stage when participants recognise the sound which was previously
heard in the same format. The maximum number of correct answers is 8 (8
same sounds are presented in the first and test stage).
c) Same word: Same word is defined as the number of correct answers made in
the test stage when participants recognise the word which was previously
presented in the same format. The maximum number of correct answers is 8
(8 same words are presented in the first and test stage).
d) Percent same: Percent same is defined as the percent of all correct answers
made in the test stage when participants recognise that the stimuli has been
presented in the same format (picture, sound, or word). 100 percent
corresponds to the maximum number of correct answers, which is for this
condition 24 (24 same stimuli are presented in the first and test stage).
e) Different picture: Different picture is defined as the number of correct
answers made in the test stage when participants recognise the picture which
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was previously shown in a different format (either word or sound). The
maximum number of correct answers is 8 (8 different pictures are presented
in the first and test stage).
f) Different sound: Different sound is defined as the number of correct answers
made in the test stage when participants recognise the sound which was
previously heard in a different format (either picture or word). The
maximum number of correct answers is 8 (8 different sounds are presented
in the first and test stage).
g) Different word: Different word is defined as the number of correct answers
made in the test stage when participants recognise the word which was
previously presented in a different format (either picture or sound). The
maximum number of correct answers is 8 (8 different words are presented in
the first and test stage).
h) Percent different: Percent different is defined as the percent of all correct
answers made in the test stage when participants recognise that the stimuli
have been previously presented in a different format. 100 percent
corresponds to the maximum number of correct answers, which is for this
condition 24 (24 different stimuli are presented in the first and test stage).
i) New picture: New picture is defined as the number of correct answers made
in the test stage when participants recognise the picture which was not
presented before. The maximum number of correct answers is 8 (8 new
pictures are presented in the test stage).
j) New sound: New sound is defined as the number of correct answers made in
the test stage when participants recognise the sound which was not
presented earlier. The maximum number of correct answers is 8 (8 new
sounds are presented in the test stage).
k) New word: New word is defined as the number of correct answers made in
the test stage when participants recognise the word which was not
previously presented. The maximum number of correct answers is 8 (8 new
words are presented in the test stage).
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I) Percent new: Percent new is defined as the percent of all correct answers
made in the test stage when participants recognise that the stimuli has been
presented in a new format (picture, sound, or word). 100 percent
corresponds to the maximum number of correct answers, which is for this
condition 24 (24 new stimuli are presented in the first and test stage).
m) Percent correct (total): Percent correct (total) is defined as the percent of all
correct answers made in the test stage when participants correctly recognise
a stimuli as the same, different or new. 100 percent corresponds to the
maximum number of correct answers, which is for this condition 72 (24 for
each condition, namely same, new and different).
6.2.3. Procedure
PD Group
The study was introduced verbally and information sheets were given out at the
monthly meetings in various PD societies throughout the UK between May and
June 2008. Potential participants were encouraged to take part regardless of whether
they had VHs or not. Those who decided to take part contacted the researcher at the
end of the meeting. Patients individually agreed on a convenient meeting time either
in their own homes or at the society meeting venue. After a brief description of the
aim of the study, the methodology, and the debriefing preference, participants were
encouraged to ask further questions before starting the experiment. All participants
were reminded to notify the researcher if they felt tired during the testing.
All participants filled in a short questionnaire of the demographic variables
and, where applicable, the nature of their VHs. In accordance with the university
research ethics, filling in the questionnaire was taken as a written informed consent.
Next, the participants were seated approximately 50 em away from a screen (close
enough to touch the screen). The executive functioning tasks from the CANTAB
battery (CANTAB Eclipse 3.0, Cambridge Cognition) were administered, and
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completed in a single session lasting approximately one hour. Debriefing took place
at the end of the study at the PD society meetings or, if preferred, was sent by post.
High and Low-Prone Normal Individuals
The same student sample from the visual memory and visual imagery study
(Chapter 4) participated in the executive functioning study. The recruitment was
therefore the same as in the previous study (see Chapter 4). After completing the
visual imagery and visual imagery task, the source memory (part I) was
administered, in which 72 trials (24 picture, 24 words and 24 sounds) were
presented in a randomized order. Each picture and written word was displayed for 2
seconds, and a white screen which lasted for 2 seconds was displayed between the
presentations of the stimuli. Participants were instructed to simply watch and listen
as the .objects were presented. No further instructions were given. Next, the
executive tests from the CANT AB battery and the source memory task were
administered, and completed in a single session lasting approximately half an hour.
After the CANT AB executive functioning tasks, a "surprise" source memory test
(part II) was presented, in which a series of 96 cards was presented: 32 objects from
all three categories (picture, word, sound) where 8 from each category were
presented in the same format, 16 in a different format and 8 distractor (new)
pictures. In this retrieval phase, participants were asked to indicate whether each
item had been seen previously as a percept (same), or was same object presented in
a different form/category (different), or was completely new (new). Source
discrimination errors were calculated, which consisted of the number of errors made
in the identification of an item's original source. All testing were completed in
January 2008. A debriefing sheet was sent to the participants who expressed a wish
to receive it.
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6.2.4 Statistical Analysis
Statistical analysis was performed using SPSS for Windows version 15.0 (SPSS
Inc., Chicago, IL). Descriptive statistics were used to describe the profile of both
PD groups and high and low-prone normal individuals. The demographic features
and the measures of the CANT AB executive tasks of hallucinating and non-
hallucinating PD patients and of the high and low-prone normal individuals were
compared using independent sample t-test and ANOV As. All CANT AB tasks are
provided with a normative database; therefore, the standardized scores were used as
a comparison for both PD groups. Independent t-tests were run to compare high and
low-prone normal participants on the source memory task.
6.3 Results
6.3.1 Demographics
Independent sample t-tests showed no difference between hallucinating and non-
hallucinating PD patients on any of the following independent variables: age,
gender, daily dopamine dosage, HY disability stage, years since diagnosis, side of
body more affected by PD, migraine, or vision problems, and any other concurrent
illness (all p-values > .188). The two PD groups only differed in the presence of
VHs in the hallucinating group (see Table 6.1).
Likewise, using the independent t-test, there was no difference between high
and low-prone participants in age, gender, vision and hearing problems, dyslexia or
handedness (all p-values > .397).
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6.3.2 CANTAB Executive Functioning and the Source Memory Task
PD Group
The standardized results of hallucinating and non-hallucinating PD patients across
different measures of the lED, SOC and SWM are displayed in Table 6.2.
Table 6.2. Standardized results of the executive functioning_tasks: Means and SDs.
Non-hallucinating Hallucinating t df p
PD patients PD patients
lED
- total errors (adjusted) -.08 (.691) -.60 (l.562) 1.099 21 .284
- total errors (raw) -.24 (.882) -.57 (1.057) -.713 21 .484
- completed stage error .50 (.733) -.08 (1.590) -1.124 21 .274
- completed stage trials .55 (.814) .15 (1.524) -.583 21 .566
- ED errors -.86 (1.072) -.56 (1.201) -.624 21 .539
- ID errors .59 (.242) .08 (1.250) 1.508 21 .146
- stages completed -.26 (.779) -.63 (1.490) .790 21 .439
- total trials -.03 (.622) -.20 (1.078) .489 21 .630
- total trials (adjusted) -.16 (.761) -.65 (1.437) 1.072 21 .296
SOC
- problems solved in -.17 (1.268) -.72 (1.685) .884 21 .387
minimum moves
SWM
- between errors .09 (.816) -.03 (.987) .305 18 .764
- double errors .29 (1.007) .48 (.376) -.501 18 .622
- strategy -.31 (.689) -.37 (.624) .180 18 .859
- total errors -.21 (.879) -.36 (1.058) .335 18 .741
- within errors .33 (.971) .49 (.404) -.426 18 .675
A standard score chart for a measure shows the number of standard deviations that
the participant's performance lays from the peer group means. rED = Intra/Extra
Dimensional Set Shift; SOC = Stockings of Cambridge; SWM = Spatial Working
Memory.
The standardized values show that hallucinating PD patients scored similarly
to non-hallucinating patients and the age-matched control group. The independent
sample t-tests showed no statistically significant differences between PD groups
across all the CANT AB executive functioning measures. There were large
individual differences, especially within the hallucinating PD group (see Table 6.2).
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High and Low-Prone Normal Individuals
Similar to the PD groups, there were no significant differences between high and
low-prone normal individuals on any measure of CANT AB and the source memory
task (see Table 6.3).
Table 6.3: Source memory and the CANT AB tasks results for high and low-prone groups:
Means, SDs, and E-values.
Low-prone High-prone t df p
Individuals Individuals
Source Memory Task
Same picture 6.25 (1.76) 5.44 (.16) 1.277 26 .213
Same sound 5.50 (.90) 5.38 (1.02) .335 26 .740
Same word 3.58 (1.83) 3.25 (1.95) .459 26 .650
Percent same 63.89 (10.41) 58.59 (12.12) 1.214 26 .236
Different picture 9.17 (2.59) 9.19 (2.17) -.023 26 .982
Different sound 8.92 (1.88) 9.50 (3.01) -.589 26 .561
Different word 8.08 (2.81) 9.62 (3.14) -1.344 26 .191
Percent different 54.52 (8.13) 58.59 (12.41) -.930 26 .361
New picture 5.92 (1.62) 5.19 (1.76) 1.122 26 .272
New sound 5.75 (1.42) 4.50 (2.25) 1.794 26 .085
New word 4.33 (2.15) 4.56 (2.03) -.288 26 .775
Percent new 66.67 (15.99) 59.37 (20.44) 1.022 26 .316
Percent correct (total) 59.89 (5.70) 58.92 (11.65) .266 26 .793
CANTAB Tasks
lED
- stages completed 7.92 (1.00) 8.5 (.89) -1.627 26 .116
- total errors 28.75 (15.64) 18.94 (10.71) 1.972 26 .059
- total trials 96.83 (26.95) 84.06 (15.66) 1.579 26 .126
SOC
- problems solved in 8.00 (1.76) 7.44 (2.00) .775 26 .445
minimum moves
SWM
- between errors 14.50 (10.97) 22.31 (18.42) -1.302 26 .204
- double errors .92 (1.73) .94 (1.84) -.030 26 .976
- strategy 32.08 (4.19) 32.69 (4.56) -.359 26 .722
- within errors 1.25 (1.82) 1.44 (3.10) -.187 26 .853
6.4 Discussion
Deficits in executive functions in PD patients without dementia are relatively well
documented, but their assessment is not straightforward. The present study is the
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first to investigate the differences in executive functioning between hallucinating
and non-hallucinating PD patients using the highly reliable and valid
neuropsychological assessment. Moreover, the administration procedure in the
present study showed that the executive functioning tasks of the CANT AB battery
are a viable tool to apply in the PD population.
No standardized measures of the executive tasks (lED, SOC and SWM) were
statistically different between PD hallucinators, PD non-hallucinators and the
control group (see Table 6.2), although PO patients in general performed worse
than the control group (see Table 6.4) as reported by several authors before (Morris
et al., 1988; Owen et al., 1992; Owen et al., 1995). Similarly, high and low-prone
normal individuals did not differ in any of the behavioural measures of the
executive functioning tests of the CANTAB battery. The comparable executive
functioning between the PD group and control group is not surprising given the
patients' demographic characteristics (see Table 6.1). The mean Hoehn and Yahr
score (1967) in PD hallucinating groups was 2.30 (SD=1.23) and 2.0 (SD=1.36) in
PD non-hallucinating group, indicating a relatively early (motor) stages of PD.
Furthermore, all patients reported relative or complete independent care for
themselves, and there was therefore a higher expectancy of the intact executive
functioning. The first finding of the present study is that when hallucinating and
non-hallucinating PD patients were matched for age, years since diagnosis, HY
disability scale, side of body more affected by PD, any ocular pathology and the
levodopa daily intake dosage, the executive functioning in both groups was intact
and comparable with the age-matched control group.
As described in Section 1.6.3, the consensus has not been reached about how,
if at all, VHs are linked to the executive functions. The results from the present
study suggest that VHs occur in the absence of executive dysfunctions; therefore,
executive dysfunctions do not precede the development of VHs. In a study of
Capitani and colleagues (2007) VHs in PD did not exceed the 25% incidence rate
even in the extremely advanced cases of dementia. Their results suggest that a
severe cognitive deficit is not sufficient by itself to invariably cause VHs.
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More likely, the results of the present study support the idea that VHs precede
cognitive decline. This is in line with the eight-year longitudinal study (Aarsland et
al., 2003) where hallucinating PD patients were three times more likely to develop
dementia than their non-hallucinating counterparts. Santangelo et al. (2007) also
support the idea that development of VHs precedes the decline in executive
functioning. Consequently, the frontal functioning (as measured by the executive
functioning tasks) is not the first area of interest in relation to VHs (although it can
become dysfunctional in the later stages of the illness). Therefore, if there is a
common underlying mechanism for both VHs and executive dysfunction, the
dysfunction first manifests in the development of VHs, when the level of pathology
is not yet extensive enough for the executive dysfunction to be unvaryingly evident.
An alternative explanation, however, is that executive functions are implicated
in VHs in PD, acting as a top-down process on an impoverished functioning of the
association visual cortex. However, these differences were not observed due to a
number of reasons such as the specificity of the executive tasks used in the present
study, the number of participants, etc. Non-hallucinating PD patients might be
protected by as yet unknown executive functions whereas the hallucinating PD
patients, where this functioning is affected, are not. One possibility could be the
anterior cingulate (Stebbins et al., 2004; Whitty & Lewin, 1957).
Given that no deficits in executive functioning were found in the hallucinating
PD group, it is not surprising there were no differences in performance on the
executive tasks between high and low-prone normal individuals. Additionally, no
behavioural differences were found between high and low-prone groups on the
source memory tasks. Therefore, the present study was unable to provide evidence
whether proneness to VHs in the normal population arises as a result of
misinterpreting internally generated mental images as externally based perceptions
(source memory generated errors). The results from the study suggest that the
executive functions are probably not the factors contributing to the proneness to
VHs in the normal population and are not a viable candidate in constructing the
hallucination-proneness model. In the continuum hypothesis, similar dysfunctions
should be expressed in both hallucinating PD patients and high-prone normal
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individuals; however, as both groups performed equally well as non-hallucinating
PD patients and low-prone individuals respectively, it seems that executive
functions, as measured in the present study, are not likely candidates as risk factors
on a hallucination continuum.
6.4.1 Limitations
Some caution needs to be taken when interpreting the results from the present
study. There were large individual differences in the hallucinating PD group (Table
6.2). These differences could blur the effect between the groups and result in
making a beta error. This type of error is especially common in experiments with a
limited amount of data due to the relative rarity of VHs in PD and the specific care
that needs to be taken when working with this fragile population (the duration of
tasks, medication variations throughout the day, etc.). With the exception of
Fenelon et al. 's (2000) study comprising of a sample of 86 hallucinating PD
patients, the studies usually operate with data of up to 30 participants. Therefore, a
possible explanation is that there are differences in the executive functioning
between hallucinating and non-hallucinating groups, but they were not observed
due to the limited amount of participants.
In light of the earlier discussion about the limitations of the CANT AB battery
(see Chapter 4), it is imperative to acknowledge that the performance on the
CANTAB tests may be impaired due to the lesions to widely distributed brain
structures. Robbins et al. (2007) argue that this is especially true of the prefrontal
cortex which has major reciprocal projections to posterior cortical areas, as well as
to subcortical areas such as the hypothalamus and the striatum (Goldman-Rakic,
1987). Furthermore, Owen et al. (1998) found that PD patients showed decreased
activity in the globus pallidus during the SWM task, whereas the age matched
control group showed increased activity in the same area. From these results, it was
suggested that striatal dopamine depletion in PD patients disrupts the normal pattern
of basal ganglia outflow, which, in tum, disrupts the various cognitive functions of
the frontal lobe by interrupting normal transmission of information through
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frontostriatal circuitry (Lee et al., 2000). In the light of the results from the present
study, it could be expected that PO patients might show some impairments of the
prefrontal cortex not due to the lesions in the prefrontal cortex, but possibly due to
the suboptimal activity in the posterior areas which may then, according to Robbins
et a1. (2007) and Lee et a1. (2000) project to the prefrontal cortex. Finally, Robbins
et a1. (2007) suggest that the interconnection between prefrontal cortex and other
brain regions makes it an ideal candidate for mediating many aspects of executive
function.
6.4.2 Further Studies
Although PO patients are a notoriously heterogeneous group, the individual
differences were much more pronounced in the hallucinating than in the non-
hallucinating PO group. The large set of independent variables (age, years since
diagnosis, HY disability scale, side of body more affected by PO, any ocular
pathology and the levodopa daily intake dosage) are therefore most likely not a final
set of factors that are necessary to be taken into consideration when planning an
experiment with this particular patient group.
Graham and colleagues (1997), for example, investigated the homogeneity of
a population of patients with idiopathic PO and hallucinosis and found two
subgroups of hallucinating PO patients. In patients with disease duration of five
years or less, VHs were associated with rapid progression of the motor component
of the disease, but not with cognitive impairment. However, in patients with PO of
longer than five years duration, VHs were associated with postural instability and
global cognitive impairment. Although the PO hallucinating group (M=7.8 years,
SO=6.3) was diagnosed slightly longer than the non-hallucinating PO group (M=6.1
years, SO=5.6), the difference in years of diagnosis was not significant (p=O.188).
If Graham's conclusions are correct, the difference between PO groups in our
sample should not be noticeable due to the heterogeneity of years since diagnosis in
the PO groups. However, the small number of patients in both groups prevented
further analysis in comparing PO hallucinators according to their years since
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diagnosis. Similarly, Owen and colleagues (1993) claimed that multiple memory
deficits in PD may differentially depend on the severity of the motor disability.
Again, there was no difference in the HY scale between the PD samples in the
present study, so no significant difference in cognitive performance was expected in
the two groups according to their severity stage. Furthermore, the mean HY
disability score was 2.3 in the hallucinating and 2.0 in the non-hallucinating group,
indicating relatively early stages of PD, and therefore a higher expectancy of intact
cognitive performance. In summary, although there is a notable difficulty in
recruitment of this vulnerable patient group, further studies need to address the
issue of years since diagnosis and severity of disability as decisive dividing factors
for development of VHs with a sufficient number of participants.
Finally, the results from the previous studies (Chapters 4 and 5) brought
attention to the possible dysfunctions of the frontal lobe in the hallucinating PD
patients during a specific visual memory task (DMS, sensitive to temporal and
frontal lobe damage; but not the SRM which is sensitive to frontal lobe functioning
alone), and in the high-prone normal individuals during the face perception task;
however, the results from the present study do not show evidence for the
involvement of the executive functions in relation to VHs in PD. Based on the
results from the present study it was suggested that VHs are independent of
executive functioning. It is suggested that the reason why more PD patients with
dementia also experience VHs is because they are often older, have been diagnosed
longer, and have consequently more advanced neurodegeneration lesions than their
non-hallucinating counterparts.
Despite the non-significant results, the executive functions as measured in the
present study, are likely to have an important protective function, associated with
preserving an insight into the hallucinatory nature of the images that PD patients
perceive. When the executive functions start wearing off (as in case of dementia),
patients lose that insight, consequently the patients are less self-conscious and are
less inhibited to report their hallucinations frequently. Some evidence behind this
reasoning is offered in cases where patients with dementia report a higher frequency
of VHs than the patients without dementia (Capitani et al., 2007; Hobson & Meara,
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1999; Janvin, Aarsland, & Larsen, 2005; O'Brien et aI., 2005), but it is important to
differentiate that frequent reports about hallucinations are a side-effect of executive
dysfunction and there may be no immediate causal effect.
Two possible paths of investigation are therefore proposed. First, there may be
an underlying executive dysfunction involved in the generation of VHs which is not
extensive enough to be observed by behavioural tasks. An investigation of
executive functioning using neuroimaging studies which explore neural differences
at a micro level, similar to the study in Chapter 5, would offer new insights. The
other possibility, as justified in Chapters 4 and 5, is that internally-driven
personality factors play an important role, which will be addressed in the following
chapter.
6.4.3 Conclusions
Based on the previous studies, it was expected that compared to non-hallucinating
PD patients, patients with VHs would perform worse on the tests of executive
functioning. However, this was not demonstrated in the present study where a
performance on the executive functioning in hallucinating and non-hallucinating
groups was comparable to the control group. Similarly, no differences were found
between high and low-prone individuals from the normal population on any
measures of executive functioning or the source memory task. The results suggest
that if VHs and executive dysfunctions are linked by the same underlying
mechanism, VHs are the first to be expressed and precede the development of
executive dysfunctions. These results do not explain the involvement of the
executive functioning in the genesis of VHs or hallucination-proneness and
therefore call for further investigation into the link between VHs and the frontal
lobe functioning. The results suggest that hallucination-proneness in the normal
population and VHs in PD may be related to internally driven personality processes.
These processes will be explored in Chapter 7.
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Chapter 7: Personality in Hallucinating PD Patients and in High-
Prone Normal Individuals
7.1 Introduction
The results from Chapters 4 and 5 give evidence that some form of frontal
dysfunction might possibly be implicated in the generation of VHs in PO, and
hallucination-proneness in the normal population. Two lines of research were
proposed to investigate the importance of the frontal functioning in the occurrence
of VHs and hallucination-proneness: via executive functioning and via personality
factors. However, the results from the executive study (see Chapter 6) show that
executive functioning was intact in both hallucinating and non-hallucinating PO
patients as well as in high and low-prone individuals. Therefore, the aim of the
present study is to determine whether specific personality processes are implicated
in VHs in PD and, following the continuum hypothesis, in hallucination-proneness
in the normal population.
PD patients have often been associated with specific personality type, the so-
called "Parkinsonian personality". The term has been linked with the following
characteristics: compulsive, industrious, introverted, morally and sociably rigid,
suspicious, self-protective, punctual, serious, stoic, quiet, emotionally and
attitudinally inflexible, lacking of novelty seeking and affect, predisposing to
depressive illness, introspective, over-controlled, anhedonic with suppressed
aggression, avoiding harm (Cloninger, 1987; McNamara, Durso, & Harris, 2007;
Todes & Lees, 1985)20. Moreover, other studies propose that PD patients were over-
controlled, depressed, introverted and inflexible before the diagnosis of PD
(Heberlein, Ludin, Scholz, & Vieregge, 1998; Poewe, Karamat, Kemmler, &
Gerstenbrand, 1990)21; however, it remains unclear to what extent does the
neuropathology of PD link to premorbid vulnerabilities (Bodis-Wollner, 2003).
20 See also Evans et al., 2006; Hubble & Koller. 1995; Kaasinen et al., 2001; Menza, Golbe, Cody. &
Forman. 1993.
21 See also Hubble. Venkatesh, Hassanein, Gray. & Koller. 1993; Menza, Forman. Goldstein. &
Golbe, 1990; Ward et al., 1984. Gerstenbrand & Karamat, 1999.
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Further, authors (Heberlein et al., 1998; Poewe et al., 1990) recognise the limitation
of retrospective and highly subjective reports from patients and their carers. It
remains unclear, therefore, whether or not the "Parkinsonian personality" is
premorbid or merely a reactive consequence of having PD.
McNamara et al. (2007) suggested that PD patients with frontal impairment
are especially susceptible to personality changes, and that the frontal lobes are
required for maintenance of prosocial personality traits. However, the link between
VHs and frontal impairment, which can be manifested in a range of personality
changes, has not been explored in detail. Meco et al. (1990) and Glantz et al. (1987)
both using the Minnesota Multiphasic Personality Inventory (MMPI) (Butcher,
Dahlstrom, Graham, Tellegen, & Kaemmer, 1989) reported a higher score on
schizophrenia scale in hallucinating PD patients, indicating a higher level of social
alienation, bizarre feelings and general dissatisfaction. However, none of these
studies provide an explanation of how these personality factors affect the
occurrence of VHs. Thus, the aim of the present study is to investigate the role of
personality factors in hallucinating PD patients: if hallucinating patients exhibit
specific personality traits as compared to non-hallucinating patients, that could
provide evidence for involvement of top-down processing of information in the
generation of VHs in PD. Unlike other studies (such as Glantz et al., 1987; Meco et
al., 1990), the present study is the first study to observe the differences in a range of
personality traits using a more generalized, yet highly reliable and standardized
personality factors questionnaire 16PF (Cattell, 1956).
Specific personality traits have also been implicated 10 hallucination-
proneness in the normal population, namely fantasy proneness and meta-cognitive
beliefs. Fantasy proneness refers to a non-pathological trait defined by a profound
involvement in fantasy and imagination (Lynn & Rhue, 1986), characterized by
having vivid fantasies with hallucinatory intensities, reporting vivid childhood
memories, experiencing strong bodily concomitants of fantasies, having out-of-
body and other paranormal (e.g. telepathic) experiences, and having intense
religious experiences. However, individuals scoring high on fantasy proneness, as a
rule, do not have genuine, life-like hallucinations (Van de Ven & Merckelbach,
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2003) and in fact, adopt lax criteria when classifying internal experiences as
hallucinations (Lynn & Rhue, 1986).
Wells et al. (2000; 1994) proposed that intrusive mental experiences are
subject to interpretation that relies on meta-cognitive beliefs (beliefs that are linked
to the interpretation, selection and execution of particular thought processes). Thus,
meta-cognitions are relevant to the study of VHs and a number of studies have
found evidence of association between meta-cognitive beliefs (Laroi & Van der
Linden, 2005) and the presence of hallucinations in both clinical and nonc1inical
samples (Jones & Fernyhough, 2006; Laroi, Collignon, & Van der Linden, 2005;
Laroi, Van der Linden, & Marczewski, 2004). More specifically, all measures of
meta-cognitive beliefs have been more pronounced in high-prone individuals,
namely intrusive thoughts, negative beliefs about the uncontrollability and danger
of thoughts, loss of cognitive confidence, thought control through worry and
positive beliefs about worry (Cangas et al., 2006; Garcia-Montes, Cangas, Perez-
Alvarez, Fidalgo, & Gutierrez, 2006; Laroi & Van der Linden, 2005). Morrison et
al. (1995) proposed that meta-cognitive beliefs influence how intrusive thoughts are
dealt with when they occur. They suggest that an internal thought is attributed to
external source in situations when the thought is not consonant with general meta-
cognitive beliefs (and are therefore considered intrusive). As investigated by Wells
et al. (2000; 1994), meta-cognitive beliefs are an executive function of excessive
self-focused attention and reflective processes. Therefore, it is likely that meta-
cognitive processes are linked to the proneness of VHs.
Although no relationship was found between executive functioning or visual
imagery and VHs in either PD patients or normal individuals (see Chapters 4 and
6), the idea of vivid fantasy or imagination remains, and needs to be addressed in
further studies. To date, no study has investigated the role of fantasy proneness in
hallucinating PD patients or in high-prone individuals from the normal population.
Similarly, no study has addressed the role of meta-cognitive beliefs in hallucinating
PD patients. Therefore, the aim of the present study is to examine personality traits,
fantasy proneness and meta-cognitive beliefs in hallucinating PD patients and, in
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line of the continuum hypothesis, in high-prone individuals from the normal
population.
7.2 Methods
7.2.1 Participants
PDGroup
11 PD patients with, and 20 PD patients without, VHs were recruited for the
personality study. All patients were members of the PD societies in the UK, with
normal hearing and normal or corrected-to-normal vision. A criterion for eligibility
was a clinical diagnosis of PD as assessed by their GPs, and excluding criteria was
a moderate or severe stage of dementia, confirmed by the carers of the PD patients,
and the loss of independent maintenance of daily living activities, also reported by
the carers. The independent variables were the same as stated in the previous
studies of this research: age, amount of daily levodopa medication, years since their
diagnosis, side of the body more affected by PD, the presence/absence of migraine,
the presence/absence of ocular pathology (not including correction glasses) and HY
motor disability stage.
Participants' demographics are summarized in Table 7.1. The criteria for
grouping patients as PD hallucinators were recurrent VHs in the past month. 3
patients had VHs once a week, 5 had them 2-5 times a week, and 3 patients had
VHs more than 5 times a week. 20 participants who have never experienced VHs
were grouped as PD non-hallucinators.
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N
Age
Years since
diagnosis
Levodopa,
daily dosage
H-Y
HallucinatingNon-hallucinating
PD atients PD atients
Control High-prone Low-prone
roo normals normals
11 (6 male) 20 (14 male)
65.91 (5.974) 69.85 (6.604)
12 (4 male) 16(4 male) 12 (4 male)
71.42(4.889) 21.1 (3.6) 21.6(3.5)
14.0 (7.76)
560.1 (291.9)
2.07 (l.058)
9.2 (7.22)
502.1 (276.7)
1.71 (.906)
Data (except the number of participants) are presented as means (±standard deviation).
HY refers to the Hoehn-Yahr disability scale (1967).
Control Group
12 age-matched participants were recruited for the personality study (see Table 7.1).
They were contacted on a snowball principle. All participants had normal hearing
and normal or corrected-to-normal vision. The exclusion criterion was a history of
psychiatric or neurological disorders. The control group did not fill in the 16PF
personality questionnaire (Cattell, 1956), as it is provided with a normative age-
matched database.
High and Low-Prone Normal Individuals
The same student sample participated in the perception, executive functions and
personality study. Therefore, 12 low-prone and 16 high-prone individuals were
recruited for the study (see Table 7.1). They were all undergraduate students from
Oxford Brookes University with normal hearing and normal or corrected-to-normal
vision. An exclusion criterion was a history of psychiatric disorder. The students
received compensation for their participation. All participants completed all stages
of the research.
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7.2.2 Assessments
The Sixteen Personality Factor Questionnaire (16PF)
16PF (Cattell, 1956) is an objective self-report personality test, which includes
measurements of 16 dimensions (Table 7.2).
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Grounded in the data itself, the questionnaire was developed. The data itself
determined the factors, while the other personality questionnaires were developed
based on methods that forced their factors to be uncorrelated, and as a result shaped
their definitions+ (Cattell & Schuerger, 2003). The development of so called Big
Five theories (proposing there are five broad factors or dimensions of personality)
(Costa & McCrae, 1985) was heavily influenced by the use of 16PF. Further,
Cattell (1946) found that the 16 primary factors gave rise to five global traits, which
are to some extent comparable to the Big Five factors (Byravan & Ramanaiah,
1995). However, the 16PF are the only Big Five scales developed without their
definitions' being constricted by methods of statistical convenience (Cattell &
Schuerger, 2003). Further, the five global scales of 16PF give an outline of
personality traits at a broad level, but the more specific 16 primary factors offer a
comprehensive understanding of the individual's distinctive personality at various
levels of organization and help to understand individual's deeper motivations
(Cattell & Schuerger, 2003; Chamorro-Premuzic & Furnham, 2003; Rothstein,
Paunonen, Rush, & King, 1994). Finally, the 16PF primary factors have been
proven to be powerful predictors of actual behaviour, which is what makes the
16PF one of the most frequently used personality tests (Cattell & Schuerger, 2003).
Internal consistency reliabilities average .76 (ranging from .68 to .87 over the
16 factors) in the normative sample of 10,261 individuals (Cattell & Schuerger,
2003). High construct and applied validity were also reported. Importantly,
Goldberg (in press) compared several personality questionnaires in their ability to
predict six clusters of behavioural criteria and found that the 16PF dimensions had
the highest predictive validity.
10 to 13 items are provided for each of the 16 dimensions (185 questions in
total). Three alternative answers are provided for each of the questions, usually true,
unsure, and false. 16PF generally requires about 45-60 minutes for administration.
Simple and clear instructions are printed for participants on the cover page of the
test booklet (see Appendix 12). Participants are asked to give their first, natural
22 Technically. the 16PF scales emerged in a factor analysis that allowed oblique rotations; in
contrast. the other systems used orthogonal rotations. despite the fact that these systems have
repeatedly been found to be significantly correlated (Cattell & Schuerger, 2003).
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answer and to answer as honestly as possible. They are encouraged to answer every
question and to avoid mainly selecting the middle, "uncertain" answer. All answers
are made on a separate answer sheet.
The answers are scored by hand or by machine; the raw scores are converted
to the "sten" scores by the standardization tables. Sten scores are distributed over 10
equal-interval standard score points (assuming normal distribution), from 1 through
10. The population average (or mean) for a sten distribution is fixed at 5.5 and the
standard deviation is 2.0 sten scores. The exact limits of sten 5 and 6 (4.5 - 6.5)
extend, respectively, a half standard deviation below and above the mean,
constituting the solid centre of the population, while the outer limits for stens 1 and
10 are 2.5 standard deviations below and above the mean. Sten scores of 4 through
7 are usually considered to be average, since they fall within one standard deviation
of the population mean and therefore represent approximately two-thirds of all the
obtained scores. Sten scores 1, 2, 3, and 8, 9, 10 are generally considered to be of
greater importance for profile interpretation as they are more extreme and occur far
less frequently in a normal population (IPAT, 1991).
Meta-cognitions Questionnaire (MCQ)
MCQ (Cartwright-Hatton & Wells, 1997) assesses individual differences in positive
and negative beliefs about worry and intrusive thoughts, meta-cognitive monitoring
and judgments of cognitive efficiency (see Appendix 13). The 65 MCQ items are
scored from 1 to 4, where 1 = 'do not agree', 2 = 'agree slightly', 3 = 'agree
moderately' and 4 = 'agree very much'. Total scores can range from 30 to 120.
Factor analysis of MCQ items reveals that the MCQ consists of five relatively
distinct subscales (Lees, Blackburn, & Campbell, 1988).
The first subscale, "Positive beliefs about worry", consists of items relating to
beliefs that worry helps one to solve problems and avoid unpleasant situations.
The second subscale, "Negative beliefs about the uncontrollability of thoughts
and corresponding danger" includes items relating to beliefs that worry is
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uncontrollable, that one must control one's worrying, and that worrying is
dangerous.
The third scale, "Cognitive confidence", includes items relating to concerns
about one's cognitive efficiency.
The fourth subscale, "Negative beliefs about thoughts in general" (in particular
relating to superstition, punishment and responsibility), includes items relating to
fears of outcomes that might result from having certain thoughts, and the
acceptance of responsibility for having such thoughts.
Finally, the fifth subscale, "Cognitive self-consciousness", includes items
related to the tendency to monitor and focus on one's thinking processes.
The questionnaire takes approximately 10 minutes to complete. Initial
validation studies found that the MCQ has good psychometric properties
(Cartwright-Hatton & Wells, 1997).
Fantasy Proneness Questionnaire (CEQ)
The "Creative Experiences Questionnaire" (CEQ) (Cronbach's alpha=O.77) is a 25-
item true-false index of fantasy proneness (see Appendix 14). Sample items are "As
a child, I had my own make believe friend or animal" and "When I think of
something cold, I actually get cold". True answers are summed to obtain a total
score, with a higher total score implying a higher level of fantasy proneness (Van de
Ven & Merckelbach, 2003). Substantial correlations have been found between the
CEQ and standard measures of absorption. schizotypy, and dissociation
(Merckelbach & van de Ven, 2001). The questionnaire takes approximately 5
minutes to complete.
Fantasy proneness levels are significantly associated with endorsement of
atypical symptoms listed by malingering instruments (Merckelbach & Smith, 2003)
and Silva and Kirsch (1992) report that participants who score high on a fantasy
proneness tasks seem to be more eager to endorse odd items when confronted with
suggestive task instructions. Likewise, Wilson and Barber (1983) reported fantasy
proneness is a important factor related to hypnotic susceptibility. Fantasy proneness
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overlaps with positive schizotypy (Merckelbach, Rassin, & Muris, 2000) and may
also be involved in reports of hallucinatory experiences (Merckelbach & van de
Ven,2001).
7.2.3 Procedure
PDGroup
The study was introduced verbally and information sheets were given out at the
monthl y meetings in various PD societies throughout the UK between March and
July 2008. Potential participants were encouraged to take part regardless of whether
they had VHs or not. Those who decided to take part contacted the researcher at the
end of the meeting. They were given an envelope with the personality
questionnaires, which they took back home, and filled them over the period of two
weeks. Participants then sent the questionnaires back to the experimenter. Apart
from the personality questionnaires, all participants filled in a short questionnaire of
the demographic variables and, when applicable, the nature of their VHs. In
accordance with the university research ethics, filling in the questionnaire was taken
as a written informed consent. Debriefing took place at the end of the study in the
same PD societies' meetings or, if preferred, was sent by post.
Control Group
Personality questionnaires were distributed to the age-matched control group. All
participants were given a stamped envelope to send it back to the experimenter once
they filled in the questionnaires. Debriefing was done either in person, by phone or
post (depending on the participant's preference).
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High and Low-Prone Normal Individuals
The same student sample participated in the personality, visual memory and the
executive functions study. The recruitment is therefore the same as in the previous
studies (see Chapters 4 and 6). After finishing the CANT AB studies, participants
were asked to fill in the personality questionnaires, which lasted approximately half
an hour. Testing was completed in January 2008. A debriefing sheet was sent to the
participants who expressed a wish to receive it.
7.2.4 Statistical Analysis
Statistical analysis was performed using SPSS for Windows version 15.0 (SPSS
Inc., Chicago, IL). Descriptive statistics were used to describe the profile of both
PD groups and high and low-prone normal individuals. The demographic features
and the measures of the personality tests of hallucinating and non-hallucinating PD
patients and of the high and low-prone normal individuals were compared using t-
tests for independent samples. 16PF questionnaire is provided with a normative
database; therefore, the standardized scores were used as an age-matched
comparison for both PD groups.
7.3 Results
7.3.1 Demographics
Using the independent t-test, there was no difference between hallucinating and
non-hallucinating PD patients on none of the following independent variables: age,
gender, daily dopamine dosage, HY disability stage, years since diagnosis, any
other concurrent illness, or side more affected by tremor. The two PD groups only
differed in the presence of VHs.
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Likewise, using the independent t-test there was no difference between high
and low-prone normal participants in age, gender, vision and hearing problems.
dyslexia or handedness.
7.3.2 Personality Tests - PD Group
There were no statistically significant differences between PD hallucinators, PD
non-hallucinators and age-matched control group on CEQ, MCQ or any factor of
the 16PF questionnaire. The sten scores for both PD groups across all factors of the
16PF are displayed in Table 7.3. Except for the non-hallucinating PD patients on
Factor A, the mean values of no other factor were below or above the cut-off line (3
and 7, respectively).
Table 7.3. Means, SDs and Hest results of the 16 pp sten scores.
Hallucinating Non-hallucinating t df P
16PF PD atients PD atients
Factor A 4.70 (1.946) 7.24 (2.705) -1.589 25 .160
Factor B 5.90 (1.595) 5.65 (1.966) .345 25 .733
Factor C 5.20 (2.251) 5.24 (1.393) -.051 25 .960
Factor E 3.600.955) 4.82 (1.468) -1.850 25 .076
Factor F 3.60 (1.897) 4.47 (1.940) -1.135 25 .267
FactorG 6.00 (1.700) 6.24 (1.715) -.345 25 .733
Factor H 3.80 (l.619) 5.35 (2.422) -1.798 25 .084
Factor I 4.50 (2.173) 4.35 (1.967) .181 25 .858
Factor L 4.50 (2.068) 5.00 (2.031) -.614 25 .545
FactorM 4.30 (2.452) 4.59 (2.320) -.305 25 .763
FactorN 5.60 (1.350) 5.71 (1.724) -.166 25 .869
FactorO 5.20 (2.394) 4.94 (1.819) .318 25 .753
Factor Ql 5.50 (2.321) 4.35 (2.234) 1.270 25 .216
Factor Q2 5.00 (2.261) 5.47 0.972) -.568 25 .575
FactorQ3 6.80 (2.201) 6.41 (1.372) .567 25 .576
Factor Q4 5.40 (1.430) 5.65 0.579) -.406 25 .688
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7.3.3 Personality Tests - High and Low-Prone Normal Individuals
Very different to the results from the PD groups, high and low-prone individuals
statistically significantly differed on several 16PF, MCQ and CEQ measures (see
Table 7.4):
Table 7.4. Means, SDs and E-values for the Eersonalit~ guestionnaires.
Low-prone High-prone t df p
normals normals
16PF
Factor A 4.92 (l.31) 6.69 (2.24) -2.618 26 .015
Factor B 2.33 (1.37) 3.19 (1.47) -1.565 26 .130
FactorC 3.67 (1.67) 4.81 (1.87) -1.678 26 .105
Factor E 5.58 (1.88) 6.19(1.97) -.818 26 .421
Factor F 4.83 (2.17) 7.19 (1.72) -3.206 26 .004
FactorG 6.00 (1.48) 6.12 (1.36) -.232 26 .818
Factor H 5.00 (1.70) 6.62 (1.96) -2.290 26 .030
Factor I 5.67 (l.15) 5.69 (1.40) -.042 26 .967
Factor L 6.080.50) 6.38 (2.03) -.418 26 .679
FactorM 5.50 (1.73) 4.12(1.15) 2.528 26 .018
FactorN 6.17 (1.95) 5.38 (1.78) 1.118 26 .274
FactorO 6.00 (2.22) 7.19(1.33) -1.648 26 .118
Factor Ql 5.58 (1.73) 4.81 (1.72) 1.170 26 .253
Factor Q2 5.67 (1.72) 4.00 (2.25) 1.838 26 .070
Factor Q3 6.17 (1.53) 5.31 (1.92) 1.266 26 .217
Factor Q4 6.67 (1.23) 6.25 (1.95) .691 26 .496
MCQ
Factor 1 38. 58 (9.95) 36.62 (10.79) .491 26 .628
Factor 2 32.58 (7.868) 40.31 (8.761) -2.411 26 .023
Factor 3 18.17 (5.34) 21.62 (8.70) -1.213 26 .236
Factor4 21.17 (4.407) 27.19 (4.708) -3.440 26 .002
Factor 5 18.67 (3.822) 22.12 (3.792) -2.380 26 .025
CEQ
CEQ 6.67 (3.626) 11.33 (4.923) -2.738 26 .011
Further, a table of intercorrelations of all the 16 factors has been produced, in order
to clarify the differences found between the high and low-prone individuals.
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7.4. Discussion
The aim of the present study was to investigate how, if at all, specific personality
factors link to proneness to VHs in the normal and in PD population. Similarly to
the previous studies of this research, hallucinating and non-hallucinating PD
patients did not differ in any demographic characteristic; the only difference
between the groups was in the presence of VHs. Apart from bottom-up processing,
the generation of VHs in PD was also suggested to be linked to specific,
personality-related, processing. The results from the present study, however, found
no association between any personality factors and the occurrence of VHs in PD
(see Table 7.3).
Quite on the contrary, compared to the low-prone individuals, high-prone
individuals reported significantly higher scores on factors A, F and H, and
significantly lower on factor M (see Table 7.4). The factors describe a good-
natured, easygoing, emotionally expressive, soft-hearted and adaptable person
(factor A; for factor descriptions see Table 7.2). Similarly, a high-prone individual
is described as cheerful, active, talkative, expressive, carefree person (factor F),
who is sociable, bold, ready to try new things, and spontaneous and abundant in
emotional response (factor H).
The development of so called Big Five theories (proposing there are five
broad factors or dimensions of personality) (Costa & McCrae, 1985) was heavily
influenced by the use of 16PF. Cattell (1946) found that the 16 primary factors gave
rise to five global traits, which are to some extent comparable to the Big Five
factors (Byravan & Ramanaiah, 1995). Krug and Johns (1986) completed a large
sample second-order factor analysis and provided a set of weights to use in
calculating the second-order scales. According to them, a second-order factor
'extraversion' can be calculated on the basis of factors A, F, Hand Q2. All factors
but Q2 (with a borderline p-value of .070, see Table 7.4) are more highly expressed
in the high-prone group. The hypothesis that these factors might underlie the same
trait is further confirmed by the correlational matrix (see Table 7.5) where the four
factors correlate significantly with each other (not all, but several correlations).
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Therefore, it seems that a global trait, rather than specific personality traits, is
related to hallucination-proneness in the normal population. In order to confirm the
hypothesis that extraversion is related to hallucination-proneness, future studies
need to employ a questionnaire measuring extraversion (e.g., EPQ; Eysenck &
Eysenck, 1991). Such study would offer a more comprehensive understanding of
hallucination-proneness.
Furthermore, low scorers on factor M tend to be anxious to do the right things,
conscientious of practical matters, attentive over details and are sometimes
unimaginative. The latter is especially surprising, since it is intuitively expected that
people who are high-prone to hallucinatory experiences are also more imaginative,
absorbed in thought and absent-minded (a high, rather than a low, expression of
factor M). The results from the present study suggest that compared to low-prone
individuals, high-prone normal individuals are open, sociable, practical and
sometimes unimaginative.
Furthermore, the results from the meta-cognitive beliefs questionnaire
describes the high-prone individuals as highly self-conscious individuals, who think
worrying is dangerous and needs to be controlled, and also fearful of the outcomes
that might results from having worrying thoughts. The results are in accordance
with other studies that found a strong positive correlation between meta-cognitive
beliefs and hallucination-proneness in both the normal population and in patients
with schizophrenia (Baker & Morrison, 1998; Laroi et al., 2004; Morrison et al.,
2000), advocating the influence of top-down processes in the occurrence of VHs.
Finally, high-prone individuals from the present study often described vivid
memories and frequent fantasizing in childhood. It could be hypothesized that high-
prone individuals are predisposed by high fantasy proneness in childhood and social
compliance in adulthood. They are socially well adjusted and are afraid of worrying
thoughts, thus becoming more self-conscious about the monitoring of their
thoughts. The results from the study support the idea that high fantasy proneness,
extraverted personality and strict thought monitoring are related to higher proneness
to hallucinatory experiences in the otherwise healthy young population.
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Stemming from the continuum hypothesis, it was suggested that VHs in PD
might be related to similar risk factors as high hallucination-proneness in the
normal population. The results from the previous studies have supported the
hypothesis that VHs in PD and hallucination-proneness in the normal population are
related to some cognitive functions (e.g., perception functioning), and unrelated to
others (e.g., executive functioning). However, comparing the results of PD patients
with full-blown VHs and high-prone normal individuals in the present study
revealed that VHs might not be a continuation of the hallucination-proneness, as
full-blown VHs do not seem to be mediated by, or dependant on, any personality-
related factors. On the other hand, high-prone individuals have specific personality
traits in common, which might make them more susceptible for rich visual
perception, resulting in higher vulnerability to hallucinatory experiences. The
results from the present study therefore do not support the continuum hypothesis, as
one risk factor (personality characteristics) are importantly implicated in
hallucination proneness in the normal population but not in hallucinations in PD.
More likely, two separate models would explain the phenomena better than a
unitary model: one model should therefore be proposed for hallucination-proneness
in the normal population and the other for VHs in PD, where some of the risk
factors may overlap, but some are specific for each of the phenomena and are
unique.
The findings from the present study have important theoretical implications
for the current understanding of the role of personality has to play in VHs in PD and
hallucination-proneness in the normal population. The theoretical question that
remains to be answered in future studies is to what extent top-down processing
modulates the functioning of the bottom-up processing in the generation of VHs in
PD and in hallucination-proneness in the normal population, and vice versa. The
results from the present study offer a novel account that while personality-related
top-down functioning affects visual perception in high-prone normal individuals
(also suggested in research with highly-susceptible hypnotised individuals and
patients with schizophrenia, see Lawrie et al., 2002; Spiegel, 2003), impoverished
functioning of the association visual cortex might with time modulate some specific
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personality traits in PD. However, the present study is the first to address this issue
and it remains to be seen whether PD patients with a long history of VHs start
accepting more bizarre experiences, and therefore change their personality traits
over the years of experiencing hallucinations.
7.4.1 Conclusions
High-prone normal individuals are characterized by specific top-down processes,
namely vivid fantasy proneness, emphasized meta-cognitive beliefs, extraverted
personality traits which possibly reflect a general response bias to endorse bizarre
items, and result in higher proneness to VHs. On the other hand, hallucinating and
non-hallucinating PD patients did not differ on any personality measures, possibly
reflecting the nature of VHs, which is independent of personality factors. Therefore,
VHs in PD are probably not a continuation of hallucination-proneness in the normal
population, as personality traits are implicated in proneness to VHs in the normal
population, but are not a risk factor in full-blown VHs in PD.
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Chapter 8: Sleep Patterns in Hallucinating PD Patients and in
High-Prone Normal Indlvidualsr'
8.1 Introduction
The dopaminergic mesolimbic system, which is dysfunctional in PD, has extensive
connections with the brains tern regions involved in the generation and maintenance
of the REM sleep", which in tum result in nocturnal and daytime sleep
disturbances in PD (Chaudhuri, Healy et al., 2006; Gugger & Wagner, 2007; Hilker
et al., 2006; Manford & Andermann, 1998; Sei & Morita, 1999). Sleep disorders are
frequently worse in PD patients with hallucinations (Chaudhuri, Martinez-Martin et
al., 2006; Gupta et al., 2004). For example, Pappert et al. (1999) reported that 82%
of hallucinating PD patients from their study experienced some form of sleep
disorder. Similarly, Pacchetti et al. (2005) and Nomura et al. (2003) suggested that
REM sleep behavioural disorder (RBD)25 is associated with increased risk of
developing VHs. Furthermore, both Iranzo et al. (2006) and Schenck et al. (1996)
noted that RBD antedates the development of a neurodegenerative disorder in 45%
- 65% of initially idiopathic RBD diagnosed patients. Compared to PD non-
hallucinators, hallucinating PD patients have been reported to have reduced total
sleep time and efficiency, reduced nocturnal REM sleep (5% in non-hallucinating
versus 20% in a hallucinating group) and daytime non-REM26 sleep, increased
motor activity during REM sleep and fragmented sleep (Comella et al., 1993;
Fenelon et al., 2000; Manni et al., 2002; Pappert et al., 1999). Antipsychotic drugs,
which are effective in treatment of VHs and nocturnal sleep disorders in
23 The study presented in the current chapter was conducted in collaboration with Dr Wiggs (Oxford
Brookes University). The results have formed the basis of a publication (see Maravic, Wiggs,
Connelly, & Barnes, 2007, see Appendix 15).
24 Rapid eye movement sleep, also known as REM sleep, is a normal sleep stage characterized by
loss of muscle tone and rapid movements of the eyes.
2S REM sleep behavioural disorder (RBD) is a parasomnia defined by irregular loss of atonia
(muscle paralysis) during the REM sleep, resulting in complex, aggressive and potentially harmful
behaviours, such as kicking, punching, and screaming.
26 Non rapid eye movement sleep (NREM) is a collective term for sleep stages I, 2 (indicating light
sleep), 3 and 4 (deep sleep). Unlike REM sleep, there is little or no eye movement during this stage.
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hallucinating PD patients, conversely cause sedation and EDS (Friedman & Chou,
2004; Olanow, Watts, & Koller, 2001). These studies suggest a strong link between
sleep abnormalities and the development of VHs in PD.
Few explanations have been proposed to explain a high incidence of sleep
disturbances in PD patients with VHs. Some authors (Comella et al., 1993; Garcia-
Borreguero, Larrosa, & Bravo, 2003) suggested that dopaminergic medication
causes intrusions of REM sleep into wakefulness, experienced as VHs. They
suggested that psychiatric symptoms start with sleep fragmentation (short nocturnal
awakenings), following by vivid dreams, and finally frank hallucinations. This
hypothesis was tested by Pappert et al. (1999) who found a strong interaction
between sleep fragmentation and altered dream phenomena (vivid dreams,
nightmares, RBD or night terrors) and between VHs and altered dream phenomena.
However, because no interaction was evident between VHs and sleep
fragmentation, the authors concluded that the three phenomena are independent but
often overlapping behaviours. Further support for independence of VHs and vivid
dreams was proposed by Diederich et al. (2005) who noted there is no strict
parallelism between emotionally intense and bizarre, but frequently forgotten,
dreams on one hand and easily recalled stereotyped VHs with retained insight on
the other. Finally, Kulisevsky & Roldan (2004) proposed that the key behaviour
may be altered dream phenomena, which can evolve into either sleep fragmentation
or VHs; however, this claim remains inconclusive.
In summary, several studies give evidence for a link between VHs and sleep
disorders. Although no comprehensive theory has been proposed, the link provides
new areas of interest in understanding the generation of VHs in PD, shifting
attention from traditional dopaminergic midbrain areas to the sleep-controlling
brainstem areas. However, the exact mechanisms of the link between sleep patterns
and VHs are not fully understood, and future studies need to address this issue.
Specifically, the advent of new objective measures of sleep patterns promises a
more elegant approach to sleep research, avoiding the disadvantages of the
laboratory-based polysomnographic settings. Therefore, the aim of the present study
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is to carefully examine a number of sleep patterns in relation to VHs in PD, using a
new objective measure of sleep patterns: actigraphy.
In line of continuum hypothesis, the aim of this research is to investigate
whether the same risk factors implicated in the generation of VHs in PO also
predispose normal individuals to high hallucination-proneness. Normal individuals
without any history of psychiatric disorders can experience VHs when sleep
deprived (Babkoff et aI., 1989; Kollar et aI., 1969) or during sleep paralysis27
(Cheyne & Girard, 2007; Girard & Cheyne, 2006; Solomonova et aI., 2007).
Healthy people can also experience prolonged hypnagogic (occurring at the
transition from wakefulness to sleep) and hypnopompic hallucinations (occurring at
the transition from sleep to wakefulness) (Manford & Andermann, 1998).
Exceeding every expectation, a UK based telephone survey (Ohayon et aI., 1996)
revealed that 37% and 12.5% of the sample (5,000 people aged 15 to 100)
experienced hypnagogic and hypnopompic hallucinations, respectively. These
hallucinations are usually vivid and may be bizarre, but not disturbing, with
preserved insight (Ohayon, 2000); strikingly similar descriptions have been
reported by the hallucinating PD patients (see Chapter 2). VHs are therefore
common in both the normal population and PD patients in the states of low arousal.
No studies to date, however, have examined the role of specific sleep patterns
in individuals that are high-prone to have hallucinatory-like experiences. If specific
sleep disruptions are a key element in high-prone normal population, they would
expand our understanding about the functional structure of hallucination-proneness.
Continued research is needed to further elucidate the generation of hallucinations
and sleep disorders in PD and the normal population, and the link between them.
Therefore, the aim of the present study is to carefully examine the link between
sleep patterns in PD hallucinators and high-prone normal individuals, using a
reliable, objective sleep methodology. The study is the first study to observe the
differences in hallucinating PD patients and in high-prone normal individuals, using
actigraphy, a non-invasive wristwatch-like methodology monitoring rest/activity
27 Sleep paralysis (type of parasomnia) is a frightening state of temporary paralysis of the body when
waking up or before falling asleep.
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cycles. The findings will contribute to the understanding of the risk factors, which
are implicated in the development of VHs not only in PD population, but also much
earlier, in a population without any psychiatric history. Finally, a possible link
between specific sleep patterns and VHs can have implications for future treatment
regimes; because sleep disorders are potentially treatable, determining and treating
specific sleep patterns that are related to VHs could in turn result in simultaneous
cessation of VHs.
8.2Methods
8.2.1 Participants
PDGroup
12 PD patients with, and 16 PD patients without VHs, were recruited for the sleep
study. All patients were members of the PD societies in the UK, with normal
hearing and normal or corrected-to-normal vision. A criterion for eligibility was a
clinical diagnosis of PD as assessed by their GPs, and excluding criteria was a
moderate or severe stage of dementia based, confirmed by the carers of the PD
patients, and the loss of independent maintenance of daily living activities, also
reported by the carers. The independent variables were the same as reported in the
previous studies of this research: age, amount of daily levodopa medication, years
since their diagnosis, side of the body more affected by PD, the presence/absence of
migraine, the presence/absence of ocular pathology and HY motor disability stage.
Participants' demographics are summarized in Table 8.1. The criteria for
grouping patients as PD hallucinators were recurrent VHs in the past month. 5
patients had VHs once a week, 5 had them 2-5 times a week, and 2 patients had
VHs more than 5 times a week. 16 participants who have never experienced VHs
were grouped as PD non-hallucinators.
153
N
Age
Years since
diagnosis
Levodopa daily
intake
HY
Hallucinating Non-hallucinating Control High-prone Low-prone
PD atients PD atients rou normals normals
12 (11 male) 16 (13 male) 17 (9 male) 11 (4 male) 11 (5 male)
68.2 (8.8) 65.1 (7.4) 71.8 (9.5) 23.1 (5.0) 23.0 (4.8)
7.4(4.l) 5.0(3.8)
581.2(247.5)
2.1 (.90)
423.3 (309.3)
1.6 (.63)
Data (except the number of participants) are presented as means (estandard deviation).
Control Group
17 age-matched control group participants were recruited for the sleep study (see
Table 8.1). All participants had normal hearing and normal or corrected-to-normal
vision. The exclusion criterion was a history of psychiatric or neurological
disorders.
High and Low-Prone Normal Individuals
11 high-prone and 11 low-prone individuals were recruited for the sleep study (see
Table 8.1). They were all undergraduate students from Oxford Brookes University
with normal hearing and normal or corrected-to-normal vision. An exclusion
criterion was a history of psychiatric disorder. All participants completed all stages
of the research. The students received compensation for their participation.
8.2.2 Assessments
Questionnaires
All participants were asked to fill-in the following self-rating sleep questionnaires:
(a) The Epworth Sleepiness Scale (ESS, see Appendix 16), a measure of daytime
drowsiness where 10 points is considered to be the cut-off point for having
daytime sleepiness problems (Johns, 1991);
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(b) The Berlin Sleep Apnoea Questionnaire (BSAQ, see Appendix 17), a
questionnaire for identifying individuals with sleep apnoea (5 points being the
cut-off point) (Netzer, Stoohs, Netzer, Clark, & Strohl, 1999) and
(c) The Pittsburgh Sleep Quality Index (PSQI, see Appendix 18) (Buysse,
Reynolds, Monk, Berman, & Kupfer, 1989), which assesses sleep quality and
disturbances over a l-rnonth time interval (a cut-off point of 5 yields a good
diagnostic sensitivity and specificity in distinguishing good and poor sleepers).
Factor 1 refers to subjective sleep quality, factor 2 to sleep latency, factor 3 to
sleep duration, factor 4 to habitual sleep efficiency, factor 5 to sleep
disturbances, factor 6 to sleep medication and factor 7 to daytime functioning.
Global PSQI is a sum of the 7 factors of the questionnaire.
(d) Participants were also asked to rate the frequency of other sleep-related
behaviours typical of PO (Chaudhuri, Martinez-Martin et al., 2006), which are
not assessed in the standardized questionnaire (restlessness of legs and arms,
fidgeting, numbness or tingling of arms and legs, nocturnal hallucinations,
painful muscle cramps, painful posture, and tremor, all causing disruption of
sleep) on a scale of "Not during the past month", "Less than once a week",
"Once or twice a week", or "Three or more times a week".
Actigraphy
An actigraphy is a small wrist-watch sized movement sensor, which objectively
measures daytime and nocturnal activity. Actigraph monitors are the most reliable
and accurate means of measuring activity levels and energy expenditure outside of a
clinical setting. A recently published independent accelerometer evaluation (Plasqui
& Westerterp, 2007) concluded that the ActiGraph is the only commercially
available device of its kind that shows positive correlation with the doubly labelled
water (OLW) technique of measuring energy expenditure. It is accepted as the most
practical method for obtaining objective, quantitative, sleep-wake cycle data over
extended periods of time (Ancoli-Israel et al., 2003; Sadeh & Acebo, 2002).
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The actigraphs used in the present study were 1-3/8" diameter waterproof Mini-
Motionloggers® (AW-64, Mini Motionlogger, Ambulatory Ambulatory Monitoring
Inc., Ardsley, NY) weighing 0.9 oz. encased in a plastic enclosure. It contains 32K
non-volatile memory, 16 Hz sample rate and 2-3 Hz bandwidth. The Mini
Motionloggers offer applications that include basic sleep estimation, high resolution
analog data collection, simultaneous environmental data collection, and
comprehensive sleep scoring and sleep distribution data on the wrist. A range of
recording capabilities exist including four validated sleep algorithms, periodic leg
movement analysis, and a suite of circadian rhythm analyses. Software for device
operation and data analysis is available for Windows 2000IXP, and comparable
systems. The ActMe Operational Software allows for quick, easy download of
actigraph data through Micro Interface/Connector. The actigraph is user exchangeable
Lithium battery powered for long use (4,OOO-hourbattery run time) and come with a
full one-year warranty. They have a faux watch face as standard. Sleep-wake data for
this study were collected at 30-s epochs, yielding up to 22 days of recording time per
initialization.
Actigraphy has also been used for unobtrusive and easy long-term
investigations of tremor fluctuations and therapeutic response in PD patients (Van
Someren et al., 2006). Analysis of frequency and pattern of movement permits
detection of basic sleep-wake patterns (Cole, Kripke, Gruen, Mullaney, & Gillin,
1992). Actigraphy was worn on the wrist of the hand that was less affected by
tremor in PD group and on the non-dominant hand in the control group for a period
of one week (during day and night-time, see Appendix 19).
The following generated variables were included in the analysis:
time to sleep (time at sleep onset),
time of final waking (time at sleep offset),
sleep period (minutes from sleep onset to offset),
activity mean (amount of movement during the sleep period),
standard deviation of the activity mean (detecting unusual variability in the
movement),
sleep minutes (total minutes scored as sleep during the sleep period),
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sleep episode (number of blocks of contiguous sleep epochs),
awakenings after sleep onset (WASO; wake minutes during the sleep period),
mean wake episode (mean duration in minutes of the wake episodes during the
sleep period),
duration of longest wake episode (in minutes),
sleep latency (the interval of time between "settling in" to go to sleep and the
onset of sleep) and
sleep efficiency (percent of time in bed spent asleep, calculated by using the
following formula: 100*sleep minutes/sleep period).
Sleep Diary
The sleep diary was completed for a subjective assessment of sleep-wake patterns
and to aid interpretation of the actigraphy data. Participants (or in 5 cases, where the
PD patient had severe micrographia'", their spouse) recorded their sleep and wake
times (including daytime naps), time they went to sleep and time they woke up,
bed-time and night-time behaviour, and any other significant events that occurred
by night or day (see Appendix 20).
8.2.3 Procedure
PD Group
The study was introduced verbally and information sheets were given out at the
monthly meetings in various PD societies throughout the UK between November
2006 and February 2007. Potential participants were encouraged to take part
regardless of whether they had sleep problems and VHs or not. Those who decided
to take part contacted the researcher either at the end of the meeting or by telephone
after deciding to take part. Patients individually agreed on a convenient meeting
28 Micrographia is abnormally small, cramped handwriting; sometimes one of the early symptoms of
PD.
157
time with the researcher either in their own homes or at the society meeting venue.
The first meeting was introductory - the researcher explained the purpose of the
study, how to fill in the questionnaires and sleep diary and how the actigraphs
worked. Diaries, questionnaires and actigraphs were left with participants. In
accordance with the university research ethics, filling in the questionnaire was taken
as a written informed consent. The next meeting (at least 5 days later) was for the
completed questionnaires and actigraphs to be returned to the researcher and also
provided an opportunity for participants to ask further questions about the study.
Debriefing took place at the end of the study at the PD society meetings or, if
preferred, was sent by post.
Control Group
An age-matched control group was contacted on a snowball principle. Similarly to
the PD group, the controls also had two meetings with the researcher; one to explain
the purpose of the study and give them the questionnaires, diaries and actigraphs
and other to collect these. Again, in accordance with the university research ethics,
filling in the questionnaire was taken as a written informed consent. Debriefing was
done either in person, by phone or post (depending on their preference).
High and Low-Prone Normal Individuals
Potential participants were 226 students from Oxford Brookes University. After
filling in the HQ, 5% of people who scored high (N=12) and 5% of people who
scored low (N=13) on HQ (see Section 3.2.1) were invited to participate in the
further study between December 2006 and March 2007. At the first meeting they
were given the instructions on how to wear the actigraphy and were given the
questionnaires and sleep diaries to fill during the one week they were wearing the
sleep watch. In accordance with the university research ethics, filling in the
questionnaire was taken as a written informed consent. 1 high-prone individual was
excluded due to a history of psychiatric disorder, and two individuals from a low-
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prone group were wearing the watch inconsistently, which prevented the further
analysis. 11 high and 11 low-prone normal individuals finished all stages of the
study, and returned the watches, sleep diaries and questionnaires on a second
meeting, when they also had a time to ask further questions about the study. All the
meetings took place in a University room.
8.2.4 Statistical Analysis
Statistical analysis was performed using SPSS for Windows version 15.0 (SPSS
Inc., Chicago, IL). Descriptive statistics and multiple ANOVAs (with Bonferroni
correction) were used to describe and compare the profiles of sleep patterns in both
PD groups, the controls, and high and low-prone normal individuals. Correlation
analysis was used for comparison of the following subjective (as measured by the
sleep diaries) and objective (as measured by the actigraphy) sleep variables that
could be directly compared: sleep onset, sleep offset, sleep duration and sleep
latency.
8.3 Results
8.3.1 Demographics
Using the independent t-tests and ANOVAs, there was no difference between
hallucinating and non-hallucinating PD patients on any of the following
independent variables: age, gender, daily dopamine dosage, HY disability stage,
years since diagnosis, any other concurrent illness, side of body more affected by
PD, migraine, or vision problems. The two PD groups only differed in the presence
ofVHs.
Likewise, using the independent t-tests and ANOVAs, there was no difference
between high and low-prone participants in age, gender, vision and hearing
problems, dyslexia or handedness.
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8.3.2 Sleep Questionnaires
PD Groups and the Control Group
There were large individual differences between hallucinating and non-
hallucinating PD patients, and the control group in their sleep habits as measured by
the sleep questionnaires (Table 8.2).
Table 8.2. Subjective reports of sleep patterns
of both PD rou s and the controls: Means, SDs and si nificance results.
Hallucinating Non-hallucinating Control
PO atients PO atients Notes
Sleep questionnaires
- Sleep diary
Time to sleep 23.02 (1.28) 22.62 (1.07) 21.92 (0.90) A
Sleep latency (mins) 11.62 (7.06) 14.84 (13.93) 22.50 (13.16) n.s.
Time of waking 6.53 (l.60) 6.38 (l.47) 6.64 (1.30) n.s.
Hours/night 5.46 (1.l4) 6.05(1.48) 7.42 (l.43) A,B
- PSQI
Factor 1 1.45 (0.69) 1.56 (0.81) 1.00 (0.38) n.s.
Factor 2 0.75 (0.87) 1.00 (0.97) 1.20 (0.78) n.s.
Factor 3 1.75 (0.96) 1.31 (1.08) 0.47 (0.64) A,B
Factor4 1.17 (1.40) 1.44(1.21) 0.80 (1.08) n.s.
Factor 5 1.83 (0.72) 1.63 (0.72) 1.13 (0.35) A
Factor 6 0.25 (0.87) 0.56 (1.21) 0.27 (0.80) n.s.
Factor 7 2.58 (0.67) 2.19 (0.83) 1.07 (1.10) A,B
PSQI 12.92 (6.99) 11.31 (4.50) 5.87 (3.62) A,B
- ESS
ESS 14.17 (3.64) 10.13 (4.63) 5.87 (4.76) A,B
-BSAQ
Sleep apnoea 4.25 (1.54) 3.38 (1.82) 2.27 (1.53) A
- Other questions
Restlessness 1.33 0.23) 1.31 (1.35) 0.20 (0.78) A,B
Fidget 1.17 (1.27) 1.81 (1.33) 0.80 (1.01) n.s.
Nocturnal VHs 1.00 (1.04) 0.50 (0.12) 0.00 (0.00) B,C
Numbness 1.00 (1.35) 0.88 (1.20) 0.40 (0.81) n.s.
Cramps 1.42 (1.08) 0.81 (0.99) 0.79 (1.19) n.s.
Posture 1.33 (1.16) 1.00 (1.32) 0.67 (1.05) n.s.
Tremor 0.92 (1.38) 1.31 (1.30) 0.00 (0.00) B
Tiredness 1.33 (1.07) 1.13 (1.26) 0.60 (0.99) n.s.
Unexpected asleep 2.17 (1.19) 1.06 (1.24) 0.47 (0.99) A,C
Data are presented as means (±standard deviations). PSQI = Pittsburgh Sleep Quality
Index; ESS == Epworth Sleepiness Scale; BSAQ = Berlin Sleep Apnoea Questionnaire;
A == Significant difference (p < .05) between hallucinating PD patients and the controls;
B = Significant difference (p < .05) between non-hallucinating PD and the control group;
C = Significant difference (p < .05) between both PD groups
n.s. == the differences between groups are not significant
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Sleep Quality and Sleep Disturbances
There was a general trend that non-hallucinating PD patients reported more sleep
disturbances than the controls but less than hallucinating PD patients. Hallucinating
PO patients went to bed significantly later than the control group. There was no
statistical difference in time of final waking and estimated sleep latency between
the three groups. The controls had a longer sleep time per night compared to both
PO groups (as measured by the PSQI factor 3 - estimated sleep duration),
suggesting more awakenings during the night-time and insomnia related problems
in both PD groups. Both PO groups scored high above the clinical cut-off for their
global scores on the PSQI. Overall, three factors of PSQI as well as the global PSQI
score were significantly higher in PD groups: sleep disturbances were only
significant between hallucinating PO patients and the controls; PO groups rated
their quality of sleep lower than the controls, they had more often trouble sleeping
because of waking up in the middle of the night or early morning, using the
bathroom, problems with breathing comfortably, coughing, snoring, feeling too
coldlhot, having bad dreams or pain.
Sleep Apnoea
Although no group met the criteria for sleep apnoea, hallucinating PO patients
scored significantly higher than the controls on the BSAQ (p = .007).
Daytime Sleepiness
Daytime sleep-related problems occurred more often in both PO groups compared
to the controls; PD groups reported more problems of daytime functioning (the
PSQI factor 7) (p = .001) and a higher level of daytime sleepiness measured by the
ESS scores (p = .001). Hallucinating and non-hallucinating PO patients
significantly differed on only two questionnaire items about other sleep-related
problems, namely the occurrence of nocturnal VHs and their levels of daytime
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sleepiness. The first is not surprising since the groups were divided according to the
presence of VHs. The difference in level of daytime sleepiness between both PD
groups was assessed both by an item enquiring about unexpectedly falling asleep as
well as with the ESS. The difference between the groups was significant on the
item, and approached statistical significance on the ESS (p = 0.065).
Other Sleep Disturbances Common in PD
Apart from these sleep-related problems, the PD groups also reported the following
night-time sleep problems: fidgeting, restlessness of legs and arms or painful
posturing of arms or legs causing disruption of sleep, painful muscle cramps, night-
time hallucinations, and numbness or tingling of arms or legs. However, the only
statistical differences between both PD groups and the controls were for
restlessness, night-time VHs and tremor.
High and Low-Prone Normal Individuals
Subjective sleep results of high and low-prone normal individuals, as measured by
the sleep questionnaires, are summarized in Table 8.3.
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Table 8.3. Subjective reports of sleep patterns of high and low-prone individuals:
Means, SDs and t-tests results.
High-prone Low-prone F df P
Slee uestionnaires normals normals
- Sleep diary
Time to sleep 24.00 (.98) 23.94 (1.72) -.099 20 .922
Sleep latency (min) 28.86 (30.77) 17.64 12.35) -1.123 20 .275
Time of waking 8.56 (1.76) 8.24 (1.18) -.505 20 .619
Hours/night 7.54 (1.27) 7.29 (1.30) -.472 20 .642
-PSQI
Factor I 1.09 (.70) .55 (.52) -2.070 20 .050
Factor 2 1.36 (.92) 1.00(1.00) -.886 20 .386
Factor 3 .54 (.69) .64 (.81) .284 20 .779
Factor 4 .54(1.04) .45 (.69) -.243 20 .811
Factor 5 1,45 (.52) 1.00 (.45) -2.193 20 .040
Factor 6 .27 (.65) .00 (.00) -1.399 20 .177
Factor 7 1.18 (.75) .54 (.52) -2.308 20 .032
PSQI 6.09(3.45) 4.18 (2.36) -1.516 20 .145
-ESS
ESS 6.73 (2.53) 6.00 (3.82) -.526 20 .605
-BSAQ
Slee A noea 2.55(1.37) .64 (1.21) -3.471 20 .002
Data are presented as means (s-standard deviations). PSQI refers to Pittsburgh
Sleep Quality Index; ESS: Epworth Sleepiness Scale; BSAQ: Berlin Sleep
Apnoea Questionnaire.
Sleep Quality and Sleep Disturbances
There is a general trend that high-prone group reported more sleep disturbances
than the low-prone group. Despite only few components from the questionnaires
where the difference between both groups was significant, the high-prone group
rated their quality of sleep (the PSQI factor 1) lower than the low-prone group; they
more often had trouble sleeping because of waking up in the middle of the night or
early morning, using the bathroom, problems with breathing comfortably, coughing,
snoring, feeling too coldlhot, having bad dreams or pain (the PSQI factor 5).
Sleep Apnoea
Although no group met the criteria for presence of likely sleep apnoea, the high-
prone group scored significantly higher than the low-prone group on the BSAQ (p =
.002).
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Daytime Sleepiness
Daytime sleep-related problems occurred more often in the high-prone group
compared to the low-prone group; the high-prone group reported more problems of
daytime functioning (the PSQI factor 7) (p = .032), but not also a higher level of
daytime sleepiness measured by the ESS scores (p = .605).
8.3.3 Actigraphy
PD Groups and the Control Group
Actigraphy results for hallucinating and non-hallucinating PD patients, and the age-
matched controls are summarized in Table 8.4.
Table 8.4. Sleep patterns of both PO groups and the controls as measured by
actigraphy: Means, SOs, and significance results.
Hallucinating Non-hallucinating Control
PD atients PD atients rou
Notes
Time to sleep 23.60 (3.28) 23.08 (1.39) 21.79 (1.61) A, B
Time of waking 5.92 (1.84) 6.29 (1.66) 5.43 (1.63)
Duration 352.16 (l15.50) 395.72 (97.27) 452.46 (59.74)
Activity mean 57.31 (21.15) 43.52 (26.68) 18.98 (10.12)
Activity SD 65.31 (19.50) 60.54 (20.67) 37.46 (12.50)
Sleep minutes 191.66 (102.09) 284.90 (116.69) 392.56 (48.72)
WASO 152.85 (59.54) 108.94 (46.92) 57.08 (49.54)
Mean WE 12.83 (5.68) 13.60 (20.37) 5.88 (2.85)
Long WE 5.84 (2.79) 4.75 (2.15) 3.27 (2.36)
Longest WE 49.52 (13.78) 43.42 (31.98) 24.42 (20.15)
Sleep efficiency 56.23 (16.21) 71.30 (17.40) 87.65 (9.71)
Sleep latency 51.66 (56.52) 29.26 (34.40) 9.46 (7.85)
Sleep episode 22.64 (7.29) 18.51 (6.19) 12.02 (5.22)
n.s.
A
A,B
A,B
A,B,C
A,B,C
n.s.
A
A
A,B,C
A,B
A,B
WASO = awakenings after sleep onset, WE = wake episode
A = Significant difference (p < .05) between hallucinating PO patients and the
controls; B = Significant difference (p < .05) between PO non-hallucinators and the
controls; C = Significant difference (p < .05) between both PO groups; n.s. = the
differences between groups are not significant.
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Differences between both PO groups and the controls were significant for
many sleep parameters and similarly to the results from the questionnaires, non-
hallucinating PO patients usually reported better sleep patterns than hallucinating
PO patients but lower than the controls. Most differences were found between
hallucinating PO patients and the controls, and some were found between non-
hallucinating PO patients and the controls. Further, only few differences were
significant between both PO groups. These findings suggest that PO groups are
more similar to each other than to the controls in terms of sleep patterns and that
both PO groups have more sleep-related problems than the controls.
Both PO groups differed from the controls on the following sleep parameters:
delayed time to sleep, increased activity mean and SO, longer sleep latency and
sleep episodes. Hallucinating PD patients also differed from the controls on
additional sleep parameters: decreased duration of sleep and increased long and
longest wake episode.
All three groups differed significantly between each other in sleep minutes,
WASO and sleep efficiency. All three parameters show the same trend:
hallucinating PO patients had the least minutes of sleep during the sleep period,
followed by non-hallucinating patients and then the controls. The same pattern
results were found for sleep efficiency. Hallucinating patients experienced more
wake minutes during the sleep period, followed by non-hallucinating patients and
finally the controls. This suggests that there are some specific sleep patterns that
change with PO and are more pronounced in the hallucinating patients.
Finally, compared to the subjective estimations (see Table 8.2), both PD
groups underestimated their sleep latency; and on the other hand, the controls
overestimated their latency time.
High and Low-Prone Normal Individuals
Actigraphy results for high and low-prone groups are summarized in Table 8.5.
Only four significant differences were noted between the groups, but many of them
were close to reaching the statistical significance. The high-prone group had more
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sleep related problems as measured with an objective measure of sleep. Most
notably the two groups differed on activity mean, sleep minutes, awakenings after
sleep onset (W ASO) and mean wake episode (Table 8.5).
Table 8.5. Sleep patterns of high and low-prone groups as measured by actigraphy:
Means, SDs, and t-tests results.
High-prone Low-prone t df p
normals normals
Time to sleep 23.12 (5.36) 23.06 (6.51) .024 19 .981
Time of waking 9.21 0.76) 9.40 (1.74) -.247 19 .807
Duration 427.38 (90.23) 485.62 (76.21) -1.603 19 .125
Activity mean 21.90 (8.12) 15.39 (4.17) 2.345 19 .030**
Activity SD 37.89 (9.36) 31.14 (6.96) 1.886 19 .075
Sleep minutes 364.36 (99.48) 445.88 (77.31) -2.108 19 .049*
WASO 70.21 (43.24) 38.86 (25.08) 2.057 19 .050*
Mean WE 5.90 (2.68) 3.91 (1.58) 2.099 19 .049*
Long WE 4.13 (2.54) 2.31 0.56) 2.004 19 .060
Longest WE 20.66 (11.09) 12.77 (7.34) 1.940 19 .067
Sleep efficiency 82.59 (12.83) 91.01 (5.37) -1.996 19 .058
Sleep latency 20.12 (22.81) 10.13 (6.44) 1.395 19 .179
Sleep episode 13.79 (2.73) 11.71 (2.49) 1.823 19 .084
WASO = awakenings after sleep onset, WE = wake episode;
* indicates p<0.05 and **p<O.01.
8.3.4 Relation between Subjective and Objective Sleep Measures
Table 8.6. Correlations between subjective and
objective sleep measures in PD and student groups.
PD patients Students
Time to sleep .357 * -.474
Time of waking .677 ** .560 *
Sleep latency -.011 -.455 *
Sleep duration .553 ** .551 *
** Pearson r is significant at the O.Ollevel (2-tailed).
* Pearson r is significant at the 0.05 level (2-tailed).
The table shows there is a statistically significant agreement between subjective
estimations and actigraphy derived measures on several sleep patterns, both in PD
groups and in the student groups.
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8.4 Discussion
The aim of the study was to examine sleep patterns in hallucinating PD group and
in high-prone individuals, which could lead to a better understanding whether the
same components present a risk factor for both VHs in PD and hallucination-
proneness in the normal population. Hallucinating and non-hallucinating PD
patients, as well as the high and low-prone individuals, did not differ in terms of
demographic characteristics (see Table 8.1); therefore, all differences in sleep
patterns were attributed to the occurrence of VHs in PD group and high
hallucination-proneness in the normal group.
8.4.1 Sleep Questionnaires
Both hallucinating and non-hallucinating PD patients showed disrupted sleep
patterns compared to the control group on the subjective measures of sleep (see
Table 8.2), additionally supported by the significantly lower quality of sleep quality
in both PO groups compared to the control group (as indicated by the PSQI factor
1). The first finding from the present study is that disturbed sleep patterns are a
hallmark of PO, irrelevant of the occurrence of VHs. This is in accordance with
other sleep studies, reporting significantly disrupted sleep in PD patients (Arnulf,
2005; Boeve, Silber, & Ferman, 2004; Chaudhuri, Healy et al., 2006; Dhawan,
Healy, Pal, & Chaudhuri, 2006; Partinen, 1997; Thorpy & Adler, 2005).
However, stemming from the continuum hypothesis, the aim of the study was
to explore if the same risk factors are identified in both clinical and non-clinical
populations. Similarly to the hallucinating PO group, high-prone individuals
reported more disrupted night-time sleep patterns, namely more sleep problems
(expressed by PSQI factor 5), a higher chance of sleep apnoea symptoms and a
lower satisfaction with sleep (see Table 8.3). Additionally, high-prone individuals
reported more disturbed daytime sleep patterns, namely "troubles staying awake
while driving, eating meals, or engaging in social activities" and "keep up
enthusiasm to get things done" (expressed by the PSQI factor 7).
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The results from the subjective sleep measures therefore suggest that similar
sleep patterns and sleep problems are related to VHs in PD as well as to
hallucination-proneness in the normal population. Although the idea of continuum
has been suggested to be replaced by two separate models (see Discussion of
Chapter 7), the results from this study are the first to show that very similar sleep
patterns might serve as a common risk factor in both VHs in PD and in
hallucination proneness in the normal population. A closer look of specific sleep
patterns was possible by the use of objective measure of sleep patterns, actigraphy.
8.4.2 Actigraphy
The use of actigraphy in the present study provided a novel account of sleep
disturbances in PD, namely fewer sleep minutes, poorer sleep efficiency, more
activity during sleep and activity deviation, long wake episodes and awakenings
after sleep onset (see Table 8.4). These results suggest that sleep patterns during
both night and day in the PD patients are qualitatively and quantitatively different
from the sleep patterns in the control group. Additionally, the hallucinating PD
patients statistically differed from both the non-hallucinating PD groups and the
control group in lower sleep minutes, lower sleep efficiency and more awakenings
after sleep onset. Similar results have been proposed by several other authors",
using the gold standard in sleep research: polysomnography. A high agreement
between the first actigraphy study to date and the polysornnographic studies is
especially valuable, because it confirms that actigraphy is a valid and reliable
measure of sleep patterns in patients with PD.
Few actigraphy and questionnaire sleep measures were significantly more
affected in the hallucinating compared to the non-hallucinating PD group, namely
sleep minutes and awakenings after sleep onset, sleep efficiency and unexpected
sleep attack during daytime. PD patients frequently reported having numerous
unwanted awakening periods during the night or in the morning (Grandas & Iranzo,
29 Comella et al., 1993; Diederich. Vaillant. Mancuso. Lyen, & Tiete, 2005; Manni et al., 2002;
Nomura et al., 2003; Onofrj et al., 2002; Pacchetti et al., 2005.
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2004; Schapira, 2004). The results from the actigraphy confirm these findings,
indicating that the hallucinating PD patients experience more awakenings after
sleep onset than the non-hallucinating patients. Consequently, fragmented sleep
during night time (expressed by more awakenings, lower sleep minutes and lower
sleep efficiency) could explain why the hallucinating PD patients often report a
higher level of sleepiness during daytime. This leads to the biggest difference
between the three groups, namely the probability of suddenly falling asleep during
daytime despite having good night time sleep. According to the results from the
present study, the hallucinating PD patients are at a higher risk of daytime
somnolence (the ESS was high above the cut-off point, see Table 8.2) and to
unexpectedly falling asleep during daytime. These findings are consistent with
Arnulf et al. (2000) who noted that VHs coincided with daytime episodes of REM
sleep and suggested that VHs in PD might reflect a narcolepsy-like REM sleep
disorder. Incidentally, a strong association between narcolepsy and RBD was also
reported by Nightingale et al. (2005).
Stemming from the hypothesis that hallucinations occur on a continuum,
depending on the risk factors taken into account, the aim of the study was to explore
if the same risk factors are identified in both clinical and non-clinical population.
Similarly to the hallucinating PD group, the high-prone individuals reported having
more sleep related problems and more disrupted sleep patterns than the low-prone
individuals (see Table 8.5). Specifically, the high-prone individuals expressed
strikingly similar arousal-related problems to the hallucinating PD patients, namely
fragmented sleep with decreased sleep minutes, several awakenings and longer
wake episodes during night time. The similarities between disrupted day and night-
time sleep patterns in the hallucinating PD patients and in the high-prone
individuals are the first objectively measured results to date, which provide
evidence for the importance of the arousal sleep mechanisms in VHs in PD and in
hallucination-proneness in the normal population.
In support of these results, dysfunctional arousal mechanisms have been also
proposed in other disorders, such as narcolepsy and narcolepsy with cataplexy,
which are often accompanied by vivid VHs (Dauvilliers et al., 2003; Heier et al.,
169
2007; Ohayon et al., 1996; Overeem, Mignot, van Dijk, & Lammers, 2001;
Scammell, 2003). In these disorders, thalamic lesions affect the brain areas that
control circadian rhythms (know as ascending reticular activating system).
Furthermore, healthy people without psychiatric history frequently report VHs
during sleep deprivation (Babkoff et aI., 1989; Kollar et aI., 1969), before falling
asleep (hypnagogic hallucinations) or on awakening (hypnopompic hallucinations)
(Ohayon, 2000; Ohayon et al., 1996).
8.4.3 SUbjective and Objective Measures of Sleep
PD patients were asked to estimate how long it takes them to fall asleep (in
minutes) at night and for each day they were asked to write the time they went to
bed and the estimated time they fell asleep. People with PD often report problems
on waking, but not problems with sleep initiation (Grand as & Iranzo, 2004;
Schapira, 2004). However, the actigraphy data are the first data to date revealing
that sleep latency in PD patients is significantly longer than in the control group and
that it is significantly underestimated when assessed subjectively (compare Tables
8.2 and 8.4). Although PD patients do not perceive the prolonged sleep latency as
troublesome, it may be an important predisposition for the development of VHs in
PD. Based on the work of Manford and Andermann (1998), it could be
hypothesized that prolonged sleep latency is a prolonged drowsy state when the
switching of thalamic relay nuclei into sleeping burst mode takes place. In this state,
the transmission of sensory inputs is not completely switched off. Consequently,
prolonged sleep latency, as observed in the present study, makes an ideal
environment for VHs to occur. Following the work of Garcia-Borreguero et a1.
(2003), it could also be similarly hypothesized that the prolonged sleep latency
extends intrusions of REM sleep into wakefulness, resulting in higher proneness for
the development of VHs. In order to examine the link between sleep latency and the
occurrence of VHs, further studies need to address this issue with the event related
marker on actigraphy to mark the occurrence of VHs. Such studies would provide
objective evidence whether a high incidence of VHs (as marked by pressing the
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event-related button on the actigraphy) is really related to the prolonged sleep
latency.
Manford and Andermann (1998) suggested that suddenly falling asleep during
daytime is regulated by the same underlying neurological mechanisms that are also
implicated in the occurrence of VHs in any clinical population, but probably
different to the mechanisms that control other sleep related problems. The results
from both PD groups and the normal group support their idea. Specifically,
brainstem areas are affected in PD, resulting in disturbed sleep patterns in both
hallucinating and non-hallucinating PD patients; however, thalamic dysfunction is
probably more pronounced in hallucinating patients, expressed as arousal
disturbances on one hand and as the occurrence of VHs on the other. Similar
patterns appear in the normal group, where the arousal disturbances are observed in
the high-prone, but not in the low-prone normal individuals. There are therefore two
different sources of sleep related disorders in PD; one is related to PD in general
(but not VHs), affecting the majority of the sleep patterns, and the other system,
which specifically controls for arousal and VHs and is more affected in
hallucinating PD patients. A similar pattern is also observed in the high-prone
normal individuals who report more arousal-related sleep problems compared to the
low-prone individuals. Future neuroimaging studies are warranted to address the
extent of thalamic arousal controlling functioning in hallucinating and non-
hallucinating PD patients and in high and low-prone normal individuals.
The findings from the present study have also important intervention
implications. In the light of what is known about both the pharmacological and
behavioural methods to alleviate sleep problems and foster better sleep behaviour
(Askenasy, 2003; Boeve et al., 2004; Friedman & Chou, 2004; Gugger & Wagner,
2007; Medcalf, 2005; Rye, 2004), specific sleep hygiene training in this clinical
group may help to alleviate some of the sleep problems associated with PD. It is far
from confirmed whether sleep related behavioural techniques could help controlling
VHs; however, further work is warranted to shed light on the therapeutic sleep
techniques in this population.
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8.4.4 Future Research Venues
More studies are needed to adequately address the detailed nature of VHs in PD and
proneness to VHs in the normal population. Specifically, a carefully designed study
with event-related buttons on the sleep watches would be invaluable as the first
study to objectively give evidence that VHs are related to the periods of low arousal
or transition from wake to sleep mode. A study of this nature would provide further
evidence for direct involvement of thalamic dysfunction in the generation of VHs in
PD. Further actigraphy studies investigating the role of sleep latency, and
neuroimaging studies investigating the role of thalamus are similarly warranted to
provide evidence for the involvement of the arousal components in the occurrence
ofVHs in PD.
The sleep study in the current research raised the additional possibility of an
indirect link between dopaminergic treatment and VHs through sleep mechanisms.
Somnolence is a recognized adverse effect of dopaminergic agonists. Dopamine
agonists have been reported to cause sudden-onset sleep spells in patients with PO
(Avom et al., 2005; Comella, 2002; D. E. Hobson et al., 2002; Homann et al., 2002;
Plowman et al., 2005) and Kaynak et al. (2005) demonstrated that daytime
sleepiness is not present in untreated PD patients but emerges later during
dopaminergic treatment. The strong link between dopaminergic medications and
sleepiness suggests that dopaminergic medication has a direct effect on arousal,
which consequently creates an ideal environment for the occurrence of VHs.
Therefore. PD patients in general are at risk to develop VHs not because of direct,
but indirect effect of dopaminergic medication through the mechanisms of arousal.
Although this hypothesis is still in its infancy and awaits empirical proof, it is in
accordance with the notion that the presence of RBD is significantly related to the
development of VHs independently of age, gender or duration of disease but
dependent on the amount of dopaminoagonist treatment (Onofrj et aI., 2002). If that
is indeed the case, PD patients would benefit from good sleep hygiene, paying
special attention to properly regulating their sleep habits. Finally, the question of
whether an increase of vigilance by pharmacological means, such as modafinil,
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could be a strategy to abate VHs in PD remains to be answered (Adler, Caviness,
Hentz, Lind, & Tiede, 2003; Diederich et al., 2005; Kulisevsky & Roldan, 2004).
Finally, the main advantage of actigraphy is that it is based on objective
measures of sleep, and not subjective estimations. Therefore, the study focused on
exploring the sleep patterns as reported by actigraphy and some particular sleep
patterns, which could not have been captured by subjective measures alone, arose as
important distinctions between hallucinating and non-hallucinating PD patients and
between high and low-prone individuals. Therefore, the study did not aim to focus
on comparison between actigraphy data and subjective estimations as much as on
what do the actigraphy patterns reveal. However, when correlational analysis has
been performed, there was a statistically significant agreement between subjective
estimations and actigraphy derived measures on several sleep patterns, both in PD
groups and in the student groups. However, several authors report about low
agreement between subjective reports and objective measures as derived by the
actigraphy, and it has been repeatedly demonstrated that subjective reports are
limited and biased compared with objective reports (Acebo et al., 2005; Kushida et
al., 2001; Sadeh, 1996). Therefore, due to the objective and easy application of the
actigraphy, the future of sleep research acknowledges subjective measures as
additional or supplementary reports only, and opts for a necessary use of objective
sleep measures (Gaina, Sekine, Hamanishi, Chen, & Kagamimori, 2005; van den
Berg, Knvistingh, & Tulen, 2008; Werner, Molinari, Guyer, & Jenni, 2008).
8.4.5 Conclusions
Problems with prolonged sleep latency, sleep maintenance during night time and
troubles staying awake during daytime (despite having enough hours of night time
sleep) all suggest that compared to PD non-hallucinators, hallucinating PD patients
have additional sleep dysfunctions related to arousal. These results support the idea
there are two different sources of sleep related disorders in PD. The sleep
controlling mechanisms are severely affected in PD, but are probably not related to
VHs. However, a thalamic arousal controlling system seems to be strongly
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implicated in VHs in PD, as expressed by actigraphy and sleep questionnaire
measures. Moreover, the current study provides a novel account for the relationship
between proneness to VHs and arousal in the normal population. Strikingly similar
arousal disturbances occurred in the high-prone individuals and in the hallucinating
PD patients, suggesting that it is not sleep related brainstem areas in general, but
rather specific thalamic arousal dysfunction that are implicated in both VHs in PD
and hallucination-proneness in the normal population. Further actigraphy studies
investigating the role of sleep latency, and neuroimaging studies investigating the
role of thalamus, are warranted to provide evidence for the involvement of the
arousal components in the occurrence of VHs in PD and hallucination-proneness in
the normal population.
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Chapter 9: Behavioural Cognitive Coping Strategies in
Hallucinating PD Patients
9.1 Introduction
PO, as any other long-term illness, has a profound effect on patients and their
families, severely affecting their daily life (Lundqvist et al., 1997). As it progresses,
the motor signs of PD worsen, medication treatment becomes less effective,
dependency increases, and the quality of life of patients and their carers decreases
(Seeker & Brown, 2005). In addition to the motor complications related to PO, VHs
add to the severity of illness, life satisfaction, and shorten life expectancy (lnzelberg
et al., 1998). Because of both motor and non-motor disabilities that are related to
PO, Frazer (2000) proposed that stress in PO is multidimensional and multifaceted.
Moreover, Aarsland et al. (1999) found that psychiatric symptoms often outweigh
the physical ones, especially because in the course of PD, VHs are persistent and
progressive (Goetz et al., 2001). As suggested in Chapter 2, VHs may intensify
anxiety levels, disrupt daily life activities, and diminish self-esteem, therefore
gravely affecting both the patient's and the caregiver's quality of life (Diederich et
al.,2003).
As outlined in Section 1.6.6, mood modifications, especially depression, have
often been linked to the occurrence of VHs in PD. However, the exact nature of the
relationship between VHs and mood remains unclear (Fenelon et al., 2000; Holroyd
et al., 2001; Inzelberg et al., 1998). The role of depression is likely to be
multifaceted and complex and future studies would benefit from exploring the link
in a more sophisticated way. One possibility, for example, is to investigate the
relationship between depression and specific behaviour strategies that PO patients
use in order to manage their hallucinations.
There is controversy concerning what treatment is best to manage VHs in PD
(Diederich et al., 2003). To date, the most commonly used means of managing VHs
in PO is with antipsychotic medications; pharmacological interventions are the only
therapies tested with evidence-based methods. However, little is known about the
behavioural management of VHs, which probably stems from a scarce amount of
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studies investigating the nature of VHs in PD. As outlined in Chapters 1 and 2, VHs
have been under-reported, and the emotional response to hallucinations in PO is
different to the emotional response in other disorders. For example, cognitive-
behavioural treatment of VHs in other disorders like schizophrenia have been long
present and proven efficient (Delespaul et al., 2002). Furthermore, behavioural
treatment has been studied extensively in disorders related to stress (i.e., spinal cord
injuries, cancer and even students in exam time and the carers of patients with a
long-term illness) (Carver et al., 1989; Elfstrom, Ryden, Kreuter, Persson, &
Sullivan, 2002; Lundqvist et al., 1997; Moorey, Frampton, & Greer, 2003; Seeker
& Brown, 2005). Therefore, the role of behavioural coping strategies needs to be
addressed in PD patients with VHs.
Lazarus and Launier (1978) defined coping as action-oriented and an
intrapersonal skill to manage external and internal demands and the perceived
discrepancy between them. The use of appropriate coping strategies has been
suggested to be a key factor in determining successful adjustment to severe physical
illness/disability (Lazarus & Folkman, 1984). According to Barber and DeRubeis
(1989) effective coping strategies do not reduce the generation of negative thoughts,
but rather encourage a set of skills that help people deal with their stress and
depression when they occur. Taking the studies together, the application of coping
strategies promises to be an effective technique for PD patients with VHs.
However, only one study has investigated the prevalence and impact of
patient-driven coping strategies to date (Diederich et al., 2003). The authors found
that the main types of coping strategies used by PD patients to cope with their VHs
are cognitive and interactive techniques. They also noticed that the frequency and
emotional response to hallucinations are not related to the type of coping strategies
that patients use. However, the authors (ibid) restricted the questions to the three
main types (cognitive, interactive and visual) and recognized the need for an open-
ended interview which would identify other effective coping strategies in
hallucinating PD patients. Furthermore, future studies need to address the
relationship between patients' emotional response to hallucinations and how well
176
they cope with them, and on this basis predict the most and the least efficient
coping strategies.
In summary, coping strategies have been effective in dealing with stress in
different disorders, but have never been satisfactorily addressed in PD with VHs.
The proposed research aims to investigate the most commonly used and effective
coping strategies that people with PD use in order to terminate or simply deal with
their hallucinations, using a semi-structured questionnaire. Furthermore, the aim of
the present study is to investigate if the patients' emotional response to their VHs is
dependant on whether or not they are able to terminate them, an issue that was
raised in Chapter 2. Apart from asking the patients about the level of stress they feel
about their hallucinations, the present study will also use a standardized measure of
depression. If the use of specific coping strategies is indeed related to lower
depression, then the strategies aiming to effectively deal with VHs in PD might be
adopted in the future treatment regimes. Ultimately, such structured interventions
could promote healthier lifestyles and a better quality for life of PD patients and
their carers.
9.2 Methods
9.2.1 Participants
Hallucinating PD Patients
The 23 hallucinating PD patients from the first study (see Section 2.2.1) were also
recruited for the coping strategy study. The demographic data are summarised in
Table 9.1.
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Table 9.1. Demo ra hie characteristics.
N
Age
Years since
diagnosis
Levodopa,
daily dose
HY
Hallucinating
PD patients
23 (16 male)
68.0 (4.2)
14.0 (7.8)
498.9(270.6)
Non-hallucinating Control
PD patients group
20 (14 male) 12 (4 male)
69.8 (6.6) 71.4 (5.0)
9.2 (7.2)
502.1 (276.7)
2.1 (0.9) 1.7 (0.9)
Data (except the number of participants) are presented as
means (estandard deviation).
Non-hallucinating PD Patients
20 PD patients, see Table 9.1, from the same PD societies as the hallucinating PD
patients were asked to fill in the Beck's Depression Questionnaire (Beck, Ward,
Mendelson, Mock, & Erbaugh, 1961). All participants had normal hearing and
normal or corrected-to-normal vision. The exclusion criterion was a history of
psychiatric or neurological disorders.
Control Group
12 age-matched participants (see Table 9.1), who were contacted on a snowball
principle, were asked to fill in the Beck Depression Questionnaire (Beck et al.,
1961). All participants had normal hearing and normal or corrected-to-normal
vision. The exclusion criterion was a history of psychiatric or neurological
disorders.
9.2.2 Assessments
Coping Strategies Questionnaire
No questionnaire has satisfactorily addressed the coping strategies in PD with VHs
to date; therefore, a new measure was developed for the current study. The Coping
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Strategies Questionnaire (CSQ, see Appendix 21) was constructed based on two
sources: (a) personal communication with the patients, and (b) the literature review
of coping strategies with VHs in PD (Diederich et al., 2003) and on coping with
stress in various disorders and illnesses30. As discussed in Section 2.1, the nature of
VHs is a highly subjective experience (Giorgi, 2006). Hence, understanding the
strategies that can be effectively used to manage VHs in PD should arise from the
patients themselves, rather than presenting the patients with a fixed set of answers.
Therefore, the CSQ combines the findings and knowledge from the previous studies
as well as spontaneous reports from the patients themselves.
The CSQ is comprised of 50 questions relating to the various coping
strategies. Patients are asked to think about how they coped with their VHs in the
past and also indicate how often they used each described method. The answers
varied from "Very often", "Often", "Sometimes" and "Not at all". Additionally,
patients were asked how often they worried about the images in the last month,
ranging from "Most of the time" to "A lot of the time", "Some of the time" and
"None of the time". Patients were also asked if they can make the images disappear,
and if so, how. Finally, they were encouraged to think of any other useful ways that
helped them make the images disappear, especially if they were not stated in the
questionnaire, and describe it as much detail as possible.
Beck Depression Questionnaire
The Beck Depression Inventory - BDI (Beck et al., 1961), see Appendix 22, is a
21-question multiple-choice self-report instrument, and one of the most widely used
instruments for measuring the severity of depression. BDI is composed of items
relating to depression symptoms such as hopelessness and irritability, cognitions
such as guilt or feelings of being punished, as well as physical symptoms such as
fatigue, weight loss, and lack of interest in sex. Participants respond how they have
been feeling in the last week; each question has a set of at least four possible answer
30 E.g .• Carver et al., 1989; Delespaul et al., 2002; Elfstrom et al., 2002; Lundqvist et al., 1997;
Moorey et al., 2003; Perron & Munson. 2006; Seeker & Brown. 2005.
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choices, ranging in intensity. For example: (0) "I do not feel sad", (1) "I feel sad",
(2) "I am sad all the time and I can't snap out of it", (3) "I am so sad or unhappy that
I can't stand it".
When the test is scored, a value of 0 to 3 is assigned for each answer and then
the total score is compared to a key to determine the severity of depression. The
standard cut-offs are as follows:
- 5-9 is considered normal,
- 10-18 indicates mild-moderate depression,
- 19-29 indicates moderate-severe depression and
- 30-63 indicates severe depression.
Higher total scores indicate more severe depressive symptoms. Total score
below 4 points indicates a possible denial of depression, faking good, and is below
the usual score for the general population.
9.2.3 Procedure
The study was introduced verbally and information sheets were given out at the
monthly meetings in different PD societies throughout the UK between October
2006 and September 2007. Potential participants with VHs were encouraged to take
part. Those who decided to participate contacted the researcher at the end of the
meeting. Patients individually agreed on a convenient meeting time with the
researcher either in their own homes or at the society meetings venue. All
participants were then given the VHs questionnaire and were asked to fill it in
before the scheduled meeting. In accordance with the university research ethics,
completing the questionnaire was taken as a written informed consent.
Questionnaires were returned at the next meeting and further questions were asked
if the patients' responses were ambiguous. A debriefing document was sent by post
to the patients at the end of the study.
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9.2.4 Statistical Analysis
The aim of the study was to provide detailed descriptions of the strategies that PO
patients use to cope with their VHs. Therefore, the participants' answers were taken
as qualitative descriptions of the phenomena. In order to identify the predominant
strategy, descriptive statistics were used to describe the profile of hallucinating PO
patients and their coping strategies. ANOV As were used to compare depression
level between PO hallucinating, non-hallucinating and the control group.
Correlation analysis was used to explore the link between stress, control over VHs
and subjective disturbing nature of VHs.
All quantitative analyses were performed using SPSS for Windows version
15.0 (SPSS Inc, Chicago, Ill., USA).
9.3 Results
9.3.1 Coping Strategies
From the results of the coping strategies questionnaire, the following eight coping
strategies were classified (Table 9.2):
181
classification.
1. Acceptance
2. Cognitive
approach
3. Emotional
coping
4. Action
oriented
5. Humour
6. Stepping out
of situation
7. Religious help
8. Relaxation
I learnt to live with the images.
I accept the images and that the situation cannot be changed
I get used to the idea that the images come and go.
I admit to myself I cannot deal with the images and quit trying.
I reduce the amount of effort I am putting into making the
images disappear.
I try to make the best of life despite the images.
Seeing the images does not prevent me from enjoying the
things I used to enjoy.
Ask people with similar experience.
Get advice from someone who knows about hallucinations.
I try to find out more about the nature of the images.
I say to myself: These images are not real.
I discuss the fears related to the images with someone.
I talk to someone how I feel about the hallucinations.
I get sympathy and understanding from someone.
I get upset by the images and let my emotions out.
I take a positive action to solve hallucinations.
I concentrate my efforts on doing something about it.
I try to come up with a strategy.
I see someone who could do something about the images.
I would be willing to take medications to cease the images.
I make jokes about the images with my family and friends.
I can laugh and see the funny side of images.
I stand back to get the images into proportion.
I try to see if the images are pessimistic.
I seek God's help.
I put my trust in God.
I try breathing slowly and deeply.
I practice relaxation.
8
8
7
7
3
2
2
"Frequency" refers to the number of patients that reported using specific types of coping.
Most patients used more than one coping strategy when dealing with their
YRs. The majority of patients have accepted that their hallucinations come and go.
Other frequent coping strategies can be classified as cognitive approach and
emotional coping (used in at least 35% of patients), and action-oriented and humour
coping strategy (used in at least 30% of patients). Other strategies were not
commonl y reported.
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All patients were asked to describe the copmg strategy they found most
useful, and the following answers were given (see Table 9.3):
Table 9.3. Descriptions of the most useful coping strategies.
I persuade myself that the images are just my imagination and not
really there.
I am aware that they are not really there.
I just understand that the images are not real.
I know my brain just misinterprets what my eyes see.
When I tell my husband about what I am seeing his response is to
tell me, 'don't be stupid there is nothing or nobody there', and the
images disappear.
If I want to make the images disappear, I close my eyes for few
seconds and tell myself they have gone.
Coping Strategy Examples
1. Action-oriented I look directly at the image. I concentrate on them.
Approach I look away from the image and when I look back, the hallucination
IS gone.
I blink and they go away or change.
I blink my eyes very quickly.
I close my eyes and when I look back, the image is gone.
I rub my eyes.
I turn on the lights.
They appear in the dark when the lights are off, so I turn the light on.
I turn off the lights.
There is usually bright white background when looking intensely, so
I turn the lights off.
It seems to be when I am really tired and cannot concentrate on
reading my book, so I stop reading and turn off the lights.
When I am not stressed but slightly fatigued, I turn off the lights and
go to sleep.
I watch TV.
2. Cognitive
Approach
3. Emotional
Coping
I talk to someone.
4. Acceptance The images appear when I wake up during the night. As I am asleep,
I cannot create a strategy to make them go away, so I just wait for
the images to disappear.
5. No strategy I don't do anything. [2 reports]
The results indicate that the majority of patients described a simple action
oriented coping strategy (56% of all patients) or cognitive approach (26%) to best
deal with their images. One patient used emotional coping and one used acceptance.
Two patients did not try to make them disappear (one of whom enjoyed having the
company of his hallucinations).
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9.3.2 Emotional Response to VHs
Means and standard deviation of PD hallucinating, non-hallucinating and age-
matched control group on the BDI are displayed in Table 9.4. The non-hallucinating
PD group and the control group just made the criteria for a mild depression (5-9
points are considered normal), and hallucinating PD patients fell in the mild-
moderate depression range (10-18 points). However, the multiple ANOVA showed
no significant difference between the three groups (F=2.052, df=2,37, P = 0.143).
Table 9.4. BDI: Means and SDs.
PD hallucinators 15.45 5.46
PD non-hallucinators 9.94 9.06
10.45 5.94
M SD
Apart from the coping strategies they use, patients were also asked if they felt
stressed about their VHs ("Stress"), if they have control over them (i.e., can at least
occasionally make them disappear) ("Control") and if they found the images
disturbing ("Disturb-subjectively"). The images reported by patients were also
classified as (non- )disturbing ("Disturb-objectively") by the researched based on the
patients' reports of the images (e.g., spider and rodents were classified as disturbing
and ordinary people and unspecific images and ordinary people were classified as
non-disturbing). The data is displayed in table 9.5.
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Control over VHs was not related to the perceived stress ("Stress), to the
subjective disturbing nature of VHs ("Disturb-subjectively") or to the objective
disturbing nature of VHs ("Disturb-objectively", see Table 9.6). Furthermore, there
was no correlation between subjective and objective rating of the disturbing nature
of the VHs. However, the perceived stress was strongly correlated with the
subjective disturbing nature of VHs.
Table 9.6. Spearman Rho correlations between
stress, control, and sub·ective and ob·ective disturbance.
Stress Control Disturb-
Control .175
Disturb-subjectively .842** .133
Disturb-objectively -.038 -.132 -.011
** Correlation is significant at the 0.01 level (2-tailed).
9.4 Discussion
23 PD patients with VHs and relatively early motor stages of PD participated in the
study. With the exception of 2 patients, each patient used more than one
constructive coping strategy. Simple behavioural strategies (either action oriented
or cognitive approaches), mainly based on the visual modifications (e.g., rubbing
their eyes, looking away, concentrating on the images, etc.) were reported as the
most efficient strategies. Very differently, Diederich et al. (2003) reported that the
interactive techniques, where the patients verify the non reality of the
hallucinations, were the most common strategy in their study; however, no patients
reported touching the images as an efficient mean of coping with VHs in the present
study.
Dopaminergic over-stimulation of the retinal neurons have been related to
partial sensory deprivation (Diederich et aI., 1998), which is a long-appreciated risk
factor for hallucinations in other clinical contexts (e.g., in Charles Bonnet
syndrome, see Rosenbaum et aI., 1987; Teunisse et aI., 1996), as it permits the
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(re)emergence or release of previously recorded percepts (Diederich et al., 2005).
PO patients from the present study frequently reported lightening the environment
(e.g., turning the lights on) as a beneficial means of ceasing the hallucinations.
Similar to the results from the study on the nature of VHs (see Chapter 2) this
coping strategy further illuminates the importance of a dimly lit environment as an
important predisposition for the occurrence of VHs. Likewise, closing the eyes (or
just blinking) and focusing on the images were described as a frequent coping
strategy. It is possible that through these strategies PO patients could improve their
visual acuity, a factor proposed to be critical in the generation of VHs (Buttner et
al., 1996; Diederich et al., 1998; Matsui, Udaka et al., 2006; Menon, 2005, see also
Chapter 4). In support of this hypothesis, some patients reported their VHs are
peripheral and they disappear when they concentrate on them, i.e., bring
hallucinations to their central vision (Barnes & David, 2001; Diederich et al., 2003).
Similarly, Holroyd et el. (1992) report that sensory stimulation eliminates VHs in
Charles- Bonnet Syndrome.
The majority of the coping strategies that were used by the hallucinating PD
patients in the present study combined practical action-oriented behavioural and
cognitive components that enhanced patients' understanding of their hallucinations.
The same combination is a basis for cognitive behavioural therapies, which aim to
develop both cognitive and behavioural skills to cope with stressors, and are
beneficial for the patients with long-term illnesses and their carers (Starker & Jolin,
1982). The use of these active coping strategies is also in line with Frazier's (2000)
notion that problem-focused active coping may be best for behavioural change, and
emotional regulation may be best for psychological reactions to illness. Further,
emotional coping may be more efficient when dealing with the ambiguity and
unpredictability of illness (Maes, Leventhal, & de Ridder, 1996), which is
especially true for patients with PD.
Apart from the coping strategies, the aim of the study was also to explore a
link between specific coping strategies and the level of depression. Although there
was a trend that VHs might add up to depression in PO, the difference on the BDI
between PO hallucinating, non-hallucinating and the control group was not
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significant. A mild-moderate depression in PD patients with VHs is therefore
probably due to the disease itself, rather than being related to VHs specifically. This
is in accordance with the reports from only 4 patients who were stressed over their
VHs in the past month (see Table 9.5). Morrison et al. (2000) suggesting that
hallucinations become distressing only when appraised as uncontrollable and
dangerous. However, this was not the case in the present study, where the control
over the images was not related to how stressed patients felt about their VHs (see
Table 9.6). Moreover, the stress about VH was not related to the objective
disturbance of images (e.g., spiders tend to have a more emotional reaction than
unspecific images); the level of stress about VHs was solely related to how
disturbing the images were for the patients themselves (even when the images were
unthreatening or even unspecific and blurred). Therefore, the level of stress in
hallucinating PD patients from the present study was rare, as most patients more or
less efficiently managed their VHs. A broad range of coping strategies that PD
patients use to cope with their VHs is probably related to low-level stress over
hallucinations; therefore, the present study gives an insight into a beneficial role of
the cognitive-behavioural approach when dealing with VHs and strongly
encourages application of a set of cognitive-behavioural skills.
9.4.1 Limitations
Apart from Diederich et al. (2005) the present study is the first study addressing the
behavioural coping strategies in hallucinating PD patients. As a pioneer study it
retrospectively needs to address several issues which were not anticipated before
the beginning of the study.
First, the questionnaire (see Appendix 21) states that "People have many ways
of coping with the images they see and stress that they put them under". During the
testing it became clear that the majority of hallucinating PD patients are in fact not
worried about the images themselves; if anything, they worry about how others will
perceive them because they have hallucinations. Furthermore, the introductory
sentence implies that PD patients with VHs should have a coping strategy; however,
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during the testing it became clear that although the majority of patients use (often
more than one) coping strategies, there were in fact two people who did not use any
coping strategies. Therefore, the introductory sentence needs to be rephrased in the
future studies.
Finally, no attempts were made to provide information about the reliability
and validity of the questionnaire. As discussed in Chapter 2, this poses some serious
limitations to the study. However, apart from the aforementioned difficulties that
come with the assessment of reliability and validity in this particular patient group
(see Chapter 2), another important issue should be raised about the reliability and
validity of qualitative data, such as the data gathered in the present study.
When working in subjective aspects of social sciences, and particularly in a
study undertaken with a small, select group of people, it is not humanly possible for
a study to be replicated (Lipscombe, 1999). This view is supported by Dey (1993,
p.221) who states 'qualitative studies aim to be sensitive to factors embedded in a
specific time and place, replication is therefore difficult'. It is widely acknowledged
in qualitative work (Flick, 2009) that no qualitative study can be replicated in the
way quantitative studies can because human behaviour is never static. The
important feature, therefore, is not replication of the study 'but the possible
replication of ideas and constructs which have developed during the study'
(LeCompte & Goetz, 1982, p.34).
Furthermore, Lipscombe (1999) suggests that validity, reliability and
objectivity are contrasted with 'credibility, transferability, dependability and
confirmability' (p.272) in qualitative research. Therefore, several strategies have
been adopted in order to ensure trustworthiness and methodological rigour, such as
devoting enough time to build rapport; spending extended periods of time in PD
societies to get more knowledgeable about PD in general (and not only about VHs
in specific); systematically gathering and recording the data (writing notes when
patients describe their coping strategies keeping a note of their own words);
acquiring feedback from PD patients by repeating what they wrote in the
questionnaire to PD patients for verification of accuracy; etc.
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9.4.2 Conclusions
PD patients with VHs from the present study most commonly used a combination
of behavioural and cognitive coping strategies (including emotional coping and
acceptance). Specific behavioural strategies reflect the nature of VHs, emphasizing
the role of peripheral vision in the occurrence of VHs and calling for further
investigation of its role in the occurrence of VHs. The hallucinating and non-
hallucinating PD patients and the control group had a comparable BDI score,
reflecting that depression in PD is probably related to the disease itself and not to
the presence of VHs. Further, only 4 out of 23 patients found their VHs disturbing,
probably indicating that PD patients use active behavioural management in order to
cope with their VHs. Stress over VHs was related to patients' subjective perception
of the images, rather than to the disturbing nature of the images or the types of
coping strategies. The present study gave evidence that the use of cognitive-
behavioural techniques is encouraged in dealing with VHs in PD.
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Summary of Part II
The results from Part I suggest that common cognitive, rather than demographic,
variables are implicated in both VHs in PD and in hallucination-proneness in the
normal population. Part II examined the role of the following risk factors: visual
memory and visual imagery (Chapter 4), early visual processing components
(Chapter 5), executive functions (Chapter 6), meta-cognitive processes (Chapter 7)
and sleep patterns (Chapter 8). The final empirical study (Chapter 9) addressed
behavioural cognitive strategies that PD patients themselves develop to cope with
their VHs. Putting the results together and comparing the risk factors in both groups
has led to a proposal of a new model for VHs, which will be discussed in Chapter
10.
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Part III
Chapter 10: Conclusions and Recommendations
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Chapter 10: Conclusions and Recommendations
10.1 Summary of the Thesis
VHs occur in a range of clinical disorders and in the normal population; different
aetiologies can therefore manifest strikingly similar symptoms. Despite various
origins, similar risk factors have been implicated in playing a role in the occurrence
of VHs in both PD and the normal population (see Section 1.6), suggesting that a
unitary model could be applied for both phenomena. However, to date no studies
have systematically explored the role of different risk factors from a continuum
hypothesis perspective, stating that VHs are expressed in varying degrees across the
clinical and non-clinical population. The aim of the present thesis was therefore to
explore whether the same risk factors are involved both in hallucinating PD patients
as well as in high-prone individuals from the normal population. Consequently, the
main contribution of the present work is in its investigations as to whether a unitary
model can be proposed for the occurrence of recurrent complex VHs in PO and for
high hallucination-proneness in the normal population. If the same set of suggested
risk factors plays a role in the occurrence of VHs in PO and in hallucination-prone
normal individuals, it could be hypothesised that VHs throughout different clinical
and non-clinical population could arise from the same deficits. This view, for
example, has been supported by Collerton et al. (2005) who suggested that one
model could be applied to all disorders where VHs arise. On the other hand, if VHs
in PO and hallucination-proneness in the normal population do not overlap, the
continuum hypothesis needs to be rejected, at least in the light of continuum
between these two specific clinical and non-clinical populations.
To this end, a range of reliable and valid neuropsychological and cognitive
tasks, questionnaires, and (in the normal population) ERPs were employed. Five
empirical studies were conducted on the basis of the risk factors that were suggested
by several authors (see Section 1.6), namely visual memory and visual imagery
study (Chapter 4), study on early visual processing components (Chapter 5), study
on executive functioning (Chapter 6), personality study (Chapter 7) and study on
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sleep patterns (Chapter 8). In addition, Chapter 9 addressed the role of coping
strategies in PD patients with VHs and emotional responses that are related to the
experiences of VHs.
All studies were carried out on carefully selected groups of participants. The
selection of inclusion and exclusion criteria was set for both PD patients and the
normal group before the studies commenced. In the latter group, all participants
were healthy participants with normal vision and hearing, and with no history of
any neurological or psychiatric disorders. The criterion for categorisation into a
high or low-prone group was the score on the HQ (see Section 3.2.1).
Strict criteria were used in the studies with PD participants. Due to confusion
in the literature about the possible effects of dementia on the generation of VHs (see
Section 1.6.3), no PD participants were recruited that had obvious signs of dementia
or were unable to take care of themselves independently. Similarly, due to the
Mayeux et al.' s (1985) claim of a strong association between the occurrence of
extrapyramidal signs and psychotic symptoms, special attention was given to the
presence and absence of extrapyramidal signs (rigidity, bradykinesia, gait and
resting tremor), as assessed by the HY disability scale (Hoehn & Yahr, 1967). All
patients were monitored in respect to their age, years since diagnosis, the dosage of
dopaminergic and other medication, ocular disorders, side more affected by tremor
and the presence/absence of migraine.
The hallucinating and non-hallucinating PD patients that participated in the
studies did not differ in any of the independent variables. Likewise, PO patients
with and without ocular pathologies performed equally well on all CANTAB tests
of visual memory and executive functions (see Table 2.4), ruling out the possible
additional effect of ocular pathology on performance. Furthermore, there was no
interaction between the presence of VHs and ocular pathology on any of the visual
memory CANTAB tasks (see Table 4.4), suggesting that the significantly worse
performance of hallucinating PO patients is more likely to be due to visual memory,
rather than perceptual, deficits. The only difference between both groups was the
presence or absence of VHs. Similarly, high and low-prone individuals only
differed in the amount of bizarre visual experiences they reported. Thus, it was
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postulated that cognitive, rather than demographic variables, play a role in the
generation of VHs and hallucination-proneness. The equality of the hallucinating
and non-hallucinating PD groups and high and low-prone normal groups made
further comparisons on various tests (Chapters 4 - 8) clearer, because the
differences between the two groups could not be attributed to the independent
variables.
As far as the nature of hallucinations was concerned (see Chapter 2), age-
related ocular problems were a frequent complication factor in the hallucinating PD
patients, probably affecting the already compromised dopaminergic-based visual
processing. The impoverished data from the early stages of visual processing
onwards may give rise to aberrant subsequent visual processing, as well as to
altered top-down processing. Well-formed and moving images suggested
suboptimal functional specialization of the visual association cortex in the
hallucinating PD patients. It was suggested that the nature of the images moulds the
emotional responses and behavioural coping strategies for PD patients with VHs.
The occurrence of hallucination-proneness was investigated in the normal
population as measured by the HQ in Chapter 3. Although it was expected that the
majority of people would report having no hallucinatory-like experiences (and
therefore a positively skewed distribution), a substantial number of participants
from the normal population reported having hallucinatory experiences on a frequent
basis. This lends weight to the argument that hallucinations exist on a continuum
with normal mental events, as suggested by several authors (Crow, 1998; Lopez-
Rodrigo et aI., 1997; Slade & Bentall, 1988). It has been suggested that
hallucinatory predisposition is a one-dimensional construct where high
predisposition of hallucinatory experiences in the visual modality was significantly
related to the hallucinatory experiences in all other modalities. It could be argued
that the hypothesis is inconsistent with the results reported in Chapter 2, as VHs in
PD occur exclusively in the visual modality. Moreover, the presence of any other
hallucinations in PD has been suggested to reflect the presence of additional
pathology, independent of PD (Bodis-Wollner, 1996). The different
phenomenological manifestation of both phenomena could therefore cast a doubt on
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the existence of a continuum between hallucination-proneness in the normal
population and VHs in PD.
However, both Chapters 2 and 3 (Part I) suggested that demographic variables
are not implicated in the occurrence of VHs in PD nor in hallucination-proneness in
the normal population. Instead, a set of risk factors were proposed which formed a
basis for the subsequent studies in Part II.
The suggested activation of the association visual cortex during the
experience of VHs in PD led to the visual memory study (Chapter 4). Hallucinating
PD patients did not differ from their non-hallucinating counterparts with the
exception of one task in the visual memory battery. The findings pointed to the
simultaneous aberrant functioning of both the visual and frontal areas in the
hallucinating PD patients which was supported by an earlier fMR! study (Stebbins
et al., 2004) where a pattern of relatively increased cortical activation in the frontal
cortex, in conjunction with a relatively decreased cortical activation in the posterior
areas, were proposed to playa role in the pathophysiology of VHs. The study was
the first to reveal the dysfunctions of the visual memory in the hallucinating PD
patients. However, there was no difference in performance of high and low-prone
individuals on any of the tasks of visual memory. Similarly to the aforementioned
differences in the phenomenological manifestation of VHs in PD and hallucination-
proneness in the normal population, these results could argue against the continuum
hypothesis, as visual memory failure was shown to playa role in VHs in PD, but
not in hallucination-proneness in the normal population. However, although no
difference on visual memory was found between the high and low-prone
individuals, the results may reflect intact behavioural, but not necessarily intact
neural, functioning. It is possible that both hallucinating PD patients and high-prone
normal individuals share the same underlying deficits, but the pathology of PD
might make the deficits more pronounced and easier to observe with the
neuropsychological testing in the PD group, but not in the high-prone normal
participants. Therefore, the electrophysiological study in the current research to
investigate the role of the visual system was conducted with the high and low-prone
normal group using the ERPs (see Chapter 5).
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In the study investigating early visual processing components, significantly
lower PI and P2 amplitudes were found in the high-prone individuals compared to
the low-prone individuals. It was suggested that the aberrations of the early visual
processing components which seemed independent of the face recognition
processes would affect the visual processing of high-prone individuals. The effect
would not be extensive enough to manifest in VHs but enough to cause frequent
occurrences of hallucinatory-like experiences in the normal population. The results
from the visual memory study gave evidence that hallucinating PD patients show
deficits of visual memory, pointing to the suboptimal functioning of the tempo-
frontal brain activity. It was suggested that the high-prone individuals have not
shown the same deficits due to the less extensive pathology compared to patients
suffering from PD, but that the same underlying mechanisms could be observed
using a neurophysiological methodology. Using the EEG, high-prone individuals
displayed significantly lowered ERP responses than the low-prone individuals in
the temporo-frontal areas for early and late visual processing components. The
results from the visual memory and the EEG study could therefore hypothetically
suggest that both hallucination-proneness in the normal population and VHs in PD
are related to the similar deficits in the visual processing pathways. However, a
special caution needs to be taken into account, as the results have not been obtained
in the same way. In order to confirm whether or not the same deficits occur in high-
prone normal individuals and in hallucinating PD patients, an EEG study needs to
be carried out on PD patients during a face-perception task. Such study would not
only ascertain whether or not the continuum hypothesis is plausible for
hallucination-proneness in the normal population and VHs in PD, but could also
give an insight whether or not there is a possible threshold, which defines the
likelihood for an individual to experience VHs.
Further, the EEG results also suggest that (early and late) ERP modulations
are especially associated with frontal activity during processing of complex
Mooney faces (see Figure 5.2, D). Similarly, the results from the visual perception
study (Chapter 4) suggest that frontal lobe functioning might be impaired in VHs in
PD, as hallucinating PD patients performed significantly worse on the temporo-
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frontal DMS task. These results present new evidence for the possible role of
frontal dysfunction in high-prone normal individuals and in hallucinating PD
patients, either through executive functions (Chapter 6) or personality factors
(Chapter 7).
Contrary to what was expected, performance on executive functioning in the
hallucinating PD patients was comparable to the non-hallucinating PD patients and
to the age-matched control group (Chapter 6). Similarly, no differences were found
between high and low-prone individuals from the normal population on any
measures of executive functioning or the source memory task. The results suggested
that if VHs and executive dysfunctions are linked by the same underlying neural
mechanism, VHs are the first to be expressed and therefore precede the
development of executive dysfunctions. In the light of the continuum hypothesis,
the results could point to the possibility that executive functions do not serve as a
risk factor for the occurrence of VHs in PD and hallucination-proneness in the
normal population. More likely, it was suggested that intact executive functions
might serve as a protecting mechanism for intact insight, rather than for facilitating
the generation of VHs, as both hallucinating and non-hallucinating PD patients had
a clear insight into the hallucinatory nature of the images they perceived.
As expected from the perception study, high-prone individuals were
characterised by some specific personality traits, namely vivid fantasy proneness,
emphasised meta-cognitive beliefs, and sociable, enthusiastic and venturesome
personality characteristics (Chapter 7). The results from the study suggest that
specific personality traits reflect a general response bias to endorse bizarre items,
resulting in higher hallucination-proneness in the high-prone normal individuals.
An alternative explanation, however, is that modifications of the early and late
visual processing components consequently lead high-prone normal individuals to
accept bizarre stimuli more willingly, as seen by higher scores on fantasy proneness
and metacognitive beliefs. On the other hand, the hallucinating and non-
hallucinating PD patients did not differ on any personality measures, possibly
reflecting the nature of VHs in PD, which is independent of the top-down processes.
On the basis of these results, it was suggested that personality traits are implicated
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in proneness to VHs in the normal population, but not in full-blown VHs in PD. The
results have important implications as they suggest that despite some similarities,
the visual systems in hallucinating PD patients and high-prone individuals function
differently. Therefore, these results argue against the continuum hypothesis and
suggest that instead of one unitary model of VHs, two different models should be
proposed: one for VHs in PD and the other for hallucination-proneness in the
normal population.
The final experimental study (Chapter 8) provides a novel account of the
relationship between VHs and specific sleep disturbances that PD patients face
during the course of their illness. The findings support previous studies reporting
that PD patients with or without VHs have more sleep problems than the control
group. This was measured by subjective and objective measures of daytime and
night time activity. It has been suggested that the sleep-controlling brain areas are
severely affected in PD, but are probably not related to VHs. However, the arousal
controlling system (probably reflecting the thalamic dysfunction) is, on the basis of
the current results, strongly implicated in hallucinating PD patients. Moreover,
strikingly similar arousal disturbances also occurred in the high-prone individuals.
The findings from the study suggest that it is not sleep related brainstem areas in
general, but rather specific arousal dysfunction that predisposes both PD patients
and normal individuals to VHs and hallucination-proneness, respectively. The
evidence from the previous studies have not offered a strong case for a continuum
hypothesis, and suggested that two, rather than one, model should be applied for
hallucination-proneness in the normal population and VHs in PD. However, the
results from the sleep study suggest that the two models might share some very
specific arousal-related risk factors. Therefore, the results from the sleep study are
the first to argue there might be an overlap in the pathology of the arousal related
sleep problems, associated with hallucination-proneness in the normal population
and VHs in PD.
Finally, Chapter 9 examined the cognitive-behavioural strategies that
hallucinating PD patients use in order to cope with their VHs. The data revealed
that PD patients with VHs most commonly use a combination of behavioural and
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cognitive coping strategies. Specific behavioural strategies reflect the nature of VHs
(e.g., modifying the lights of the environment and changing the focus of visual
attention). Anxiety over VHs was extremely rare in the hallucinating PD patients;
therefore, depression in PD may be related to the disease itself and not specifically
to the existence of VHs. The study offered a detailed list of coping techniques
which need to be implemented in the future development of the cognitive-
behavioural approach to a treatment of VHs in PD.
In summary, a line of evidence suggests that although there are similar risk
factors which are implicated in both hallucination-proneness in the normal
population and VHs in PD, the two phenomena also have specific and unique non-
shared risk factors. The main contribution of the thesis has been to suggest that on
the basis of the current studies, the continuum hypothesis probably does not hold
true, at least not in the case of VHs in a clinical population of PD patients and in
hallucination-proneness in the non-clinical normal population. Instead of the
continuum hypothesis, two separate models have been proposed, where some risk
factors may overlap to a certain degree: one for VHs in PD and the other for
hallucination proneness in the normal population.
10.2 A Proposed Model for VHs in PD
Different aetiologies sometimes generate surprisingly similar phenomenologies and
recurrent complex VHs are often manifested in very different disorders. Therefore,
it is important to understand a full delineation of a specific phenomenon in different
disorders and to explore whether a set of the same risk factors predisposes
individuals to a higher occurrence of VHs in different disorders. The aim of this
thesis was to determine whether the same set of risk factors are implicated in the
occurrence of VHs in PD and in the high hallucination-prone normal population.
Based on the data from this thesis, a new conceptual framework will be proposed to
explain VHs in PD and hallucination-proneness in the normal population.
Several models have been proposed for the occurrence of VHs across different
disorders (Section 1.6). For example, Cogan (1973) suggested that VHs are release
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phenomena, caused by disruption of the normal flow of visual impulses, with
subsequent release of endogenous cerebral activity from the visual system. This
idea was later developed by Manford and Andermann (1998) who recognized the
importance of midbrain (especially thalamic) involvement in the generation of VHs.
The main contribution of their model is its acknowledgement that VHs are
attributed to abnormalities of the ascending cholinergic and serotonergic brainstem
and thalamic pathways involved in the control of sleep-waking state, andlor to the
defective visual processing accompanied by abnormal cortical release phenomenon.
The model of Manford and Andermann (1998) was further developed by Barnes et
al. (2003) who provided neuropsychological evidence for a multi-factorial model
for the occurrence of VHs in PD. The model included the combination of degraded
visual information about the environment, impaired source monitoring, together
with failing memory and an over-reliance on previously stored schemata, which on
occasion "fill in" for missing detail and provide the basis for visual hallucinations.
Diederich and colleagues (2005) also suggested that VHs should be considered as a
dysregulation of the gating and filtering of external perception and internal image
production. Additional contributing elements and anatomical links for their model
include poor primary vision, reduced activation of primary visual cortex, aberrant
activation of associative visual and frontal cortex, lack of suppression or
spontaneous emergence of internally generated imagery through the ponto-
geniculo-occipital system, intrusion of rapid eye movement dreaming imagery into
wakefulness, errative changes of the brainstem filtering capacities through
fluctuating vigilance, and medication-related overactivation of mesolimbic systems.
Compared to the models of Manford and Andermann (1998) and Bames et al.
(2003), Diederich et al. (2005) focused on visual impairment, probably reflecting
dopaminergic dysfunction from the level of retinal functioning onwards.
The data from the present research support the multifactorial nature of the risk
factors that are involved in the generation of VHs in PD. The proposed model
suggests that visual acuity, primary and associative visual system and the arousal
system all play an important role in the occurrence of VHs in PD (see Figure 10.1).
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Age-related vision problems, not sufficient on their own to cause VHs, add to
dopamine deficiency in the retina, causing reduced signals to the primary visual
cortex. SUboptimal input may therefore be a necessary, but not sufficient, risk factor
for the generation of VHs. Carefully designed ophthalmologic studies are the future
area of research in hallucinations in PD, addressing the role of specific ocular
pathologies in relation to VHs, which will lead to innovative and holistic approach
to the treatment options and preventive management for VHs in PD. Moreover,
future studies need to examine how, if at all, the extent of ocular pathology affects
the nature of VHs and its effect on the retina and functioning of the primary visual
cortex.
Reduced activation of the primary visual cortex, while not extensive enough
to give rise to simple hallucinations (as often happens in severe ocular pathologies,
e.g. Charles Bonnet Syndrome, blindness, etc.) may consequently result in higher
activation in the visual association cortex (Holroyd & Wooten, 2006). However, to
date, a scarce amount of neuropsychological studies have addressed the role of
functioning of the association visual cortex in hallucinating PD patients. The data
from the visual memory study (see Chapter 4) were the first to give evidence that
compared to non-hallucinating PD patients, hallucinators display deficits in visual
memory. The study showed a link between the specific visual memory task
(Delayed Matching to Sample) and the presence of VHs; however, the link between
higher visual processing system and the occurrence of VHs in PD needs to be
addressed in further detail. An obstacle in achieving this goal is a lack of reliable,
valid and standardized tasks of higher visual processing that are appropriate for the
population with substantial motor disabilities.
The arousal dysfunction in the hallucinating PD patients diverts the current
attention from dopaminergic to serotonergic and cholinergic systems, and probably
reflects a complex neuropharmacological imbalance in the occurrence of VHs in PD
(see Section 1.3). Dopaminergic agonists are not likely to cause VHs when used for
other illnesses or even when induced in healthy volunteers (Turner et al., 1984).
This may be, in part, because PD patients tend to be older and neurodegeneration is
more widely spread, but also because the pattern of pathophysiology in PD
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predisposes the individual to the hallucinatory effects of these drugs (Manford &
Andermann, 1998). In addition, administration of levodopa in PO corrects visual
abnormalities (Bodis- Wollner, 1990) and a direct toxic effect of levodopa on vision
seems an unlikely cause for the generation of hallucinations (Manford &
Andermann, 1998). Therefore, while the role of dopaminergic systems is well
recognized in predisposing PO patients to VHs, hallucinations are not a simple
dopaminergic result, but an interactive connection of various processes. Some of
these processes are based on, and facilitated by, dopaminergic medications whereas
the others, like arousal sleep patterns, are not. Research about the precise link
between VHs, the "on-off' dopaminergic states, and the medication fluctuations is
also warranted to shed a light on the possible facilitating medication effects upon
VHs.
These findings are in accordance with the qualitative descriptions of VHs (see
Chapter 2), where PO patients often report that hallucinations are especially
frequent in the evenings when the environment is dim or when patients feel relaxed
and drowsy. Conversely, the reports decline during the times of high activation or
during sleep. The pathways between the retina and the visual association cortex on
the model (see Figure 10.1) are therefore modified depending on the patients'
arousal states as well as on the environment's lighting.
In addition to the arousal dysfunction, hallucinating PO patients significantly
overestimated their sleep latency times (see Chapter 8), which has been suggested
to reflect dysfunctions in the basal ganglia (Harrington, Haaland, & Hermanowicz,
1998; J. G. Smith, Harper, Gittings, & Abernethy, 2007). Similarly, Naish (2003)
has suggested that there are parallels between hypnotically induced hallucinations
and those of conditions such as schizophrenia, highlighting that the distortion of
time-estimation is a particular parallel that accompanies all hallucination-provoking
conditions. Whereas previous studies have shown a striking similarity between PO
and hypnosis, the present research offers the first evidence that the link is especially
pronounced in PO patients with hallucinations. Further neuroimaging studies on
time distortion in hallucinating and non-hallucinating PO patients are needed to
ascertain the definite underlying mechanisms.
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Poor performance of hallucinating PD patients on the DMS task suggests that
the compromised functioning of the visual association cortex may be linked to frontal
functioning. Similar suggestions were proposed by Barnes et al. (2003), who noted
that hallucinating PD patients subscribe a meaning to an unknown object much earlier
than their non-hallucinating counterparts (although not always correctly), indicating a
role of specific, possibly frontal, top-down processing. Contrary to what was expected
(see Section 1.6.3), little evidence was found that frontal lobe functioning is a risk
factor for the generation of VHs in PD. Except for the aforementioned visual memory
task, no other measures of either executive functioning or personality factors
suggested a role of the frontal lobe functioning in the occurrence of VHs. The current
results suggest that the executive functions measured have a protective function in
hallucinating PD patients, most likely in preserving the insight into hallucinatory
nature of the images that patients perceive. Once the neurodegeneration affects these
functions (for example, in patients with dementia), the insight diminishes. However,
other as yet unknown inhibitory executive functions may suppress the spontaneous
firing from the visual association cortex, hence preventing the generation of VHs. It
remains to be seen in future studies whether different kinds of executive functions act
as protective agents in non-hallucinating PD patients, inhibiting the spontaneous
firing of information, and not being able to suppress it in patients with hallucinations.
One possible route of investigation is via extrastriatal functions, similar to the ones
observed by "go/no-go" tasks (Barnes & Boubert, 2008).
The results of the current research suggest strong posterior, bottom-up
processing of information in VHs in PD. The hypothesis is in line with the unimodal
experience of VHs, which are typically perceived in the visual modality. A more
evident role of the frontal lobe involvement would conversely suggest a multimodal
experience of hallucinations, which is in line with the results from the high-prone
normal individuals (see Chapter 7 and Section 10.3) as well as from the literature
about patients with epilepsy, Alzheimer's Disease, and schizophrenia who typically
experience multimodal hallucinations and present frontal lobe dysfunctions (Bassiony
& Lyketsos, 2003; Cummings, 1992; La Vega-Talbot, Duchowny, & Jayakar, 2006;
Moberg et al., 1999).
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In summary, the results from the studies of the present thesis support the
multifactorial nature of the risk factors that are implicated in the generation of VHs in
PO, namely the visual system from retina onwards and the arousal system, but not the
executive functioning. These results go against some integrative models (Barnes et
al., 2003; Diederich et al., 2005), which emphasise a strong reliance on the executive
functioning in the process of generation of VHs. The results, however, support the
model of Manford and Andermann (Manford & Andermann, 1998), and offer
neuropsychological evidence for their neurological-neuropharmacological model. The
main research avenue in the future will be to provide more empirical evidence for the
proposed model and to broaden the current understanding of the interaction of
different functions in the occurrence of VHs in PD (see Section 10.4).
10.3 A Proposed Model for Hallucination-Proneness in the Normal Population
VHs are not necessarily symptomatic of pathology: the study on hallucination-
proneness in the normal population (see Chapter 2) has established the occurrence of
hallucinatory experiences in a substantial number of individuals from the normal
population. Following the continuum hypothesis (Peters, Joseph, & Garety, 1999)
which holds that psychosis-like experiences are distributed, to varying extents,
throughout the general population and that full-blown psychosis represents the most
extreme end of the population continuum, it was proposed that VHs in PD and
proneness to VHs in the normal population might share similar predispositions,
expressed in a lesser degree in the normal population.
However, on the basis of the results from these studies it was suggested that two
separate models could explain hallucination-proneness in the normal population and
VHs in PD better than one unitary model, even though some risk factors might be
shared by the underlying mechanism of both phenomena. For example, the results
from the studies revealed that surprisingly similar disturbances of the arousal system
are implicated in both hallucinating PD patients as well as in high-prone individuals
from the normal population. Further, suboptimal functioning of the visual system has
been implicated to playa role in hallucination-proneness in the normal population as
206
well as in VHs in PO; however, a certain degree of caution needs to be taken into
account, as the results were gathered with different methodologies: dysfunction of the
visual memory in the hallucinating PD patients was tested by the neuropsychological
battery and the modifications of early and late ERP responses has been observed
using EEG.
Apart from the risk factors that were shared by both hallucinating PO patients
and high-prone normal individuals, a number of personality-related risk factors were
suggested to have an impact in the development of hallucination-proneness in the
normal population, but not in the group of hallucinating PO patients. Unlike in the
hallucinating PO group, high-prone normal individuals expressed a range of specific
personality traits (see Chapter 7), which were suggested to make them more
susceptible for rich visual perception and higher vulnerability to hallucinatory
experiences. Alternatively, specific modifications of early visual processing
components may modify their personality traits. Furthermore, the phenomenological
nature of both phenomena in PO and in the normal population was expressed in
different ways. A crucial difference between the two phenomena, for example, is that
PO patients reported on hallucinations that were almost exclusively related to visual
modality, whereas high-prone individuals from the normal population had
hallucinatory-like experiences in several different modalities (the implications of this
will be discussed later in this subsection). VHs in PD are therefore not likely to be a
continuation of hallucination-proneness in the normal population, as some risk factors
are implicated in proneness to VHs in the normal population, but are not a risk factor
in full-blown VHs in PO (see Figure 10.2).
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Van de Ven and Merckelbach (2003) speculated whether the fact that
participants with hallucinatory reports score higher on fantasy proneness than those
without such reports reflects a general response bias to endorse bizarre items or a
subtle reality-testing deficit. The EEG study from the present thesis (see Chapter 5)
was the first study to date to give evidence that high-prone individuals show aberrant
modifications of the early visual processing components in the face paradigm, and
therefore supports a hypothesis that high-prone individuals without clear
hallucinations or a history of psychiatric disorder actually have bizarre experiences
and process information differently. Altered modifications of the early visual
processing components were suggested to give rise to additional facilitating factors,
namely the top-down processing. However, it remains to be seen in future studies to
what extent bottom-up processes modify top-down processing and vice versa.
Hughlings Jackson has argued that hallucinations and illusions are caused by a loss of
higher centre control on lower centres resulting in lower centre over-activity and
increased sensitivity to peripheral input: "Evolutionary accent is a passage from
centres easily transmitting accustomed stimuli and resisting novel stimuli, up to
centres which have to be forced into activity" (p.33, Jackson, 1887). A similar idea
that visual perception depends on feedback connections from higher to lower visual
areas has been suggested by the re-entrant processing theory (Di Lollo, Enns, &
Rensink, 2000; Fahrenfort, Scholte, & Lamme, 2007). Some authors (Schneider,
Crosby, Bagchi, & Calhoun, 1961; Vignal, Chauvel, & Halgren, 2000) have
suggested that activity related to hallucinations can be propagated from one brain
region to another, namely from the frontal lobe along white matter pathways to face
specialised cortex in the ventral occipitotemporal lobe.
It has been suggested that the generation of VHs in PD rely strongly on the
dysfunction of the posterior areas, as opposed to hallucination-proneness in the
normal populations which seems to be much more dependent on the functions of the
frontal lobe areas. This hypothesis would also explain why high-prone normal
individuals, prone to have hallucinatory-like experience in the visual modality, also
express a higher tendency of hallucinatory-like experiences in the other modalities
(see Chapter 3). Hallucinating PD patients, on the other hand, exhibit little evidence
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for a frontal lobe dysfunction and characteristically present their hallucinations in
the visual modality.
The arousal dysfunctions in the high-prone, but not in the low-prone, normal
individuals were strikingly similar to the ones observed in the hallucinating PD
patients. These dysfunctions point to an important role of the arousal system in
predisposing healthy young individuals to a higher incidence of hallucinatory-like
experiences which is probably due to deficient gating of sensory inputs.
Implications for future research concerning disrupted arousal system on VHs will
be discussed in Section 10.4.
In summary, a predisposition to VHs in the normal population is probably
alleviated by a set of risk factors, namely the aberrant modifications of the early
visual processing components, deficient arousal functioning and a specific
personality profile, but not on the failing executive functions (including source
memory, see Chapter 6). Although in its infancy, this model is the first to date to
suggest the multifactorial nature of hallucination-proneness in the normal
population. Further empirical evidence is needed to confirm the model and its
implications for other disorders accompanied by recurrent complex VHs (see
Section 10.4).
10.4 Methodological Limitations and Implications for the Future Studies
New avenues for research and several limitations have arisen during the stages of
data acquisition, analysis and interpretation. The present work is composed of
several experimental chapters, each designed to examine one risk factor at a time,
and the models for VHs in PD and hallucination-proneness in the normal population
have put these risk factors together. However, both models raise the issue of how
different risk factors that were implicated to play a role in the generation of VHs
and high hallucination-proneness, relate to each other. In other words, one of the
main perspectives of the future research in the area of VHs should be to determine
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how specific brain functions, reflecting the activity of specific brain areas, relate to
each other.
In a recent paper, Ffytche (2008) has proposed dual perspectives of
hallucinations: topological (topos = place) which emphasise dysfunction localised
to specific brain regions and hodological (hodos = path) which emphasise
dysfunction related to connections between brain regions. Stemming from the two
perspectives, the topological approach would suggest the hypo-function in the
primary visual cortex and hyper-function of associate visual centres in the
hallucination-prone brain, while the hodological approach would suggest a
weakened connection between the two. In addition, hallucinating PD patients and
high-prone normal individuals express specific arousal-related sleep patterns;
however, their hodological relation to the aforementioned systems remains unclear,
but probably through the loss of ascending brainstem inputs to the visual system
(Ffytche, 2005b, 2007). A supporting argument for hodological dysfunction has
been proposed in schizophrenia and hypnotised participants who hallucinate under
hypnosis, where a reduction of effective connection has been observed between
frontal and posterior temporal regions (Lawrie et al., 2002; Spiegel, 2003).
Ffytche (2008) argues that hodological and topological perspectives interact in
a multifaceted and dynamic way, and that it is imperative for future studies to offer
a better understanding of "how different connectivity measures relate to one another
and the conditions under which such relationships break down" (p.1080). A clear
advantage of the combined hodotopic perspective is that it highlights areas that
remain poorly understood. Therefore, future studies should use measures that can
examine hodotopic differences in the brain of hallucinating PD patients and high-
prone normal individuals. However, although several approaches have been
suggested, e.g. tractography, fMRI and EEG connectivity measures (ibid), the
hodotopic perspective in its existing form is too simple to appropriately address all
the aspects of hallucinations or hallucination-proneness.
Furthermore, in order to fully validate the suggested models for VHs in PD
and hallucination-proneness in the normal population, three approaches should be
considered, namely multifactor, longitudinal and multidisciplinary approach. Future
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studies would benefit from taking all risk factors into consideration in one
comprehensive project. Such a project would have an immediate effect on the
length of the project and on ethical considerations (especially in PD group).
However, it would provide a valid and reliable approach in delineating the risk
factors and, ultimately, models for the occurrence of VHs in PD and for
hallucination-proneness in the normal population. Furthermore, in order to provide
evidence for multiply determined nature of VHs in PD and hallucination-proneness
in the normal population, all the possible risk factors need to be taken into account.
The present studies, however, usually took only one risk factor at a time into
account. This poses another limitation, namely, that a one-factor-at-a-time approach
offers correlational evidence, but precludes assessment of causality. Therefore, a
major limitation of the present work is that it takes one at a time, rather than a
number of possible risk factors into account. Such an approach is needed in the
future when exploring a concept which is highly likely to be multiply determined.
On the basis of such approach it would be possible to get evidence of which factors
have the strongest predictive value.
However, the main obstacle in carrying out research in a fragile population
such as PD must be exposed here. Although it has been acknowledged that VHs in
PD are most likely to be multiply determined, one must not forget that due to
several considerations it would be very difficult (if not impossible) to carry out such
a big study. Because of its length, a project would have to be carried out in smaller
units over a period of several meetings. Because of the diminishing effectiveness of
parkinsonian medications over a period of time which cause severe tremor or
dyskinesia, each meeting would need to be scheduled to last no more than one hour.
Several meetings would therefore need to be carried out, which can pose ethical
problems for the use of participants in lengthy studies. As discussed before, the
progression of PD varies greatly among patients, so some patients who experience
an abrupt progression of symptoms might well show a very different clinical picture
from their first testing and change radically until the end of testing. Often, PD
patients have some additional, usually age-related, disorders apart from PD, which
could delay testing or some would opt out. Furthermore, the dosages are frequently
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changed (usually to increased dosages of dopaminergic agonists), which not only
poses higher risks for developing hallucinations (so non-hallucinating patients could
become hallucinating before the end of testing), but is often related to other (usually
motor-related) disorders, which would make testing prolonged until the patients get
used to the medications (or change them again, which is also common). Therefore,
although the correlational approach may not be ideal and as many factors as
possible should be taken into account, this is not really possible in practice.
The present studies have taken only the most recognized risk factors into
account; but there are many other risk factors proposed in other disorders related to
VHs, such as the Perception and Attention Deficit model in dementia with Lewy-
bodies (Collerton et al., 2005, see Section 1.7.4). Longitudinal studies are highly
warranted in the research of progressive illness, aiming to understand the
pathological development of PD as well as to verify the proposed models for the
Occurrence of VHs in PD and for hallucination-proneness in the normal population.
Such studies would not only reveal how risk factors develop over time, but also
elucidate the potential protecting mechanisms (e.g., through the development of
non-hallucinating PD patients or through patients who start hallucinating later in the
course of their illness). Finally, a multidisciplinary approach is necessary to fully
comprehend the neurological, pharmacological, ophthalmologic, psychological, and
statistic implications of VHs in PD.
The majority of studies investigating the differences between hallucinating
and non-hallucinating PD patients have been conducted on a limited amount of
participants, and the studies from the present thesis faced the same difficulty.
However, one must recognise not only the rarity of condition, but also specific
subgroups (i.e., the presence/absence of VHs, relatively mild motor signs of PD,
preserved cognitive abilities, no history of psychiatric disorder, etc.). Therefore,
although the small number of participants represents a higher risk for statistical
errors in the data analysis, the subgroups have been carefully selected and represent
the "pure" examples of idiopathic PD in mild-moderate stages of PD. Similarly,
although small groups of high and low-prone individuals participated in the present
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studies, all participants were carefully chosen and represented the low and the high
end of the proneness continuum.
Another specific problem related to the low number of PD participants is an
unclear risk effect of years since diagnosis. PD is a neurodegenerative disorder; it is
therefore expected that the dopaminergic doses will increase and the
neurodegeneration will get widely spread over time. Therefore, some aspects of PD
are concurrent with, rather than dependant on, the progress of the illness. For
example, the dopaminergic dosages are increased with progressive
neurodegeneration, and there is a higher risk of developing psychiatric signs, such
as VHs, dementia or depression; however, these signs might not be dependant on
the dopaminergic medication itself but to the general neurodegeneration processes.
It is possible to take the years of diagnosis into consideration and divide patients
according to their years of diagnosis (Graham et al., 1997); however, such an
analysis was not possible in the present work due to a limited amount of patients in
the hallucinating PD group.
Several treatment related issues have occurred during the personality (Chapter
7), sleep patterns (Study 8) and coping strategies (Chapter 9) studies. It is
imperative that future work expands beyond neuropharmacological treatment to the
area of cognitive-behavioural therapy, not only for VHs but for other non-motor
signs of PD as well. Longitudinal studies are necessary to reveal the efficacy of
behavioural coping strategies PD patients use in order to cope with their VHs.
Further, if sleep treatment is efficient in treatment of sleep related problems (using
simple sleep hygiene techniques), then such treatment could have a beneficial
effect, reducing or stopping VHs due to the suggested link between sleep problems
and VHs. A strict relationship between RBD and VHs has yet to be demonstrated,
which would have immediate effect on the treatment of VHs.
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10.5 Concluding Remarks
VHs in PD are associated with a higher risk for nursing home placement, higher
mortality rate and a financial burden upon society (Pappert et al., 1999). Early
recognition of non-motor symptoms is crucial not only for the quality of life of
patients with PD, but also for the holistic approach, including support for carers
(Chaudhuri, Healy et al., 2006). A multidisciplinary and comprehensive
understanding of the non-motor signs of PD, one of them being VHs, provides
better cognitive-behavioural support and in tum improves the quality of life of
patients and their carers. As life expectancy increases, more people are diagnosed
with PD. In order to efficiently cope with the stress, symptoms of PD and financial
outcomes, future studies are crucial to explore long-negligent, complex and
dynamic non-motor signs of PD, and how they relate to each other and to the
possible risk factors.
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Appendix 1. Visual Hallucinations Questionnaire for PD patients.
Visual changes in Parkinson's Disease Questionnaire
Name: ___
Age: _
Gender: Female Male
1.Are you taking any medication at present? Yes No
o 0
If yes, please state the drug(s) and the dose you take each day
Drug Dose
2. How long have you been diagnosed with Parkinson's Disease?
3. Do you suffer from any other long term illness? Yes No
o 0
If yes, please state which one and approximately when it was
diagnosed.
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4. Which side are your symptoms of Parkinson's Disease more
pronounced?
Left Right Both
o o o
5. Do you suffer from migraine? Yes No
o 0
6. Can you still get around the house unassisted (without help
from another or a wheelchair)? Yes No
o 0
7. Haveyou ever consulted a doctor about an eye problem?
Yes No
o 0
If yes, please give details
8. Do familiar things around you ever appear to change their
appearance unnaturally in some way? Yes No
o 0
If yes, how often does this happen
Morethan 5 times a week 1-5times aweek Less than once aweek
o o o
9. Do you see things that are not really there? Yes No
o 0
If yes, how often does this happen
Morethan 5 times a week 1-5times aweek Less than once aweek
DOD
If you answered "Yes" to question 8 or 9 (or both), please answer
the following questions.
253
10. Do these things you see have a particular form? (eg. people,
objects, animals, shapes etc.) Yes No
o 0
If "Yes", please give details on the most common images that you
see:
11.Do these visual images come suddenly? Yes No
o 0
12.How long do the images appear for? Hours Mins Seconds
o o o
13.Do these images move? Yes No
o 0
14.Do these images appear:
- when you wake up 0
- when you go to sleep 0
- morning 0
- afternoon 0
- evening 0
15.How many images appear? One 2-5 More than 5
o 0 0
16. Do these images talk to:
You 0
To each other 0
They don't talk D
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17.What is the clarity of these images?
- Sharp 0
- Blurry 0
- Transparent 0
- Variable 0
18.What is the colour of these images?
- Black and white 0
- Single colour 0
- Multiple colour 0
19.When these images appear are your eyes open or closed?
- Open 0
- Close 0
- Both 0
20. How do these images appear to you? Real Unreal Not sure
o o o
21. What is the ambient light when you see these images appear?
(For example, do you often see the images more in a darkened
room or a bright day lit room etc.)
- Bright 0
- Dim 0
- Dark 0
- Variable 0
22. Do these images start with or derive from the real perception?
(egowhen you are looking at an object or person) Yes No
o 0
23. What is the content of the images (e.g. are the images always
the same or do they change in their activities)?
- Stereotyped 0
- Different 0
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24.Do these images occupy your field of vision?
- Completely D
- Partially D
25.Are the images distorted in some way? Yes No
D D
If "Yes", please give detail
26. Do you think that it is your medication which causes the
images? Yes No
D D
Pleasegive your explanation:
27. Is there anything else that you would like to tell about the
imagesand was not stated in the questions?
- THANK YOU VERY MUCH FOR YOUR HELP! -
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Appendix 2. Participant Information Sheet for PD Patients.
Participant Information Sheet
VISUAL DISTURBANCES IN PARKINSON'S DISEASE
Visual disturbances in Parkinson's disease can be extremely distressing; there
is frequency under-reported and sometimes inadequately treated. We are
studying the neurological and psychological processes underlying visual
disturbances in normal aging and in patients with Parkinson's disease. This will
be achieved by carrying out detailed neuropsychological tests and
questionnaire based research.
We would like you to help us in taking part in this study, but before you decide
to take part it is important for you to understand why the research is being done
and what it will involve. Please take time to read the following information
carefully.
What is the purpose of the study?
The aim of this study is to determine cognitive factors that underlie the
emergence of visual disturbances in Parkinson's disease as well as in a normal
population. Aside from the basic scientific interest, the issue of visual
disturbances has important implications for the treatment, and remediation of
these symptoms in Parkinson's disease and other neurological disorders.
Do I have to take part?
Taking part in the research is entirely voluntary. You are under no obligation to
do so, but your help would be much appreciated. If you do decide to take part
you will be given this information sheet to keep as a reference sheet and at
some time in the future you will be asked to sign a consent form. All the
information will be treated in strictest confidence and you can withdraw from the
study at any time without giving your reasons for doing so.
What will happen to me if I take part?
The study will involve filling in questionnaires designed to test your visual
perception and the nature of your visual disturbances. Before taking part in any
of the tests used, you will be given a brief description and rationale for using it,
as well as instructions for each part. Again, there are no right or wrong answers
in any of the tests used. It is important you understand that taking a part in this
study is entirely voluntary and that you will be free to withdraw from the study at
any time without giving your reasons for doing so. You are also free to ask any
questions before, during or after taking part in a study.
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What are the possible benefits of taking part?
You will be given the opportunity to make a contribution to our scientific
understanding of visual disturbances in Parkinson's disease, which will be
important for future treatment options and patient care.
Will what I say in this study be kept confidential?
All information collected will be kept strictly confidential and used for the
purposes of this study only. All of the data will be coded with the subject
number in a way that will not allow you to be identified individually. This
anonymisation will occur at the point of the data collection. Only the named
researcher will have the access to data, stored in a computer file available by
password only. Data generated by the study will be retained in accordance with
the University'S policy on Academic Integrity.
What will happen to the results of the research study?
The data collected will be used for the purposes of this study only. If you wish
to withdraw from the study at any stage, we will also withdraw every
unprocessed data.
Further, if you express an interest you will be informed of the results of the
study and will be given a copy of the article or conference abstract. This
information will be given to you using a mean that you prefer (a personal
meeting, by phone or by post). For any other queries about the results of the
study, you can contact either the primary researcher or their supervisors on the
address or a phone stated below.
Who has reviewed the study?
The research has been approved by the University Research Ethics
Committee, Oxford Brookes University.
Contact for further Information
This is a project by a research student Ksenija Maravic from Oxford Brookes
University, supervised by Dr Vince Connelly and Dr Jim Barnes. If you have
any questions regarding this study or about any issues raised in this
information please feel free to contact one of us in the Psychology Department
at Oxford Brookes University, Tel: 01865 483771 or at our email address
below.
Ksenija Maravic Dr Vince Connelly
kmaravic@brookes.ac.uk vconnelly@brookes.ac.uk
Dr Jim Barnes
jim.barnes@brookes.ac.uk
If you should have any other questions about the way in which the study has
been conducted, you should contact the Chair of the University research Ethics
Committee on ethics@brookes.ac.uk.
THANK YOU VERY MUCH FOR YOUR HELP!
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Appendix 3. University Research Ethics Committee Approval (UREC).
University Research Ethics Committee
Dr Jim Barnes
School of Social Sciences and Law
Oxford Brookes University
Gipsy Lane
Headington
Wheatley Campus. Wheatley Oxford OX33 IHX UK
t. +44 (0)1865 485741
ethics@brookes.ac.uk
www.brookes.ac.uklresearchlethicslethicshome.html
18 May 2006
Dear Dr Barnes
UREC060193 Title: Visual Hallucinations In Parkinson's Disease
Thank you for your recent letter outlining your response to the points raised in my
previous letters for the above study and attaching the revised documents. I am
pleased to inform you that, on this basis, I have given Chair's Approval for the
study to begin.
The UREC approval period for this study is six months after the completion date of
the data collection component, so until 30 March 2009. If you need the approval to
be extended please do contact me nearer the time of expiry.
In order to monitor studies approved by the University Research Ethics Committee,
we will ask you to provide a (very brief) report on the conduct and conclusions of
the study in a year's time. If the study is completed in less than a year, could you
please contact me and I will send you the appropriate guidelines for the report.
Yours sincerely
Teresa Smallbone
Chair
University Research Ethics Committee
Cc Ksenija Maravic
Vince Connelly
Morag Maclean
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Appendix 4. Hallucination-Proneness Questionnaire for the Normal Population.
Introduction
This questionnaire asks questions about sensations and perceptions you
may have experienced. Some of the experiences are unusual, some of
them are more everyday.
We realise ticking answers may not always represent your experience as
accurately as you might like. However, we would ask you to tick the
answers that most closely match your experience and avoid missing any
questions out.
There are no right or wrong answers, and we would appreciate it if you
could be as honest as possible when giving your answers. The data will be
used for research purposes only. It takes 5-10 minutes to fill out the
questionnaire.
If you have any queries about the study, please contact us on
kmaravic@brookes.ac.uk (Ksenija Maravic) or jim.barnes@brookes.ac.uk
(Jim Barnes).
Age: __
Gender: F M
Vision problems (including contact lenses, glasses, etc): YES NO
Comment --------------------------------------------------------------Hearing problems: YES NO
Comment __
Any known neurological or psychiatric disorder: YES NO
Comment __
Dyslexia: YES NO
Handedness: RIGHT-HANDED LEFT-HANDED
Student email account:
Importantl:
If you decide to take part in a second stage of the study, we will ask you to
provide us with your student account email address, via which we can
contact you. Information about your email account will be kept confidential.
Further, all of the data from the second stage will be coded with the subject
number in a way that will not allow you to be identified individually. Only the
named researcher will have the access to data, stored in a computer file
available by password only. Data generated by the study will be retained in
accordance with the University's policy on Academic Integrity.
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Section 1
Instructions
Please read the statements about auditory sensations, and tick either
o - Certainly does not apply to me
1 - Possibly does not apply to me
2 - Unsure
3 - Possibly applies to me
4 - Certainly applies to me
1) The sounds I hear in my daydreams seem so true that sometimes I think they are real
o 1 234
o 0
Comments: __
o o o
2) Sometimes I hear a voice speaking my thoughts aloud (not talking to yourself)
o 1 234
o 0
Comments: _
o o o
3) In the past I have had the experience of hearing a person's voice and then found that no
one was there
o 1 234
o 0
Comments: _
o o o
4) I have been troubled by hearing voices in my head
o 1 234
o 0
Comments: _
o o o
5) Sometimes I notice that sounds are much louder than they normally would be
o 1 234
o 0
Commenm: __
o o o
6) I can hear my own thoughts repeated or echoed
o 1 234
o 0
Comments: _
o o o
7) Sometimes I have heard voices commenting on what I was thinking or doing
o 1 234
o 0
Comments: _
o o o
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8) In the past I have had the experience of hearing two or more unexplained voices talking
with each other
o 1 234
o 0
Comments: _
o o o
9) I can hear sounds or music that people near me don't hear
o 1 234
o 0
Comments: _
o o o
10) Some days I find that sounds are distorted in strange or unusual ways
o 1 234
o 0
Comments: _
o o o
Section 2
Instructions
Please read the statements about visual sensations, and tick either
o - Certainly does not apply to me--
1 - Possibly does not apply to me
2 - Unsure
3 - Possibly applies to me
4 - Certainly applies to me
1) People in my daydreams seem so true to life that sometimes I think they are real
o 1 234
o 0
Comments: _
o o o
2) On occasions I have seen a person's face in front of me when no one was in fact there
o 1 234
o 0
Comments: _
o o o
3) Sometimes I can sense the presence of animal or person, despite being unable to
see any evidence
o 1 234
o 0
Comments: _
o o o
4) Occasionally I see shapes, lights or colours even though there is nothing really there
o 1 234
o 0
Comments: _
o o o
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5) Sometimes I find the appearance of things or people seems to change in a
puzzling way, e.g. distorted shapes or sizes or colour
o 1 234
o 0
Comments: ----------------------------------------------------
o o n
6) From time to time my face seems different from usual
o 1 234
o 0
Comments: __
o o n
7) Some days lights or colours seem brighter or more intense than usual
o 1 234
o 0
Comments: __
o o o
8) Sometimes everyday things look abnormal to me
o 1 234
o 0
Comments: __
o o o
9) It has happened that I have seen things, people or animals that other people cannot
o 1 234
o 0
Comments: _
n o o
Section 3
Instructions
Please read the statements about other types of sensations, and tick either
o - Certainly does not apply to me
1 - Possibly does not apply to me
2 - Unsure
3 - Possibly applies to me
4 - Certainly applies to me
1) No matter how hard I try to concentrate, unrelated thoughts always creep into my mind
o 1 234
o 0
Comments: _
o o o
2) Sometimes a passing thought will seem so real that it frightens me
o 1 234
o 0 o o o
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Comments: ----------------------------------------------------
3) From time to time I experience unusual burning sensations or other strange
feelings in or on my body
o 1 234
o 0
Comments: ----------------------------------------------------
o o o
4) Sometimes I have the sensation that my body, or a part of it, is changing or has
changed shape
o 1 234
o 0
Comments: ----------------------------------------------------
o o o
5) Often I can detect smells which don't seem to come from my surroundings
o 1 234
o 0
Comments: __
o o D
6) Everyday odours sometimes smell unusually different
o 1 234
D D
Comments: __
o D D
7) Sometimes I notice smells or odours that people next to me seem unaware of
o 1 234
o 0
Comments: __
o o D
8) Occasionally my skin is more sensitive to touch, heat or cold than usual
o 1 234
o D
Comments: --------------------------------
o oo
9) Sometimes food or drink seems to have an unusual taste
o 1 234
o 0
Comments: __
o o D
10) From time to time I find that my experience of time changes dramatically
o 1 234
o 0
Comments: __
o Do
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- Thank you! -
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Appendix 5. Participant Information Sheet for Students.
Participant Information Sheet
STUDY ON VISUAL EXPERIENCES AMONG STUDENT POPULATION
The present study is designed to gather data related to the continuum
hypothesis of hallucinations. According to this hypothesis, hallucinations can be
considered to be one end of a continuum of normal conscious experience that
includes vivid imagery, daydreams and thoughts. Previous research has
suggested that the mechanisms responsible for the occurrence of
hallucinations have a common origin in normal people and clinical patients that
are age independent (Slade and Bentall, 1988). The purpose and procedure of
the present study is to test whether hallucinatory experiences respond to the
continuum hypothesis and whether they occur in all age groups in the normal
population.
We would like you to help us in taking part in this study, but before you decide
to take part it is important for you to understand why the research is being done
and what it will involve. Please take time to read the following information
carefully.
What is the purpose of the study?
The aim of this study is to test whether hallucinatory experiences respond to
the continuum hypothesis and whether they occur in all age groups in the
normal population.
Why have I been chosen?
In order to achieve the aim, we are trying to take a look at some cognitive
factors in a large group of normal student population. We will take a look at
these factors in students who are highly-, medium- or low-prone to have
hallucinatory like experiences. However, this is not a clinical study, so falling in
any of these categories has no clinical implications whatsoever; we are simply
interested in your point of view.
Do I have to take part?
Taking part in the research is entirely voluntary. You are under no obligation to
do so, but your help would be much appreciated. If you do decide to take part
you will be given this information sheet to keep as a reference sheet and at
some time in the future you will be asked to sign a consent form. All the
information will be treated in strictest confidence and you can withdraw from the
study at any time without giving your reasons for doing so.
What will happen to me if I take part?
The study will involve filling in questionnaires designed to test your visual
perception, visual imagery and some personality traits questionnaires. Before
taking part in any of the tests used, you will be given a brief description and
rationale for using it, as well as instructions for each part. Again, there are no
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right or wrong answers. It is important you understand that taking a part in this
study is entirely voluntary and that you will be free to withdraw from the study at
any time without giving your reasons for doing so. You are also free to ask any
questions before, during or after taking part in a study. Further, you will be
reimbursed for your time (maximum 2 hours) and any out of pocket expenses
that you may have incurred (£10).
What are the possible benefits of taking part?
You will be given the opportunity to make a contribution to our scientific
understanding of different visual experiences in normal population, which might
have important future implications for understanding and treatment options in
patient population.
Will what I say in this study be kept confidential?
All information collected will be kept strictly confidential and used for the
purposes of this study only. All of the data will be coded with the subject
number in a way that will not allow you to be identified individually. This
anonymisation will occur at the point of the data collection. Only the named
researcher will have the access to data, stored in a computer file available by
password only. Data generated by the study will be retained in accordance with
the University's policy on Academic Integrity.
What will happen to the results of the research study?
The data collected will be used for the purposes of this study only. If you wish
to withdraw from the study at any stage, we will also withdraw every
unprocessed data. Further, if you express an interest you will be informed of
the results of the study and will be given a copy of the article or conference
abstract.
Who has reviewed the study?
The research has been approved by the University Research Ethics
Committee, Oxford Brookes University.
Contact for further Information
This is a project by a research student Ksenija Maravic from Oxford Brookes
University, supervised by Dr Vince Connelly and Dr Jim Barnes. If you have
any questions regarding this study or about any issues raised in this
information please feel free to contact one of us in the Psychology Department
at Oxford Brookes University, Tel: 01865 483771 or at our email address
below.
Ksenija Maravic Dr Vince Connelly
kmaravic@brookes.ac.uk vconnelly@brookes.ac.uk
Dr Jim Barnes
jim.barnes@brookes.ac.uk
If you should have any other questions about the way in which the study has
been conducted, you should contact the Chair of the University research Ethics
Committee on ethics@brookes.ac.uk.
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- THANK YOU VERY MUCH FOR YOUR HELP! -
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Appendix 6. Factor Matrix of the PCA.
Table 3.5. Factor matrix of the PCA.
Factor
1 2 3 4 5 6
Visual
Item 1 .508 .527
Item 2 .465
Item3 .512 .404
Item4 .594
Item5 .613 -.430
Item 6 .649
Item 7 .656
Item 8 .617
Item 9 .473 .409
Auditory
Item 1 .525
Item 2 .479 .432
Item3 .465
Item4 .442 .487
Item5 .599
Item 6 .524
Item 7 .549 .440
Item8 .462 .463
Item9 .535
Item 10 .607
Other
Item 1 .496
Item2 .642
Item3 .611
Item4 .552
Item 5 .626
Item 6 .642
Item 7 .620
Item8 .571
Item 9 .634 -.427
Item 10 .615
All 29 items of the HQ loaded on the first factor, even with the .40 suppression
value (Stevens, 1992). The factor analysis supports the one-dimensional solution of
the hallucination-proneness in the normal population.
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
a:
~
zo
::lE
:::t:o
1--<CU):;=:E
,0)
D. .-WCwan
..J"(1),2
Wc:::t: ..
1-0
a:==
0.8
!.Lo
(I) ....z-o
1=o
::)
a:
I-
(I)
Z
a:g
zo:e
:::t:c
~0:;=1:
,0)
D. .-
WC
wit)
..J ..
(1),2
Wc:::t: ..
1-0
a:==
0.8
!.Lo
(I):;:;zo
1=o
::)
~
(I)
~
.....o:!:::
Co
E
Q)
.c-a.t
00- .....(/)E
00_u
(/)
.c:t;
Cl(/)
:J Q)o(/)
C :J
Q)C'IS
_U
.c:!:::
Cl_
'';::::;C'IS
.c
Q)-
.0-s:
"0.2>--:JO
O(/).c_
(/)O
a.C
C'IS-.....:J_ .0
(/)0
Q).S
.c -
I-:§
~~
Cl
.5:c
.0
~.....
.9'co
E
Q)s:-a.o- .(/)t::
00_ .....
.cE
00
:J U
o.~
c"O
Q) (/)
-Q)..c(/)
.2> :J
-C'IS
Q)U
.o.t:=
"0-
-C'IS
:J..c
0-
..c-(/)..c
a..2>
C'IS-.....0
1i)(/)
Q)o
..cc
1--
.:J
,.....0
llij:
.....Ie.!)
Q)a::
.cQ)
-..c
c-
O Co
E c
0 .....
~ ~
Q) Q)
.0.0
"0"0
:J'S
00
..c..c
(/)(/)
:>.
C'IS
"0
C'IS
~
:Jo
..c
V
C\I
c
~
.9
.~.....
.9'co
E
(/):c
I-
M
~
"0
C'IS
~
:Jo
..c
V
C\I
C
~
o-.~
.....o-'co
E
.~s:
I-
M
(/)
Q)
:;:::.s:
~
"ffi
Eoc
"ffi
"0c
C'IS.....
~.c
(/)
oc
''::
:J
'0
C.....
~
Q)
.0
>-
C'IS
E
(/)
Q)
~.s:
t5
C'IS
C'IS
Eo
C
"ffi
"0
C
C'IS
.....
~
.c
(/)
Cl
C
''::
:J
"0
C.....
~
Q)
.0
>-
C'IS
E
cco
~o
I-
Cl)
W>
Z
o
I-
Cl)
W
e.!)«a..
.....I
.....I«
Z
a::
::)
tu
a::
o
I-
w
a::
::)
Cl)
W
III
cco
~o
I-
CJ)
W>Z
~
Cl)
Wo
~
.....I
.....I«
Za:
:::::>
tu
a::
~
w
a::
::)
Cl)
W
III
Appendix 20. Sleep Diary.
Date
Time woke/woken?
Time got up?
Did you feel tired at any
time today? When and for
how long?
Time of breakfast (B), B:
lunch (L) and dinner (T) L:
D:
What did you do in the
hour before bed?
Time to bed?
Time to sleep?
What happened in
between going to bed and
falling asleep? Please
describe what you did
once in bed. If you had
difficulty falling asleep
please say why (if known)
and what strategies you
used (if any) to try and fall
asleep.
Time and length of any
wakes during the night?
Please describe why you
woke (if known) and what
you did to try and get back
to sleep again.
Anything else of
importance?
Hallucinations -
what time?
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Appendix 21. Coping Strategies Questionnaire for Hallucinating PD Patients.
COPING STRATEGIES
People have many ways of coping with the images they see and stress that
they put them under. We would like to find out more about your response to
the images and how you perceive them. First are some general questions
you might like to consider:
How stressful has the last month been for you?
Very stressful Moderately stressful Slightly stressful Not at all stressful
o 0 0 0
Did you worry about the images in the last month?
Most of the time
o
A lot of the time Some of the time None of the time
o 0 0
And now on the following pages is a list of different methods for coping.
Think about how you have coped with the images you see in the past and
circle how often you have used each method described. No one uses all the
ways of coping described, but most people use some of them.
Very Some- Not
often Often times at all
I try breathing slowly and deeply to cope
with anxiety because of the images. 4 3 2 1
I stand back to get the seriousness of 4 3 2 1
images into proportion.
I practice relaxation. 4 3 2 1
I try to see if my thoughts about the images
were unduly pessimistic. 4 3 2 1
I discuss my fears about the images with
someone close to you. 4 3 2 1
I take positive action to solve a problem 4 3 2 1
related to the images.
I cope with the images by talking myself 4 3 2 1
through it.
I concentrate my efforts on doing 4 3 2 1
something about it.
I try to come up with a strategy about what 4 3 2 1
to do with the images.
I make a plan of action about the images. 4 3 2 1
I think hard about what steps to take. 4 3 2 1
I think about how I might best handle the 4 3 2 1
images.
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I put aside other activities in order to
concentrate on the images. 4 3 2 1
I focus on dealing with my images, and if
necessary let other things slide a little. 4 3 2 1
I ask people who have had similar 4 3 2 1
experiences what they do.
I try to get advice from someone about 4 3 2 1
what to do.
I talk to someone to find out more about
the nature of the images. 4 3 2 1
I talk to someone who could do something
concrete about the images I see. 4 3 2 1
I talk to someone about how I feel. 4 3 2 1
I get sympathy and understanding from 4 3 2 1
someone.
I look for something good in what is 4 3 2 1
happening.
I have learnt to live with it. 4 3 2 1
I accept that this has happened and that it 4 3 2 1
can't be changed.
I get used to the idea that the images 4 3 2 1
come and go.
I seek God's help. 4 3 2 1
I put my trust in God. 4 3 2 1
I get upset by the images and let my 4 3 2 1
emotions out.
I feel a lot of emotional distress because of 4 3 2 1
the images I see.
I get upset because of the images I see,
and am really aware of it. 4 3 2 1
I say to myself: "These images are not 4 3 2 1
real"
Sometimes I sit back and enjoy the images 4 3 2 1
in front of me
I admit to myself that I can't deal with the 4 3 2 1
images, and quit trying.
I would be willing to take medications that
would make the images disappear. 4 3 2 1
I reduce the amount of effort I'm putting
into making the images go away. 4 3 2 1
I look forward to seeing the images. 4 3 2 1
I feel like I have no control over the images. 4 3 2 1
I feel like the others do not understand how
it is to see the images. 4 3 2 1
The images seem like an undeserved 4 3 2 1
punishment.
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The images have somehow made me 4 3 2 1
more humble.
I try to make the best of life despite the 4 3 2 1
images.
I make jokes about the images I see with 4 3 2 1
my friends/family.
I am doing fewer social activities because 4 3 2 1
of my images.
I can laugh and see the funny side of 4 3 2 1
things.
I restrain myself from doing anything about
the images too quickly. 4 3 2 1
I gain comfort from seeing the images. 4 3 2 1
Seeing the images does not prevent me
from enjoying the things I used to enjoy 4 3 2 1
Can you make the images appear? Yes No
0 0
If "Yes", please describe how:
In order for the images to go away, have you ever tried:
Yes No Tried, but were not useful
- to look directly at the image 0 0 0
- to look away from the image 0 0 0
- to turn on the lights 0 0 0
- to turn the lights off 0 0 0
- to try to touch the images 0 0 0
- to persuade yourself the images
are not really there 0 0 0
- just waiting for the images
to disappear 0 0 0
Could you think of any other useful ways that you could make the images go
away (please describe as detailed as possible):
*** Thank you for answering the questionnaire ***
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